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ABSTRACT
This thesis looks at changes in joint laxity associated with the menstrual cycle,
pregnancy, and the menopause and the potential contribution of female
hormones to that laxity.
A pilot study revealed that there was a potential link between the phases of
the menstrual cycle and the onset of musculo-skeletal injury.
Following an extensive literature search studying the various hormones
involved in the menstrual cycle, and their receptors in musculo-skeletal
tissues, an interesting picture emerged that appeared to support the evidence
evinced in the pilot study. This was particularly so with regard to papers that
attempted to show a link between athletic injury and the phases of the
menstrual cycle.
Four experiments were designed using a Hyperextensometer capable of
examining the range of movement in the first metacarpo-phalangeal joint of
the subject's dominant hand. Women with a normal menstrual cycle, pregnant
women, breast feeding women, and women after the menopause, were all
examined to discover if their hormones had an effect on the mobility of the
joint concerned.
-The results of the menstrual cycle study showed that every subject underwent
, an increase in laxity as she progressed throughout the cycle, and that change
was particularly significant in the first phase of the cycle. The pregnancy study
showed that once again all subjects measured showed an increase in joint
laxity as the pregnancy progressed, however this laxity change was neither
,
uniform throughout the pregnancy nor the same from one subject to another.
The majority of subjects however experienced an increase in laxity in the
middle months of their pregnancies. The study found that when comparing
prima parous to multiparous subjects the primaparous group changed earlier.
The post natal study looked at changes in laxity that took place in breast
versus bottle feeding mothers. It failed to draw any significant conclusions
from the data. Finally the menopause study showed that women who take a
hormone replacement retain joint laxity more than a control group.
The implications of these findings were discussed.
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Introduction
"Structure governs function" is a key tenet in osteopathic philosophy.
According to Stone this is better written as: "motion relates to physiology"
(Stone 1999) .
G.R.E.N.RJ.M.
Growth
Reproduction
Excretion
Nutrition
Respiration
Irritability
Movement
These are the characteristics of biological life. Every living thing, and every
cell within every living thing possesses and displays these characteristics, and
no one of them is any more important to life than any other. However, the
presence or absence of motion is often used as a defining characteristic
within medicine, as for example when a paediatrician uses the APGAR score.
when a child is born. He assesses the heart rate via the pulse, the breathing
rate and effort via motion in the chest, and the degree of activity or motion in
the child in generaL, together with the child's muscle tone. All of these factors
..
use motion as an indicator of normality in that child.
We understand death to be the ultimate absence of motion at a macro and a
micro level.
2
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The process of autoregulation ensures that the organism minimises cell
damage by allowing motion only within pre-set physiological parameters.
Using the example of a synovial joint, quality and quantity of motion are
governed by the shape, plane, and integrity of the articular surfaces. The joint
capsule and the intra- and extra-articular ligaments are designed to limit
motion at the end of the joint's normal physiological range. The skeletal
muscles and their accompanying tendons guide motion and control the speed
of motion as well as providing postural stability and control. The force, speed
and direction of pull of the muscles all contribute to the control of motion. The
central nervous system controls the whole, relating the postural and
proprioceptive functions to the body's desire for motion. All of these factors
are controlled by a remarkable system of hormones, enzymes, and other
.
biological and psychological factors which contribute towards motion control.
The qualitative assessment of motion can be further sub-divided into three
categories: hypo mobility, normal mobility, and hypermobility.
This thesis looks at one of the factors that may be responsible for changing
and governing motion control in a specific selected joint in female subjects.
During more than 25 years of osteopathic clinical practice the author has
netlced that some women, particularly during their reproductive years, have a
tendency to musculo-skeletal instability. Often a relatively minor trauma will
.
produce an unexpected and painful reaction in the musculo-skeletal system
"'that [s apparently out of all proportion to the magnitude of the trauma. For
example, she may bend down to pick up a book, and her low lumbar muscles
will go into spasm. At other times she is able to lift, bend, and carry shopping .
3
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with little effect. The trauma rarely produces long-lasting or serious damage;
usually it is simply a spinal apophyseal joint overstrain, or a simple painful but
short-lived muscle spasm. Often, if it is a chronic condition, she hurts the site
of an old injury, rarely initiating a new problem.
The fact that many of these patients were female and these incidences
occurred during their reproductive years led the author to seek a potential link
between these facts. Was there a relationship between the incidence of pain
and the phases of her menstrual cycle? On an anecdotal level, some women
report that they suffer musculo-skeletal pain when they are at mid-cycle or
when they are pre-menstruaL, but there is little evidence to date to suggest
that this might be linked to a change in mobility in the articular system.
The thesis begins with a pilot study investigating the incidence of acute
chronic and recurrent musculo-skeletal pain during the different phases of the
menstrual cycle as seen in osteopathic practices in the United Kingdom.
This led on to a series of studies investigating laxity at different stages in the
female life cycle. The first study involved women who had an accurate and.
predictable menstrual cycle, the second study investigated women during
pr:egnancy, the third study investigated laxity in women who were lactating,
and the fourth study investigated women after the menopause.
"The results of these studies and the conclusions drawn are then critically
reviewed.
4
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Aims of the thesis
The main aim of the thesis is to investigate joint mobility in women. At
different times within a woman's life for, example during the menstrual cycle,
or during pregnancy, the profile of the sex hormones such as oestrogen and
progesterone in her blood will change according to physiological limits. The
hypothesis is that these sex hormones have a potential effect on the tissues
regulating mobility in the articular system and, that the mobility of the joints
has the potential to change during the various phases of a woman's
reproductive life.
Subsidiary aims of the-thests
The first subsidiary aim of the thesis is to investigate musculo-skeletal pain
incidence during the menstrual cycle, the timing of the onset of pain in relation
to the days of the cycle, and the chronicity of that pain as seen in patients
presenting for treatment in osteopathic practices throughout the United~
Kingdom. The hypothesis is that women report musculo- skeletal pain at
specflc points in the menstrual cycle with greater frequency than at other
times and this is related in some way to the phases of the cycle.
The second subsidiary aim of the thesis is to carry out a series of experiments
on women during different phases of reproductive life to investigate mobility at
,
the first metacarpo-phalangeal joint of the subject's dominant hand. The
5
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hypothesis is that joint mobility can change under the influence of the sex
hormones, and that as the levels of these hormones change during the
different phases of her reproductive life, therefore potentially so does her
mobility.
If the women do report pain with greater frequency at different phases of the
menstrual cycle, is this then related to changes in joint mobility itself governed
and affected by changes in the levels of the circulating sex hormones?
6
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Chapter One:
The Pilot Study
7
Chapter One: The pilot study
Introduction
A pilot study was undertaken to explore the potential links between the
menstrual cycle and musculo-skeletal pain patterns reported in
osteopathic practices in the UK. Three preliminary surveys were
distributed, reviewed, and modified over a six month period. Patients
were drawn from the author's private practice. The purpose of this
preliminary work was to refine the questions used in the main survey
itself.
It was found from the preliminary surveys that one factor that seemed to
be consistent amongst these women was the phase of the menstrual
cycle at the time of the injury. Because of these findings, a much larger
sample group from all around the UK was studied to investigate the
potential association between the phases of the menstrual cycle and the
incidence of musculo-skeletal pain or injury.
Literature Review
A review of the literature using the current Medline database, the National
Library of Medicine database and OVID online, showed that pain
thresholds change i'1 relation to the phases of the menstrual cycle ...
Neurotransmitters and neuropeptides of the central nervous system can
"
also be affected by the changes in levels of the sex hormones. The
, review, then studied incidence of athletic injury and in female athletes,
8
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because this would also be relevant when looking at pain incidences and
the menstrual cycle as found in osteopathic practice.
Pain thresholds have been found to change at different times within the
menstrual cycle. In menstruating women, pain thresholds are highest in
the mid-menstrual phase, and in those women who take oral
contraceptives, pain thresholds were highest at the pre- and mid-
menstrual phases (Rao et al., 1987).
The menstrual cycle can also modify the number of tender points noted
on palpation in patients who suffer from fibromyalgia. The number of
tender points was greater in the follicular phase of the cycle, as compared
to the luteal phase in women who were not using oral contraceptives
(Hapidou et al., 1998).
Patients who suffer from pain in the muscles of mastication have also
been studied to see if the ovarian hormones have a part to play in their
pain thresholds. The conclusion here was that the pain thresholds are
influenced by the ovarian cycle, but only to a minor extent (Cimino et al.,
2000).
Temporomandibular joint pain rises towards the end of the cycle and
peaks during menstruation when compared with the control groups and
with males (Le Resche et al., 2003).
It has been postulated that the effect on pain thresholds may be due to an
"
effect of the sex hormones on the central nervous system (CNS).
, Oestradiol, progesterone and some of their metabolites modulate the
activity of neurotransmitters and neuropeptides in the CNS (Kuhl, 2002).
9
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The distribution and concentration of sex steroids in the various eNS
regions is partly dependant on the serum levels, but also on the local
synthesis of the steroids. In general oestradiol and testosterone exert a
stimulatory effect, and progesterone an inhibitory effect, on neuronal
activities which are mediated by excitatory and inhibitory amino acids and
neuropeptides. Somatic complaints such as back pain and abdominal
pain are highest before and during menstruation and have been found to
be associated with a lowered pain threshold due to a fall in beta
endorphins within the central nervous system (Straneva et al., 2002).
It is not just pain thresholds in general that can change but also the
thresholds of different types of pain. Pressure pain thresholds, pinch pain
thresholds, heat pain thresholds and tactile thresholds will vary between
the sexes, and they also vary in different phases of the cycle and from
woman to woman (Bajai et al., 2001).
Thus it has been demonstrated that women will report different levels of
pain at various phases of the menstrual cycle.This is probably due to the
effect of the changing levels of sex hormones on the part of the central
nervous system responsible for reporting these different sensitivities
(Straneva et al., 2002).
There have been studies investigating the use of oral contraceptives and
musculoskeletal pain. Oral contraceptives cause attenuated muscle
soreness in subjects performing an exhaustive stepping activity in the
laboratory when compared to a control group (Thompson et aI., 1997).
Women using the oral contraceptive had a lower rate of injuries
10
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compared to women who were not using them The authors believed that
the results were explained by the observation that oral contraceptives
ameliorate some symptoms of the premenstrual and menstrual phases of
the cycle which might also affect coordination and hence the risk of injury
(Moller-Nielsen and Hammar, 1989).
In the study on patients with temporomandibular pain referred to above,
women using oral contraceptives were compared to those not using "the
pill" and they both showed an increase in pain in the menstrual phase
compared to control groups; however, the "non pill" users also showed a
second peak of pain around days 13-15 (Le Resche et al., 2003). It is
significant that this is the ovulatory phase when the levels of oestrogen
rise to a peak before falling thus allowing the pre-ovulatory surge of
lutenising hormone.
Athletic injury and the menstrual cycle
With the participation of women in athletics growing rapidly over the last
two decades, a disturbing gender specific pre-disposition has emerged
regarding anterior eructate ligament (ACL) injuries. (Arendt, 1995;
Siauterbeck, 1995; Teitz, 1997; Wojtys, 1998; Hewett, 2000; Siauterbeck,
2001 ;Toth ,2001; Arendt, 2002; Siauterbeck, 2002). Female athletes
,have a two to eight-fold higher incidence of ACL injury then their male
counterparts (Toth a-ndCordasco, 2001). It has been estimated that
11
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80,000 women will sustain ACL tears per year ( Arendt, 2001; Arendt et
al., 2002,). The majority of these injuries occur by non-contact
mechanisms, most often during landing from a jump or making a lateral
pivot whilst running.
The risk factors for these types of injury may be categorised as intrinsic
(anatomical. histological. biochemical. and hormonal) or extrinsic
(environmental or biomechanical).
The level of female sex hormones oestrogen, progesterone and relaxin
fluctuate physiologically during the menstrual cycle and are reported to
increase ligamentous laxity; thus they are a possible cause of decreases
in both passive and active knee instability in female athletes ( Siauterbeck
and Hardy, 2001; Deie et al., 2002; Siauterbeck et al., 2002).It is
therefore appropriate to consider whether there is a relationship between
the phases of the cycle when assessing mechanisms of ACL injuries in
female athletes (Wojtys et al., 2002).
Target cells for oestrogen and progesterone were first identified in the
fibroblasts of the human ACL as early as 1996 (Liu et al., 1996). This
study, using immunohistochemical techniques, localised both oestrogen
and progesterone receptors in a series of tissues from both male and
female human subjects. All ligament specimens were obtained at surgery.
Both oestrogen and progesterone receptors were localised to..
synoviocytes in the synovial lining of the knee joints fibroblasts in the ACL
d
stroma, and cells in the blood vessel walls supplying the knee joints,
,sugge~ting that female sex hormones have an effect on the structure and
composition of these tissues.
12
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In 1998, a more sophisticated method of reverse transcription-
polymerase chain reaction was used to evaluate the expression of
oestrogen and progesterone receptors in ligament tissues from male and
female rabbits and male and female humans. The presence of these
receptors in the knee ligaments were found in significant numbers, with
female subjects having a proportionally larger volume of receptors when
compared to males (Sciore et al., 1998).
Relaxin receptors were finally identified in the human ACL in 2003
(Dragoo et al., 2003).
Remnants of ACL were harvested from men and women undergoing
routine ligament reconstruction. Relaxin was biotinylated [Biotinylation: A
technique whereby biotinyl groups are incorporated into a molecule in
vitro to visualise specific substrates by incubating them with biotin
labelled probes] and bioassayed for biological activity with the use of the
mouse inter-pubic ·ligament. Samples from the women but not from the
men showed uniform specific binding that was limited to synovial lining
cells, stromal fibroblasts and cells lining blood vessels. These results
indicate that relaxin exhibits specific binding in the female anterior
cruciate ligament and again seem to support the hypothesis that sex
hormones have a part to play in the rupture of these ligaments in female.....
athletes because the presence of relaxin receptors allows the hormone to
"
weaken the ligament (Dragoo et al., 2003).
13
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Thus a greater proportion of receptors for oestrogen, progesterone and
relaxin all exist within the ACL in females than males (Sciore et al., 1998).
A number of studies have looked into the effect of sex hormones within
the phases of the menstrual cycle, specifically on fibroblast proliferation
and pro-collagen levels, as an indicator of collagen synthesis (Liu et al.,
1997; Yu et al., 1999; Rasanen and Messner, 2000; Yu et al., 2001).
Collagen synthesis was found to be significantly reduced with increasing
oestradiol concentration. On days 1 and 3 of the menstrual cycle, there
was a dose-dependent decrease in the proliferation of ACL fibroblasts
with increasing oestradiol concentrations. This dose-dependent effect of
decreased fibroblast proliferation with increasing oestradiol concentration
became less apparent at 7, 10, and 14 days. On days 1 and 3 pro-
collagen synthesis decreased in a dose-dependent manner with
increasing oestradiol concentrations. This decrease contributes to the
great increase in joint laxity observed during the first phase of the cycle.
On days 7, 10, and 14, this dose-dependent effect was attenuated as the
concentrations of oestradiol increased. An increase in fibroblast
proliferation and pro-collagen type 1 synthesis was observed with
increasing progesterone concentration. However, the effect was more
pronounced at lower oestrogen concentrations, suggesting that oestrogen
levels were the dominant factor (Liu et al., 1997; Yu et al., 1999).
Pregnancy is one time when ligaments change under the influence of sex
'hormones such as relaxin and oestrogen. Two studies have looked at the
"
ACL specifically during pregnancy (Blecher and Richmond,1998; Charlton·
14
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et aI., 2001), and the results support the hypothesis. The first study noted
that substantial remodelling from large diameter to small diameter
collagen fibres occurred in the ACL graft ligament in a woman who had
undergone ACL reconstruction two months before conception. The
authors considered this was due to the relaxin levels, but did not appear
to correlate this with any blood analysis for the hormone. The second
study was more specific and looked at both ACL translation as measured
using a specific arthrometer test, and then correlated these
measurements with oestradiol levels during the third trimester of the
pregnancy and the post-partum period. The results showed that high
serum oestradiol levels during the third trimester of pregnancy correlate
with increased anterior tibial translation and that this anterior tibial
translation decreases with the return of the serum oestradiol to non
pregnant levels.
Not all authors agree with these conclusions.
In a study in 2002'by Arnold et al., using an arthrometer, knee joint laxity
was measured in 57 female athletes and 5 men in a 4-week period.
Analysis of variance of the mean readings between the groups revealed a
significant change in weekly serum relaxin levels, but not in anterior knee
translation. Regression analysis also failed to find a relationship between
tt:]e variables. Therefore they concluded that relaxin does not have an
'"
effect on knee laxity (Arnold et aI., 2002). Although the presence of sex
"
hormones, particularly oestrogen, may predispose female athletes to
'higher ,injury rates, they did not find the higher injury rates correlated with
<C
changes in ACL laxity.
15
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Other researchers, (Wojtys et al., 1998; Arendt et al., 2002; Wojtys et al.,
2002), have different conclusions regarding the relevance of non-contact
ACL injuries and the timing of the cycle.
To summarise, there appears to be abundant but contradictory evidence
to suggest that the cyclic sex hormones may have a part to play in
determining at which point in the menstrual cycle women might present
with pain to osteopathic practices.
In order to examine these hypotheses further, a study was undertaken
researching into the pain presentation patterns of women presenting to
osteopathic practices in the UK.
Method
A simple questionnaire was designed, piloted, and amended three times
between 1993 and 1994, before the final version was felt ready to be
qlstnouted. The subjects for this preliminary work all came from the
author's private practice. Five hundred practitioners were chosen at
" random by polling one practitioner in three from the register of The
General Council and Register of Osteopaths. Each practitioner was sent
two copies of the questionnaire,and asked to complete them for the next
K
two female patients of menstruating age presenting to the practice with
musculo-skeletal pain. Each patient taking part in the study was given an
information sheet (see appendix) and given the opportunity to withdraw
16
Chapter One: The pilot study
from the study if they did not wish to take part. Ethical approval for the
study was obtained from the Ethics Committee of The British School of
Osteopathy.
The Questionnaire
1. The age of the patient
2. The length of the menstrual cycle
3. Present problem (please tick the predominant complaint)
Low-back pain
Sacra-Iliac or Pelvic joint pain
Cervical spine pain
Peripheral joint pain
Other pain (please specify)
4. Chronicity of the pain (please tick one of the following)
Acute onset
Chronic pain
Recurrent acute onset
5. When did the pain start in relation to the last menstrual cycle (i.e.
Vl!henwas the last period in relation to the pain.)
Comments on the questionnaire:
17
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Instructions to practitioners included the following points of additional
information designed assist them in their participation in the study.
Question 2: The length of the menstrual cycle
If the subject admitted to not having a regular cycle, as defined by her,
she was excluded from the study and the osteopath was asked to find
another subject. Subjects were also excluded if they were using any
hormone preparations such as Hormone Replacement Therapy (HRT),
an oral contraceptive, or hormone implants as it was thought that the
menstrual cycles of these subjects were not under the control of a natural
hormone profile.
The length of the cycle and the predictability of a regular cycle were
deemed to be very important to the outcome of the study. In a regular
menstrual cycle of 28 days, ovulation occurs in the middle of the cycle.
The luteal phase of the cycle is fixed and constant so that 14 days after
ovulation menstruation will occur (Johnson et al., 1994). Therefore the
relationship of pain to the cycle can only be accurately ascertained if only
those women with a predictable and regular cycle are included in the
study.
For Question 4: Chronicity of pain
1'his question is particularly important when looking at incidences of
acute chronic or recurrent acute pain. Is the character of the pain related
"
to one particular phase of the cycle?
For Question 5: When did the pain start in relation to the menstrual cycle? .
18
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This was not thought to be an easy question to answer in every case so
the osteopath was advised to apply the following formula.
"Determine where she is now in her cycle, and subtract the number of
days she has had pain in order to calculate the day that pain started in
her cycle".
I.e. if she has had 9 days of pain, and she is on day 6 of her menstrual
cycle counting the first day of bleeding as day one, then the pain occurred
on day 25 of a 28-day cycle.
The Hypotheses
.
The experimental hypothesis states that there is a relation between the
incidence of pain and specific days of the menstrual cycle. The null
hypothesis states that pain is equally likely to occur randomly within the
menstrual cycle.
The second experimental hypothesis states that there is an increased risk
a! specific points within the cycle of specific sites of pain such as low-
back pain, cervical spine pain, upper extremity, and lower extremity pain.
, The second null hypothesis is that these specific sites of pain are
independent of specific days within the cycle and are just as likely to
occur at one time within the cycle as at any other.
,
The third experimental hypothesis states that the chronicity of pain
occurrlnq within the menstrual cycle is again related to specific dates
within the menstrual cycle. The null hypothesis is that acute chronic and
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recurrent pain is just as likely to occur at one point within the cycle as at
any other.
Results and statistical analysis
Altogether 304 responses were received out of the 1,000 questionnaires
sent out and the mean age of the responders was 34 (± SO 7.43) years.
One was rejected for further analysis as it referred to day 36 of a
subject's menstrual cycle. The other 303 incidents were divided into five
categories:
Table 1: Area of Pain and Incidences
Area of Pain Incidences
Low-back 109
Cervical Spine 67
Upper Extremity 25
Lower Extrem ity 28
<
Other Pains 74
The category "other pain" included responses indicating sacro-iliac joint
pain and buttock pain. It was felt that there was not sufficient scope in the
questionnaire to justify including these as either a separate category or
combined with the low-back pain category.
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Analysis of "All Pain"
Figure 1 shows the frequency of incidence of all pains being reported in
each three-day time band starting from day one of the subject's menstrual
cycle. This was the first day of menstrual bleeding.
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Figure 1: The Frequency of "All Pain" in the menstrual cycle (n=303)
These results illustrate that a higher frequency of pain was reported
around days 12-14 and days 21-23 and 24-26.
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Figure 2: The percentage occurrence of "All Pain" in the menstrual cycle (n=303)
As shown in figure 2 these frequencies represented 21.05% 12.83% and
17.11% of the totals recorded respectively. At other times in the cycle
this did not exceed 8% except for days 0-3 where the peak was around
9.54%
Using a Chi2 test on the data (Chi2 = 111.018, df= 10) the results were
.found to be significant (p<0.001). This shows that there is a relationship
between the day of the menstrual cycle and the onset of pain. Hence the..
,
null hypothesis that pain is likely to occur with the same frequency
anywhere in the cycle can be rejected.
The results were then analysed to determine if specific sites of pain were
associated with the days of pain onset during the menstrual cycle.
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Analysis of Low-back Pain
Figure 3 shows the frequency of incidence of low-back pain alone being
reported in each three-day time band starting from day one of the
subject's menstrual cycle, the first day of menstrual bleeding.
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Figure 3: Incidence of "Low-back Pain "as displayed with "All pain" in the menstrual cycle
(n=109). •
These results illustrate that a higher frequency of incidences were
reported around days 12-14, days 21 to 23 and days 24-26.
Figure 4: The percentages of "Low-back Pain "incidence in the menstrual cycle (n=109).
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Figure 4 shows that 27.93% of incidences of lumbar spine pain were
reported between days 12-14,13.51% between days 21-23, and 17.12%
between days 24-26%. All other days failed to record 10% of the total
incidences.
Using a Chi2 test on the data (Chi2 = 35.914, df= 10) the results were
found to be significant (p<0.001). This shows that the null hypothesis that
low-back pain is likely to occur with the same frequency anywhere in the
cycle can be rejected.
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Analysis of Cervical Spine Pain
Figure 5 shows the frequency of incidence in relation to cervical spine
pain alone occurring in each three-day time band starting from day one of
the subject's menstrual cycle.
Figure 6 shows that 17.65% of incidences of cervical spine pain were
reported between days 12-14,13.51% between days 21-23 and 14.71%
between days 24-26. At the start of the cycle during the menstrual phase,
incidences of 11.78 % were reported for days 0-2 and 11.76% for days 3-
5; this fell to less than 5% -during days 6-8 only to rise again in the pre
ovulatory phase. The number of reported incidences then fell in the early
luteal phases but not as sharply as in the low-back pain group. They then
rose to the secondary peak as the cycle approached days 24-26.
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Figure 5: Incidence of "Cervical Spine Pain" as displayed with "All pain" in the menstrual
cycle (n=67).
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These results demonstrate that a higher frequency of incidences were
reported around days 12-14, days 21 to 23 and days 24-26 .
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Figure 6: Percentage of "Cervical Spine Pain" incidence in the menstrual cycle (n=67)
Using a Chi2 test on the data (Chi2 = 87.263, df= 10) the results were
found to be significant (p<0.001). This shows that the null hypothesis that
cervical pain is likely to occur with the same frequency anywhere in the
cycle can be rejected.
Analysis of Upper Extremity Pain
.Figure 7 shows the frequency incidence of Upper Extremity pain in each
of the three day time bands starting from day one of the subject's..
menstrual cycle.
It shows that the incidence of pain reported arising from the upper
extrernities was not h!gh amongst the subjects reporting pain. When it
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was there it was found mainly in the second half of the cycle, peaking in
frequency between days 12-14.
Figure 8 shows the greatest percentage of upper extremity pain was
between days 12-14 with 36% being reported. This fell to 16% between
days 15-17 and to 8% between days 18-20 rising briefly to 16% again
between days 21-23 before falling away to zero as the menstrual phase
of the cycle approached.
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Figure 7: Incidence of "Upper Extremity Pain" as displayed with "All Pain" in the
menstrual cycle (n=2S).
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F'igure 8: f>ercentage of "Upper Extremity Pain" incidence in the menstrual cycle (n=2S).
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Using a Chi2 test on the data (Chi2 =6.13, df=10) the results were found
not to be significant (p>0.05). This suggests that in the upper extremity,
pain unlikely to occur at anyone specific time in the cycle compared to
any other time in the cycle. This null hypothesis cannot be rejected.
Analysis of Lower Extremity pain
Figure 9 shows the frequency incidence of lower extremity pain occurring
in each three-day time band starting from day one of the subject's
menstrual cycle.
It shows that there was not a high reported frequency of lower extremity
pain occurring in the menstrual cycle. When it was present it was mainly
in the last third of the cycle.
Figure 10 shows that the greatest percentage of incidences of lower
extremity pain were reported between days 21-23,24-26, and 27-29 with
17.86% of incidences being reported in each band. 10.1% of incidences
of-lower extremity pain were reported in days 3-5 and days 12-14.
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menstrual cycle (n=2S).
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Figure 10: Percentage of lower extremity pain incidence in the menstrual cycle (n=2S).
Using a Chi2 test on the data (Chi2 = 5.56, df= 10) the results were found
not to be significant (p>0:05). This suggests that as was the case with the
upper extremity, pain in the lower extremity is unlikely to occur at anyone
specific time in the cycle compared to any other time in the cycle. The null
hypothesis cannot be rejected
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Analysis of Other Pain
Figure 11 shows the frequency incidence of other pains being reported in
each three-day time band starting from day one of the subject's menstrual
cycle.
This shows that the incidence of other pains was nearly evenly distributed
across the menstrual cycle with small peaks of frequency occurrence
occurring between days 3-5,24-26 and 27-29.
Figure 12 shows that the greatest percentage of incidences of other pain
was reported between days 27-29 with 19.74%. Days 3-5 and days 24-26
had incidences of 13.16% respectively. The rest of the incidences being
reported for other pain faited to rise above 10%; however they were
evenly spread throughout the month with the exception of days 0-2 where
no incidences were reported.
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Figure 11: Incidence of "Other Pain" in the menstrual cycle as displayed with "All Pain"
(n=74).
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Figure 12: Percentage of "Other Pain" incidence in the menstrual cycle (n=74).
Using a Chi2 test on the data (Chi2 = 58.291, df= 10) the results were
found to be significant (p<0.001). This shows that the null hypothesis that
other pain is likely to occur with the same frequency anywhere in the
cycle can be rejected.
Table 2: The Chi2 and p values for site of pain
Chi" P df
All pain 111.018 <0.001 10
Low-back pain 35.914 <0.001 10
,
Cervical spine pain 87.263 <0.001 10
Upper extremity 6.13 >0.05 10
pain
L:ower Extremity 5.56 >0.05 10
,
pain
Other pain 58.291 <0.001 10
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The Analysis of the Chronicity of the pain
In order to demonstrate the responses to the questions relating to the
character of the pain in the menstrual cycle, bar charts were plotted for
each of the three categories in the questionnaire relating to chronicity of
pain, acute chronic and recurrent, as found in the results from the
questionnaire.
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Figure 13: The Incidence of acute pain in the menstrual cycle
Figures 13, 14, and 15 show that there are specific patterns with regard
,to pain onset within the cycle and the chronicity of pain. Acute pain has
two peaks one relatIng to the mid-cycle at days 12-14 and one to days
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24-26, with incidences of 20% and 22% respectively. The other phases of
the cycle did not have incidences that rose above 10%.
The chronic pain figure shows a peak only at days 12-14, but it was a
high peak of nearly 40% incidence. The level of incidence in the rest of
the cycle for chronic pain did not rise above 15%.
40.0%
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day of pain onset
The recurrent pain figure shows a high peak at days 21-23 with an
Figure 14: The incidence of chronic pain in the menstrual cycle
~ncidence of 18%, but also peaks at 0-2 days 12-14 days and 24-26 days
with incidences between 10% and 15% for each peak.
_,
Thus it appears that the ovulatory phase of the cycle occurring between
, days 1,2-14 showed a peak in incidence for each category of chronicity,
.'
but particularly in regard to chronic pain.
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Recurrent pain showed a number of peaks of incidence including the
Figure 15: The incidence of recurrent pain in the menstrual cycle
ovulatory phase but pain did appear to be spread more throughout the
cycle than either acute or chronic pain alone. The premenstrual phase of
the cycle between days 24-26 showed peaks of incidence for each
category of pain.
Table 3: The Chi2 and p values for chronicity of the pain
. Chi~ P df- ,
Acute Pain 56.827 <0.001 10
Chronic Pain 88.579 <0.001 10
Recurrent 40.570 <0.001 10,
Pain "
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Using Chi2 tests on the data, the results were found to be significant at
p<O.001 for each case. This suggests that the null hypothesis which
states that chronicity of pain is not associated with the days of the cycle
can be rejected.
Discussion and Conclusions
The study revealed some relevant associations relating to injury
incidence and cycle phase. However, it was not without limitations and
this may be reflected in the results. The practitioners concerned may
have introduced bias in the way that they reported the data and
completed the forms. Did they understand the point of the survey and
could they have unwittingly introduced their bias into the results in order
to agree or disagree with the hypothesis?
The design of the questionnaire was kept specifically brief and simple so
as to isolate the research question. This may have produced a large
•group of "other pains".
A different design of the questionnaire might have separated this group
into smaller categories and thus improved the category response groups
:-by increasing them. It was interesting to learn from the study that the
incidence in cervical spine pain and the incidence of low-back pain were
different.
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The results relating to chronicity of a pain showed that acute, chronic, and
recurrent pains also have different patterns of presentation. The use of a
visual analogue scale, for example, would have given greater objectivity
to this response because the words acute and chronic are subjective, and
not objective terms, which gives a potential imprecision to the responses
received.
If cyclical female hormones have an influence on joint function through
their effects on collagen or skeletal muscle for example, then the question
is posed, 'Why do different tissues respond at different times?" Is it
because of the histological difference of the tissues in the cervical spine
as opposed to the lum~ar spine or pelvis, or are there receptors in
different tissues which respond to specific hormones and which therefore
are clinically significant only at specific times within the cycle?
Furthermore does this have an effect on the chronicity of pain in the
cycle?
• The literature review demonstrated that cyclic female hormones have an
effect at a number of levels including pain thresholds, the changes in the
circulating levels of cyclic female hormones act on the central nervous
~system and on pain transmission mechanisms, and can potentially
influence athletic injuries.
The results of this study show there is a clear relation between pain onset
, in the menstrual cycle and the chronicity of that pain. Even the site of the
pain may differ in each cycle phase.
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Based on these results patients might be advised to avoid anything which
might adversely challenge their musculo-skeletal systems such as
carrying heavy loads or vigorous sports especially if they have a history of
acute, recurrent or chronic musculo-skeletal pain, as the risk of injury
might be higher at these times. They should certainly be advised to note
when injuries occur in the future, and to ascertain if they are in fact
occurring at specific times within the menstrual cycle. This would add
weight to the advice for avoiding injuries that could become repetitive.
The fact that female athletes injure themselves with greater frequency
than their male counterparts has been well reported. Female athletes
have a two to eight-fold higher incidence of ACL injury then their male
counterparts (Toth and. Cordasco, 2001), but the evidence required to
advise female athletes to change their training or the timing of their
events has not been sufficient to date. This study does suggest that
ligamentous laxity during the normal menstrual cycle is another factor to
be considered when understanding the puzzle of the timing of female
athletic injuries. However, it is not simply ligaments alone that contribute
• to joint laxity. Skeletal muscle changes and the potential for skeletal
muscle fatigue might also alter joint laxity if muscle strength varies at
different times in the menstrual cycle or during pregnancy or after the
. menopause.
The next part of the thesis reviews the literature relating to the sex
, hormones and the menstrual cycle as well as their effects on tissues
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remote from the reproductive system; it is proposed to investigate
whether any such changes have a global or simply a local effect
Using the hyperextensometer, laxity was measured on specific days
within the cycle. Blood measurements for the hormones oestrogen,
progesterone, and relaxin were determined to ascertain the potential link
between hormone levels and joint laxity.
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Introduction to the experimental studies
The pilot study demonstrated that there are potential peaks of incidence
of acute musculo-skeletal pain in relation to the menstrual cycle. There
are many possible explanations for this pattern, and the clear association
between the calendar and the onset of pain was thought to be worthy of
further study.
Hormones are capable of affecting the physiology of many body tissues
so long as the tissues concerned have receptors to the hormones
concerned.
The factors that control movement around a synovial joint include skeletal
muscle tissue with all of the associated stretch receptors and Golgi
tendon organs, the tendons themselves, the joint capsule, the ligaments,
the articular cartilage, and the·neuronal pathways responsible for
•proprioception, as well as the brain and higher centres.
The receptors for the sex hormones are located in the nuclei of the target
:tissues. Is the sensitivity of these tissues to the sex hormones capable of
change during the menstrual cycle and thus is the joint laxity likewise
capable of change? Muscular and ligamentous tissues in particular have
, an important role to play in protecting the joints from overstrain and
dislocation at the end of their range. Is there somehow a weakening
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effect of the sex hormones on the tissues concerned and was this in
some way responsible for the pain patterns that emerged during the pilot
study?
In order to investigate the effects of these sex hormones on joint mobility,
a series of studies was designed to investigate the mobility of a single
synovial joint at various stages within a menstruating woman's life, to
ascertain the relationship between these stages and potential changes in
mobility.
A single synovial joint was chosen because if it changed, that change
would potentially be representative of a global change on all body tissues
in relation to the circulat~ng sex hormones, and not just a change within
the pelvis.
The equipment used was the Joint Hyperextensometer first designed by
Jobbins, Bird and Wright in Leeds in 1979. The advantages of this
equipment are that it is light and portable, and according to the authors
'(Jobblns, Bird et al., 1979) it is an accurate and reproducible way of
measuring the range of movement into hyperextension at the carpo-
metacarpal joint of the index finger of the dominant hand. It is a non-
..
invasive procedure that takes less than a minute to use and so was felt
suitable for evaluation with regard to future use",as the instrument of
choice in this series of studies.
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The Hyperextensometer
The Hyperextensometer is a simple piece of apparatus comprising of a
carrier for the index finger of the dominant hand, which is mounted on a
shaft supported in rolling elements which are themselves mounted in
housing. The whole assembly is fastened to a base plate. Velcro tape is
used to secure the first interphalangeal joint of the index finger of the
dominant hand to the carrier in such a way as to align the rotational axis
of the metacarpo-phalangeal (Mep) joint parallel to the axis of the
operating shaft.
Rotation of the joint wa~ caused by manually rotating a knurled knob
which was co-axial with the operating shaft, and which drives the
operating shaft via a clutch mechanism.
This clutch mechanism is of the spring loaded ball detente type and can
be pre -set to slip at a given value of torque. It is capable of applying pre-
•set torque varying between 2.0 and 7.0 kg/cm (0.19 and 0.68 Nm). The
amplitude of rotation of the index finger at the moment of slip was
indicated by a pointer fixed to the operating shaft and in close proximity to
..
a protractor that was fixed to the housing as shown in Figure 16 below.
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Figure 16: The Hyperextensometer from the front
Operation of the Hyperextensometer is straightforward. The subject is
made comfortable with the forearm and hand of the dominant side
supported by the base plate. The axis of rotation of the meta-carpo-
phalangeal ( MCP) joint of the index finger is aligned parallel to the axis of
the operating shaft by the researcher looking from above and from the
side to ensure that the internal angles are 90 degrees and that the axes
of rotation of the operating shaft and the axis of rotation of the MCP are
< correct.
The finger is strapped to the carrier such that there is no movement
:possible from the intermediate phalangeal joint...
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be 90 degrees
All internal angles should
carrier shaft MCP
Axis of rotation of the
Figure 17: Alignment of the subject's hand on the Hyperextensometer
The operator places the flat of his left hand firmly onto the dorsum of the
subject's hand so as to ensure that there should be no movement at the
wrist joint during the measurement. It is essential that the forearm of the
-subject remains in contact with the base plate, and that the internal
angles of 90 degrees as shown in the photograph above, is maintained at
all times. This procedure is designed to obtain the maximum possible
:consistency of the readings and to eliminate a possible source of error.,
The indicating pointers are zeroed, and the knob is rotated counter-
clockwise until a click is heard which resets the clutch mechanism. The
apparatus is now set for measuring. The angles mentioned before are
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checked once again, before the knob is firmly rotated at a constant speed
in one swift movement in a clockwise direction with the operator's right
hand until the pre-set level of torque is reached and the clutch slips.
The whole procedure takes no more than 2 seconds. The amplitude of
rotation is then measured on the protractor scale and recorded. Three
readings are taken and an average of the three is finally recorded as the
measurement taken on the day.
Occasionally one of the readings was found to be very different from the
other two. The difference was assumed to be due to operational error,
and if this was the case the readings were repeated in groups of three
until three consecutive readings enabled a consistent average to be
recorded. This was not a common occurrence, and considering the many
hundreds of readings obtained from the apparatus it was not thought to
influence the accuracy of the overall results.
Validation of the Hyperextensometer
Preliminary studies showed the following to be critical to obtaining reliable
data:-
, The subject had to be sitting and relaxed
"
The elbow had to be bent to 900 and supported
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The forearm had to be parallel with the ground
The axis of the movement of the MCP joint of the index finger had to
coincide with the axis of the machine although minor variations in position
were not critical.
The firm pressure on the rest of the hand and the wrist prevented any
extraneous movement interfering with the measurement of the MCP joint
alone.
In practice it was found that repeat readings in a single individual became
consistent with adherence to these precautions.
In the original paper by Jobbins et al., (1979) it was stated that a torque
on the clutch mechanism of 2.6 kg.cm (0.26 Nm) caused both extremes
of the range of movement observed in a large population studied to fall
within the recording range of the machine. Hence for joint laxity studies
the machine was set at this value.
Jobbins et al., (1979) studied the correlation of the Hyperextensometer
both with the Beighton Ligamentous Laxity Scoring system (LLS), a
standard rheumatology test method in common usage, and a more
complex global score of joint laxity devised by themselves and calculated
-by summating the range of movement measured by goniometer of all the
joints in the body. In a population of 54 indlvlduals, some selected to
demonstrate extreme joint laxity, both correlations were significant, for the
Beighton scale (p<0.001), and for the global index (p<0.001). That
contlrmed that comparisons can be made with the clinical scoring system
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in common use and suggests that, at least in the population tested, laxity
at the Mep joint of the index finger reflects joint laxity in the rest of the
body.
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Introduction
The human menstrual cycle is a series of predictable biochemical and
physical events that occur in sexually mature females approximately
every twenty eight days. The changes in the sex organs and other tissues
are governed by the production of sex hormones, the most significant
being oestrogen, progesterone and relaxin. These hormones have
profound effects on all body tissues including connective tissues. This
thesis examines the effects of cyclic sex hormones in women. The first
experiment investigates the potential links between the events in the
normal menstrual cycle and stability and laxity in a synovial joint. The
underlying premise is that if women are found to hurt themselves during
the menstrual cycle, the incidence of injury is related to the phases of the
cycle and is potentially related to laxity in synovial joints. The logical place
therefore to begin this investigation is with a review of the events that
happen within the menstrual cycle and with a review of the evidence that
might exist linking these events and the factors that control movement at
synovial joints.
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Chemistry Biosynthesis and Metabolism of Oestrogens
There are three naturally occurring oestrogens in significant quantities in
the plasma of human females, J3 oestradiol (E2), oestrone (E1), and
oestriol. The principal oestrogen secreted by the granulosa cells of the
ovarian follicles is J3 oestradiol. Small amounts of oestrone are also
secreted, but most of this is formed in the peripheral tissues from
androgens secreted by the adrenal cortices. A small amount is secreted
by the thecal cells of the corpus luteum.
The oestrogenic potency of J3 oestradiol is 12 times that of oestrone and
80 times that of oestriol (Guyton and Hall, 1996). For this reason J3
oestradiol is considered to be the major oestrogen and therefore the
number of its receptors to be found in tissues is an indicator of how those
tissues are affected in their function by the presence of the hormone.
Oestradiol, oestrone and oestriol are metabolised in the liver, and all
< these compounds along with other metabolites are excreted in the urine.
Appreciable amounts are secreted in the bile and reabsorbed back into
the bloodstream in the enterohepatic circulation.
Figure 18 and Table 4 show the concentration of the hormones in the,
plasma during the menstrual cycle. Almost all of the oestrogen comes
. from the ovary, and there are two peaks in the volume of its production:
one is just before ovulation and one is during the mid-luteal phase. Arter
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menopause, oestrogen secretion declines to very low levels. The volume
of progesterone is highest in the mid-luteal phase of the cycle.
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Figure 18: The hormones of the menstrual cycle.
From Tortura and Grabowski page 1034 9th Edition Published by John Wiley and sons .2000
, Chemistry, Biosynthesis, and Metabolism of Progesterone
Progesterone is secreted by the corpus luteum, the placenta, and (in
small amounts) the "Graafian follicle of the ovary. It is an important
intermediate in steroid biosynthesis in all tissues that secrete steroid
hormones, and small amounts apparently enter the circulation from the
testes and from the adrenal cortex.
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The hormone a hydroxyl progesterone is secreted along with oestrogens
from the ovarian follicle and its secretion is in parallel with that of ~
oestradiol. Two percent of the circulating progesterone is free, whereas
80% is bound to albumin. The remaining 18% is bound to corticosteroid
binding globulin. Progesterone has a short half-life and is converted in the
liver to pregnanediol, which is converted to glucuronic acid and excreted
in the urine (Ganong, 2003).
Table 4: 24 hour production rates of sex steroids in women in different phases of the
menstrual cycle.
Modified and reproduced with permission from Review of Medical Physiology by William F Ganong 21st
Edition; Lange 2003
.
Pre-
Sex Steroids Early Follicular ovulatory Mid-luteal
Progesterone (mg) 1.0 4. 25
17HydroxyProgesterone(Mg) 0.5 4 4
Androstenedione (Mg) 2.6 4.7 3.4
Testosterone (~g) 144 171 126
Oestrone (~g) 50 350 250
Oestradiol(~g) 36 380 250
Oestrogen and progesterone, like all steroids, are small hydrophobic
molecules. Thus they diffuse freely through the plasma membrane of all
cells. However, in target cells, which are cells that change their gene
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expression in response to a hormone, such as those of the endometrium,
they become tightly bound to oestrogen and progesterone receptors. The
complex of receptor and its hormone moves to the nucleus, and there it
binds to a specific hormone response element. These response elements
are specific sequences of DNA, in the promoters of certain genes that are
needed to turn genes on and off. Thus the complex of the hormone and
its receptor forms a transcription factor which is a protein needed to
initiate the transcription of a gene (Kimball, 2004). Receptors for
progesterone are not as widespread as those of oestrogens, and are
usually only to be found in very specific sites.
The presence of progesterone receptors located in the nuclei of smooth
muscle cells in the round ligament was demonstrated in 1993 (Smith et
al., 1993). The authors looked at samples of the round ligament in pre-
and post-menopausal women and analysed them histochemically for
oestrogen and progesterone receptors. They found that the round
ligament was a specific target organ for these hormones. It is unlikely
• therefore that this hormone is going to be actively involved in changes in
peripheral joint laxity within the menstrual cycle by an action on
connective tissue alone. It might well be a partial effect on skeletal
..
- muscle strength but there is a lack of evidence to support this view. The
changes in laxity are more likely to be due to the effects of oestrogen and
relaxin on these tissues.
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Chemistry Biosynthesis and Metabolism of Relaxin
Produced by a range of species, relaxin is a reproductive hormone with a
role in pregnancy (Weiss 1991). The hormone regulates the growth and
remodelling of reproductive tissues during late pregnancy. For instance in
the pig, rat and guinea pig, the hormone helps loosen the cervix during
parturition (Sherwood 1994). In humans, however, the hormone is at its
highest concentration early in pregnancy, leading researchers to believe
that it is involved in the implantation of the blastocyst (Schwabe and
Bullesbach, 1990; Schwabe and Bullesbach, 1994; Johnson et al., 1991;
Johnson et aI.,1994).
Outside of pregnancy, relaxin is also secreted during the formation of new
blood vessels, during wound healing, and can contribute towards
counteracting the effects of congestive heart failure. These and other
functions mean that relaxin - when more is understood about the
hormone - could be an excellent candidate as a drug for a whole range of
illnesses and disease (Bani 1997).
Relaxin is a peptide with a molecular weight of approximately 6,000
Daltons, it consists "of two dissimilar A and B chains linked by disulphide
bridges. It is an analogue of insulin that shows no cross reactivity to
insulin receptors.
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In humans two molecular forms of relaxin have been identified, with high
sequence homologues designated H1 and H2 relaxin, and encoded by
two distinct genes. Of these H2 relaxin corresponds to the circulating
relaxin produced by the ovary. The H1 form of relaxin seems to be
produced only by the decidua (Bani, 1997).
R,elaxin is produced by a range of mammalian species. During pregnancy
relaxin is thought to determine not only the time of onset of labour but
also its subsequent progression (Johnson et al., 1993). Furthermore it
has been shown to be important in the normal growth of the uterus and
endometrium in primates and rodents, and may have a similar role in
women.
Relaxin has been shown to be produced in the luteal phase of non-
pregnant women every cycle as shown in figure 19 , although the reason
for this is unsure. It may have an effect the softening and opening the
cervix which allows for the monthly menstrual flow (Johnson et al., 1993).
'The factors that regulate the levels of circulating relaxin during the
menstrual cycle and during pregnancy are uncertain, although animal and
some human data suggest that in pregnancy at least the levels are
'determined in the cycle of conception.
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Plasma Levels of Relaxin in the
luteal phase of the menstrual
cycle
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Figure 19: The geometric means of the plasma levels of relaxin during the luteal phase
of the menstrual cycle in nine normal volunteers.
5 7
Days within the luteal Phase
From Relationship between ovarian steroids, gonadotrophins, and Relaxin during the menstrual cycle.
Johnson MR et al., .Acta Endocrinologica 1993 129: 121-5
There is further evidence to suggest that there is a strong positive
relationship between the circulating levels of relaxin and those of
oestrogen as E2 (Johnson et al., 1993). This implies that either the
synthesis of E2 and relaxin is regulated by a common factor, or that E2
'rather than LH regulates relaxin synthesis during the menstrual cycle.
This work has been confirmed by other researchers (Samuel et al., 1996).
The degradation pathway for relaxin is unclear. It is probably mediated
:through the liver and excreted via the bile and lor the urine (Ganong
2003).
56
Chapter Three: The Menstrual Cycle Study
The Chemistry, Biosynthesis, Metabolism and actions of
Follicle Stimulating Hormone (FSH) and Lutenising
Hormone (LH).
Follicle Stimulating Hormone is a gonadotrophic glycoprotein secreted by
the anterior pituitary gland in response to gonadotrophin-releasing
hormone (GnRH), which is released by the hypothalamus. The same
pituitary cells also secrete Lutenising Hormone, another gonadotrophin.
Both FSH and LH are composed of alpha and beta subunits. The specific
beta subunit confers the unique biological activity. Both FSH and LH bind
to receptors in the testis and ovary and regulate gonad function by
promoting sex steroid production and gametogenesis (Jabboeur, 2002).
In females, LH stimulates oestrogen and progesterone production from
the ovary. A surge of LH in the mid-menstrual cycle is responsible for
ovulation, and continued LH secretion subsequently stimulates the corpus
luteum to produce progesterone. Development of the ovarian follicle is
largely under control of FSH, and the secretion of oestrogen from this
follicle is dependent on both FSH and LH (Jabboeur 2002).
Despite an extensive search of resources on ijle current Medline
database, the National Library of Medicine database and OVID online,
evidence has yet to be found showing receptors in collagen tissues or
skeletal muscle for FSH or LH. The effect of these hormones appears to
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be confined to the production of oestrogen and progesterone and it is
these hormones which, as stated above, can have an effect on joints and
skeletal muscles.
The degradation pathway for LH and FSH is again unclear. It is probably
mediated through the liver and excreted via the bile and the urine.
The role of Oestrogen, Progesterone and Relaxin in the
normal menstrual cycle
The physiological effecfs of oestrogen are widespread. It is a hormone
responsible for the secondary sexual characteristics in females, and it
influences the production of the cervical mucus and the structure of the
vaginal epithelium. During the menstrual cycle oestrogen causes the
proliferation of the uterine endometrium. It inhibits FSH and encourages
fluid retention.
The effects of progesterone are mainly evident in the second half of the
..cycle. It causes secretory changes in the lining of the uterus, where the
..
endometrium develops tortuous glands and an enriched blood supply in
anticipation of a fertilised ovum. These changes occur only in an
endometrium already primed by a high level of oestrogen.
58
Chapter Three: The Menstrual Cycle Study
Relaxin is found only in the normal menstrual cycle during the late luteal
phase. Its action has been deemed to be on the cervix where it changes
the composition of the collagen fibrils and helps to ripen the mucous plug
and allows the cervix to open just as it does during labour (Sherwood,
1994). The actions of relaxin outside of the genital tract are numerous
and will be dealt with later.
Oestrogen and Skeletal Muscle
That there are nuclear receptors in skeletal muscle for male and female
sex hormones is well established. Oestrogens exert their action via
specific protein receptors that are members of the steroid Ithyroid
receptor super family of transcription regulation factors (Taylor and AI-
Azzawi, 2000).
By 1980 androgen receptors were detected in the quadriceps muscles of
adult male and female rats (Michel and Baulieu, 1980). However, despite
using a variety of techniques for separating and measuring hormone
receptor complexes, at that time, oestrogen receptors had not been
found. The androg9'n-binding sites were of relatively low concentration.
However, the typical binding specificity of the androgen receptor and the
regulatory effects of the androgens on their own receptor supported the
possibility that so~e effects of androgens on skeletal muscles may have
been initiated directly at the cellular level through this receptor.
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By 1982 the presence of oestrogen receptors in the cytosol of rat skeletal
muscle had been established (Dahlberg,1982). Later research showed
that the mechanism of action of steroid hormones in target tissues
included the binding of the steroid molecule to specific receptors in the
cytoplasm (Gustafsson et al., 1984). Steroid receptors were therefore
regarded as mediators of hormone actions. The number of such
receptors in tissues reflects their hormone sensitivity, and the receptor
levels are indicative of the relative potential for the direct hormonal action
of the tissue in question. Using synthetic ligands and a charcoal
absorption assay, the presence of specific androgen, glucocorticoid and
oestrogen (in rabbits only) receptors was demonstrated in human and
rabbit skeletal muscle cytosol. These tissues were therefore regarded as
targets for these hormones (Dahlberg, 1982).
In 1984 research. was undertaken into hormone receptors in human
spinal muscles of patients diagnosed with scoliosis (Saatok et al., 1984) .
•Twenty patients of both sexes, at different ages, and with different
aetiological reasons for the condition were investigated. Androgen and
glucocorticoid receptors were found but surprisingly no oestrogen
..receptors.
Using a more sophisticated method of analysis it was found that steroid
receptor complexes existed for each specific steroid. The concentration of
androgen and oestrogen receptors was of the same magnitude, whereas
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the corresponding value for the glucocorticoid receptor was about ten-fold
higher (Gustafsson et al., 1984), This is not surprising considering the
physiological effects of the glucocorticoids on skeletal muscle.
In 1986 and 1987 two papers were published reporting the presence and
distribution of oestrogen receptors in the temporo-mandibular joints
(TMJ) of baboons (Aufdemorte et al., 1986; Milam et al., 1987). It was
found that the TMJ complex contains numerous cells with receptors for
oestrogen. The receptors were found in the articular surfaces of the
condyles, articular disc, and capsule in the females but not in the males.
Likewise the muscles of mastication contained relatively few receptors.
As a result the researchers postulated that the role for the sex steroids
was one of maintenance and repair in the joint rather than a specific
effect on the muscles of mastication acting over the jaw. Why this should
be found in females rather than males, however, is still to be understood.
Oestrogen receptors have been found in a diversity of muscle sites .
•The diaphragm, laryngeal muscles, pelvic floor muscles, urogenital
ligaments and the myometrium all contain receptors, but not the rectus
abdominus muscle. Again the reasons for this are still unclear (Bechet et
.al., 1986; Smith et al., 1990; Mann et al., 1995; Wu et al., 2003).
The latest work suggests the presence of two oifferent oestrogen
receptors in human tissue; these are oestrogen receptor alpha and
oestrogen receptor beta (Lemoine et al., 2003). Both types of mRNA
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have been found in mouse, rat, and bovine as well as human tissue
samples (Wu et al., 2003). The expression of oestrogen receptor mRNA
alpha was 180 times higher than that of oestrogen receptor mRNA beta.
In the ovary, oestrogen receptor beta was present in multiple cell types
including granulosa cells in small, medium, and large follicles, thecae and
corpora lutea, whereas oestrogen receptor alpha was weakly expressed
in the nuclei of granulosa cells, but not in the theca or corpora lutea. In
the endometrium both oestrogen receptor alpha and oestrogen receptor
beta were observed in the nuclei of epithelial cells and in the nuclei of the
stromal cells, but significantly oestrogen receptor beta was absent from
the endometrial glandular epithelia. Oestrogen receptor beta cells were
found in male urogenital tissues, and in most areas of the brains of both
sexes (Taylor and AI-Azzawi , 2000).
It can be concluded, therefore, that the almost ubiquitous immuno-
,histochemical localisation of oestrogen receptor beta indicates that these
receptors playa major role in the mediatlon of oestrogen's action outside
of the musculo-skeletal system, whereas oestrogen receptor alpha seems
10 predominate within the musculo-skeletal system alone. The
disappearance of these receptors, therefore, might have an important role
to play in muscle strength and thus joint mobili(y after the menopause.
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The effects of Oestrogen on muscle function
Oestrogen affects muscle function in many ways. It has been shown to
promote growth and accelerate skeletal development (Benson et al.,
1989, Schiessl et al., 1998). Concentrations of oestrogen receptors in
rabbits have been found to be higher in slow twitch fibres compared to
fast twitch fibres (Gustafsson et al., 1984).
The structure of the oestrogen molecule has a very specific effect on
growing muscle cells. This again must be a function of the oestrogen
receptor types. Oestrone (a metabolite of oestradiol but possessing less
biological activity) has been shown to induce a significant increase in
myoblast growth, whereas beta oestradiol had no such effect (Kahlert et
al., 1997).
The effects of beta oestradiol on the tension and fatigue responses of
<single fibre or fibre bundles prepared from frog skeletal muscles have
been investigated (Hatae, 2001). The administration of the hormone
caused a transient potentiation of tetanus tension by field stimulation at
:'every minute.
Fatigue was produced by repeated tetanic stimulation every second until
, tensi~n declined to approximately 40% of the initial level. Fibres were
then allowed to recover. With the presence of beta oestradiol the time to .
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recover was less than for a control group. The presence of alpha
oestradiol (an isomer) made no difference, suggesting the existence of
very specific receptors in frog muscle (Hatae, 2001). These are most
likely to be the beta receptors described above.
The effect of endurance training on transcripts of oestrogen receptor
alpha in rat skeletal muscle has also been investigated (Lemoine et aI.,
2002). The results demonstrated that 7 weeks of endurance training
increased the level of ER alpha receptors. This increase was greater in
females compared to control groups.
Specific physiological variables and skeletal muscle functions may be
capable of change along with menstrual cycle phases (Becker et al.,
1982). However, the exact influence of the menstrual cycle phase on
exercise performance, muscle strength, and fatigue is unclear, despite
correlation between muscle strength and the various phases of the
menstrual cycle having been the subject of many researches (Bruce et
al., 1992; Phillips et al., 1992 a; Phillips et al., 1992 b; Phillips et al., 1993;
Phillips et al., 1995; Phillips et al., 1996; Skelton et al., 1999; Janse de
Jonge et aI., 2001).
It is probable that this lack of clarity might be due to the variation of
methods (muscle strength measure and assessment of cycle phase) and
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variations of oestrogen levels in different subjects at the same phase of
the menstrual cycle (Landgren et al., 1980; Bassey et al., 1995).
In her doctorate thesis, Onambele (2002) suggested that there can be a
negative correlation, no correlation, or a positive correlation, between the
menstrual cycle phase, the hormones and muscle strength.
Negative correlation between normal menstrual cycle phase, oestrogen,
and skeletal muscle force
A group of studies in normally menstruating subjects report that muscle
force increases when the oestrogen level is low. One study using tests
such as handgrip and th'e standing long jump indicated that performance
was significantly greater during the menstrual phase compared to the
follicular and luteal phases (Davies et aI., 1991).
No correlation between normal menstruation cycle phase, oestrogen, and
skeletal muscle force.~
Two studies suggest that muscle function, and muscle strength are
independent of the phases of the menstrual cycle. One study suggested
that the active woman with a normal menstrual cycle experienced no
significant changes in maximum knee flexion and extension or
endurance, as a result of cycle phase, (Rice, 1988; Janse de Jonge et
al., 2001)
65
Chapter Three: The Menstrual Cycle Study
It has even been suggested that the reports of difference in muscle force
with the menstrual cycle might be due to motivational factors rather than
ability (Allen and Bailey, 1982). A study looking at the effects of
motivation and cycle phase on the handgrip strength of a group of young
women showed no significant differences either between groups
(motivated or normal) or between the various phases of the cycle.
Friden et al., (2003) found that there was no significant variation in
muscle strength and muscle endurance during the menstrual cycle .They
used a serum measure for cycle phases and the LH surge was detected
in the subject's urine (Friden et al., 2003). The self-criticism of this paper
is interesting as the authors were careful to note this was a study of
moderately healthy university students and not of highly trained athletes.
It is the author's opinion that this is an important statement as the findings
are more likely to relate to women in general and how and when they
undergo injury than specifically to female athletes.
Positive correlation between normal menstrual cycle phase, oestrogen,
and muscle force
A review of these and other studies reports a rapid muscle response to
changes in oestrogen (Phillips et al., 1995). Some studies found that at
mid-cycle, when the oestrogen levels are highest, muscle strength is
greatest (Phillips etal., 1993; Phillips et al., 1995; Phillips et al., 1996;
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Reise et al., 1995). Other studies report that the greatest difference in
strength is seen between the luteal and ovulatory phases of the cycle,
which is different from what would be expected from a direct oestrogen
effect, whereby the greatest strength difference would be between the
follicular and ovulatory phases (Sarwar et al., 1996).
In summary, the effects of oestrogen hormones on skeletal muscles are
profound, and the greater the number of receptors the greater the
possibility of the direct action of the hormone on the muscles concerned,
especially if they are slow twitch fibres as are often found in postural
muscles. It is the effects of the receptors to the various hormones that
can contribute towards the strength or weakness of individual muscles.
Likewise if there are receptors in ligaments or other collagenous
structures, it is important to assess the effects of hormone interactions via
these receptors and the effects they might be capable of producing if a
~reater understanding of mobility changes in relation to hormones is to
take place .
.
Oestrogen, Relaxin and Connective Tissues
The effects of relaxin on the inter-pubic ligaments was first demonstrated
morefhan 70 years ago (Hisaw,1926).
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All connective tissue remodelling occurs through a continuous cycle of
protein synthesis and degradation (Dahlberget al., 1994; Foos et al.,
2001). In this process, old or damaged structures are degraded and
replaced with newly synthesized molecules. The balance between the
degradative and biosynthetic arms of the process is controlled by the
relative activities of matrix metallo proteinases and tissue inhibitors of
rnetallo proteinases (Foos et al., 2001). The expression of some of these
proteins is regulated by steroid hormones (Wahl et al., 1997; Rajabi et al.,
1991; Matrisian, 1994 ).Oestrogen dependent collagenase production
and progesterone dependent inhibition of collagenase have been
observed in the pubic ligaments of pigs (Wahl et al.,1997). Furthermore,
increasing the concentration of oestrogen in an ACL tissue culture model
resulted in decreased fibroblast and pro-collagen production (Liu et
al.,1997).
The effect is synergistic with the ovarian steroids and is likely mediated
t~rough the induction by relaxin of collagen remodelling. The exact
method of action on collagen metabolism is still unclear; similar in vitro
studies on human fibroblasts showed that relaxin promotes collagen
secretion on one hand (Wiqvist et al., 1984) whereas it causes a
decrease in collagen production and an increase in collagenase synthesis
and collagen breakdown on the other (Unemori et al., 1990). Possibly,
~hese conflicting results depend on the different responsiveness to relaxin
of fibroblasts comlnqfrom different anatomical sites. These findings raise
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the possibility that relaxin acts through the interplay between synthesis
and demolition of collagen. Sherwood, (1994), in a major review of
relaxin, thought that this hormone may have an outstanding role at
parturition by inducing the metabolic changes in the connective tissues of
the cervix and the inter-pubic ligament needed for collagen remodelling.
In some species there is a relaxin surge in the pre-partum phase which is
held responsible for successful dilation of the birth canal. However,
because there is no relaxin in pre-labour humans, it has been suggested
that local relaxin produced by the deciduas and the placenta and / or
increased sensitivity by the target cells to relaxin ( when it appears) may
be involved in these changes (Bryant-Greenwood and Schwabe, 1994).
The discovery of relaxin in the normal menstrual cycles (Johnson et al.,
1993; Sherwood, 1994), and thus its ability to induce collagen remodelling
in situations other than during pregnancy suggests relaxin can potentially
have a global effect rather than just a local effect on collagen (Bryant-
~reenwood, 1982). Its therapeutic use for the induction of cervical
ripening (MacLennan, 1991) may be important in assisting in cases of
. delayed labour.
The use of relaxin in the treatment of skin disease is also interesting but
K
has now fallen out of favour (Casten and Boucek, 1958). Another
,research group in 2001 found that the use of recombinant relaxin in the
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treatment of systemic sclerosis (or scleroderma) was ineffective (Gavino
and Furst, 2001).
Relaxin has also been shown to influence renal vasodilatation, increase
vascular endothelial growth factor expression and angiogenesis, promote
dilation of blood vessels, and inhibit release of histamine (Bani, 1997).
Relaxin acts alone or in combination with other hormones in its effects on
connective tissues. In the non-pregnant state, ligament growth can be
induced in an oestrogen primed animal only following administration of
relaxin (Wahl et al., 1997 .
.
Progesterone inhibits collagenase activity but relaxin has no direct
inhibitory effect. Kapila and Xie (1998) looking at remodelling in the fibro-
cartilaginous disc of the temporo-mandibular Joint implicated relaxin
alone, or again with beta oestradiol as a factor responsible for collagen
remodelling. Luque et al., (1966, 1998) and Samuels (1998) both found
that relaxin plays an important part in collagen remodelling and
reorganisation in rat tissues. Kristiansson (1996) linked high levels of
,. relaxin in the early part of IVF pregnancies to back pain radiating to the
sacrum but failed to suggest the mechanism for the symptoms other than
citing ligament laxity as being the problem.
,The recent work of Hsu and his research team, has finally demonstrated
specific receptor sites for relaxin in various tissues. With the identification .
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of these receptors it is now possible to investigate specific cells and
tissues that are responsible for relaxin in diverse pathological and
physiological tissue states (Hsu et al., 2003).
The effects of other hormones on connective tissues
That connective tissue components, in particular collagen, are affected by
various hormones has been known for a long time as shown above. The
exact mechanism whereby the collagens can change has been unclear
until recently because the methods of analysis and the ability to isolate
specific receptor sites was yet unknown.
As late as 1974 Harvey et al., looked at the effects of steroid hormones,
for example the glucocorticoids, on human fibroblasts in vivo (Harvey et
al., 1974). They researched the effects of cortisol and prednisilone on cell
proliferation, DNA synthesis, and collagen synthesis. They found that
.
both substances stimulated collagen synthesis at very small
concentrations (0.01 micro grams per ml). Higher concentrations of the
steroids caused a marked suppression of DNA synthesis but a smaller
reduction of cell proliferation over a three day culture period.
Kucharz, in two papers in 1988, also explored the hormonal control of
,
collagen metabolism (Kucharz,1988a; Kucharz, 1988b). He reviewed the
effect of thyroid hormones and thyroid stimulating hormone on collagen.
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Thyroid hormone influences collagen biosynthesis and degradation, and
this effect is responsible for various observed pathophysiological
phenomena including alterations in the urinary excretion of
hydroxyproleine and hydroxylysine, pre-tibial myxoedema, impaired
wound repair and other fibrosis associated processes. Thyroid stimulating
hormone (TSH) also directly affects the connective tissues, with
hyperthyroidism being associated with joint laxity, and may be one of the
factors associated with thyroid eye disease (Daumerie, 2002; Kucharz,
2003). Other factors include the effects of thyroxine directly on the optic
muscles and the deposition of a muco-polysaccharide behind the eyeball
to give the exopthalmic appearance.
In another paper Kuchartz (1998b) also looked at glucocorticoids on the
metabolism of collagen. He found that they decrease the amount of
messenger RNA coding procollagen chains. This decrease is caused by
depressed activity of the specific enzymes of intracellular stages of
collagen biosynthesis. Extra-cellular maturation of collagen is affected by
steroids, but changes reported depend on rate of collagen turnover. He
felt that the effect of collagen degradation is a matter of controversy
• because unlike Unemori, (1990), he found that there was little evidence
that the hormones decrease the activity of collagenase.
The main difference functionally between these hormones and oestrogen,
progesterone and relaxin is that these hormones are not secreted in a
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predictable and cyclic fashion as are the hormones of the menstrual
cycle. Their effects, therefore, are not going to be cyclical either, and
therefore they are unlikely to be related to the incidence of injury at
specific times in the cycle.
The significance of the sex hormones on the function of
the ligaments
The mechanical strength of the pelvic ligaments supporting the female
pelvic organs has long been thought of as one of the factors involved in
controlling the position 'and function of these organs after the menopause.
The sex hormones are thought to be significant in the adequate function
of these ligaments and their role in preventing uterine and vaginal
collapse and prolapse.
Chen's research group looked for alpha and beta oestrogen receptors in
the vaginal walls and utero-sacral ligaments in pre-menopausal and post-
menopausal women (Chen et al., 1999). They analysed the expression of
messenger RNA for the receptors, and concluded that alpha and beta.
oestrogen receptors" were expressed in the vaginal walls and utero-sacral
ligaments of pre-menopausal women, but that fhe beta receptor cells
were absent from the vaginal walls after the menopause, thus
predlsposinq these ~womento pelvic organ collapse.
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Stewart's research group studied collagen types I and III in uterine
leiomyomas in various phases of the menstrual cycle (Stewart et al.,
1994). They posed the question that as different hormones are present at
various phases of the cycle did one hormone have more or less an effect
on type I and type III collagens than another hormone? Uterine
leiomyomas contain abundant quantities of extra-cellular matrix, in
particular collagen types I and III and fibronectin. From looking at the
levels of messenger RNA for these proteins, they concluded that
leiomyomas show increased levels of messenger RNA for collagen types
I and III compared to normal myometrium. However, this difference is
manifested only during the proliferative phases of the menstrual cycle.
These findings suggest that leiomyomas are more sensitive to oestrogen
levels which are higher in the proliferative phase of the cycle than the
normal myometrium.
As indicated above, various researchers had investigated the therapeutic
uses of relaxin in skin diseases, notably scleroderma (Gavino and Furst
2001). Varila et al., (1955), looked at the effect of topical oestradiol on the
skin collagen in post-menopausal women and found that it increased the
amount of skin collagen and stimulated Type I and Type III collagen
synthesis both in the quality and quantity of fibrils.
The effects of the sex hormones on collagen have the potential for
widespread effects- not just confined to pelvic ligaments or to reproductive
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tissues. Abubaker et al., (1966) concluded that sex steroids have an
effect on the collagen and protein content of the articular discs of the
temporo-mandibular joint in rats as indicated by the difference in the
values between control males and females and by the disappearance of
this difference on castration of both male and female animals This was
also manifested by the significant effect of oestradiol on collagen content
of castrated male rats, and by the effect of oestrogen combined with
progesterone on the protein content of castrated females.
It has been postulated that the capsules of the spinal apophyseal or facet
joints also contain receptors for 17(3oestradiol. Nadaud et al., (2001)
.
showed that a degenerative spondylolisthesis is four to five times more
common in females than in males suggesting that hormonal influences
account for the gender difference. The researchers investigated facet
joint capsular ligaments for the presence of such receptors. They found
that none of the specimens contained receptors and that if hormones do
playa role in the development of a degenerative spondylolisthesis, then it
is probably not one of the sex hormones that is involved. It therefore still
remains to be seen if relaxin receptors can be identified in these sites and
.are therefore implicated in the development of the condition.
Brynhildsen et al., (1998) tried to implicate hormone replacement therapy,
HRT, as a risk factor for low-back pain amongst menopausal women, and
felt that there was a significant, albeit weak, positive association between.
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current use of HRT and low-back pain. They felt that the results could not
be explained by differences in occupation, smoking habits, or current
physical activity. Instead they speculated that the hormonal effects on
joints and ligaments may be involved.
~ummary
The literature review examined the current state of knowledge of the
physiology of the sex hormones involved in the menstrual cycle. It then
reviewed the evidence demonstrating the presence of specific receptor
sites in connective tissues and skeletal muscles, and went on to review
the literature showing the effect these hormones have on these tissues.
The literature review investigating the incidence of injury in relation to the
menstrual cycles of athletes, as shown in the in the previous chapter,
revealed that many thousands of female athletes injure themselves each
year in sport compared to males (Toth and Cordasco, 2001; Arendt et al.,
2002).
If, in fact, these women are injuring themselves because they are more
vulnerable to injury, then potentially it is the change in joint laxity caused
by the change in th~ supporting tissues at different phases of the
menstrual cycle that might be contributing to these events.
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The aim of the study
The aim of the laxity study is to investigate the potential change in laxity
as demonstrated at a peripheral joint at different phases of the menstrual
cycle.
The Hypotheses
The main experimental hypothesis states that women with a normal and
predictable menstrual cycle experience changes in joint laxity. The null
hypothesis is states that there is no relation between the phases of the
cycle and joint laxity.
<The second experimental hypothesis states that if these changes exist
they correlate with changes in the levels of one or more of the circulating
sex hormones .The null hypothesis states that there is no relationship
:between joint laxity and the levels of the circulating sex hormones.
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Method and research protocol
Sixty female volunteers were recruited from the clinic at The British
School of Osteopathy, students from the British School of Osteopathy,
and patients attending the author's private osteopathy practice. The
criteria for inclusion in the study were that they had to have a predictable
menstrual cycle and that they had not used oral contraceptives or any
other hormone preparation for at least three months prior to being tested.
It was also important that there was no history of inflammatory joint
disease or trauma to tne joint under test for the subject to be included in
the study.
Ethical considerations
<All subjects were given an appropriate information sheet about the
relevant study forthem, and then they were required to sign a consent
form a copy of which was given to them to keep. Ethical approval for the
'studies had been obtained from the Ethics Committee of The British
School of Osteopathy and from the Ethics Committee of The Chelsea and
Westminster Hospital where the blood samples obtained from the laxity
study were to be analysed.
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The female subjects were given a menstrual diary to keep for three
months prior to being measured for the first time. This was despite the
fact that only women who thought that they had a regular and predictable
cycle were included in the study group. The rationale behind this is that
many women who think that they have a regular and predictable
menstrual cycle are not regular at all, but never know because they have
never checked themselves accurately. It was essential for the study to
measure women on specific days in the cycle; therefore, a calendar was
used to ascertain the regularity and predictability of the subjects to be
included in the experimental group.
Of the 60 original volunteers, 43 were eventually rejected as they were
.
not found to have a predictable and reliable menstrual cycle after all. For
the purposes of the study it was considered essential to measure the
subjects on the exact day specified in their cycle. If they were found to
menstruate earlier or later than expected by more than one day, then the
results obtained had to be abandoned as they were not true
representative readings of what was happening on a specific day. Thus
reliable data were forthcoming from only 17 participants.
The average age of the experimental group was 25.35 (st dev 7.99 years;
.sem 2.30 years ).
Twenty male volunteers were also chosen from the student population of
the British School of Osteopathy to act as a control group for the first part
of the study relating to changes in laxity and phases of the menstrual
79
Chapter Three: The Menstrual Cycle Study
cycle. The only inclusion criteria for this group were that there should be
no history of any inflammatory joint disease and no history of trauma to
the joint under examination.
The average age of the male subjects forming the control group was
28.70 years (st dev 5.88 years; sem 1.43 years).
Continuous quantitative data were collected from the subjects using the
Hyperextensometer as described before. The female subjects either
came to the author's private practice or to the British School of
Osteopathy for measurement, or they were visited at their homes and
measured on the following days in the menstrual cycle.
Day 3 to ascertain a base level of hormone readings
Day 12 at the expected pre-luteal surge for oestrogen levels
Day 21 at the expected progesterone peak
Day 27 at the expected relaxin peak.
At each test session the subjects were first measured using the
Hyperextensometer described above. Three readings were obtained and
jhe averages recorded; Then 2 ml of blood was taken from the median
cubital vein of the non-dominant arm.
The blood was separated and the serum was labelled and stored at
minus 20 C in a refrigerator especially purchased for this purpose kept in
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a store room under lock and key at the British School of Osteopathy.
Eventually at the end of the study the samples were sent to the
biochemistry laboratory of the Chelsea and Westminster Hospital for
analysis. Thus for each phase of the cycle an understanding of the data
relating to the effects of the hormone relative to the joint laxity was
obtained.
The control group subjects were measured using the Hyperextensometer
once per week at seven day intervals for four weeks at the British School
of Osteopathy. As males are not subject to cyclic changes in their
hormones in the same way that females are, and as they were only being
studied to ascertain if there was a change in male joint laxity over a four
week period, it was not deemed necessary for them to undergo the blood
analysis.
The raw data were entered onto a Microsoft Excel spreadsheet for data
• analysis. SPSS version 13.0 and Stats Direct version 2.4.S.were also
sometimes used in addition to the Excel data analysis package.
In all statistical analysis a value of p<O.OSwas deemed significant,
_p<0.001 highly significant and p<0.0001 extremely significant.
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Results and statistical analysis
Laxity and the control group
The Shapiro Wilk test showed the data obtained from the control group to
be normally distributed (p=0.1359 n=20) .
.
Normalised laxity for the control group
2 3o
weeks
Figure 20: The changes in laxity in males over four weeks
4
Figure 20 shows that the male subjects did exhibit a change in laxity in
the joint measured over a four week period.
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The data was normalised by dividing the laxity readings at each phase by
the mean of the readings to remove variation between subjects whilst
leaving the variation between the phases.
A repeated measures ANOVA test applied to the data showed that these
changes were not considered statistically significant (p=O.7394). With a p
value> 0.05 a post hoc test was not considered necessary.
Laxity and the experimental group
The data from the experimental group were subjected to a Shapiro-Wilk
test which showed there was no evidence of non-normality (p=0.632
n=17) and so the data were analysed using parametric tests.
Normalised laxity data for the experimental
group
~ >; 1.2
.;< :!:: 1.1
~~ 1
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Figure 21: The change in laxity in females over the four weeks of a menstrual cycle
Prog RelaxBase LH
Cycle phase
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The data was normalised by dividing the laxity readings at each phase by
the mean of the readings to remove variation between subjects whilst
leaving the variation between the phases.
Figure 21 shows the normalised laxity data for the experimental group
plotted against menstrual cycle phase. Base refers to the Base phase of
the cycle between days 1 and 3 when the levels of the circulating sex
hormones are not significant. LH refers to the phase of the cycle around
day 14 when the surge of Lutenising Hormone causes ovulation to occur.
Prog refers to the phase in the cycle around day 21 days, when the
expected peak in the levels of circulating Progesterone occurs, and Relax
refers to the time around day 27 when the levels of circulating relaxin are
at their highest.
The chart shows a rise in laxity between the base phase and the LH
phase. There is a hardly discernable change between the LH phase and
the Progesterone phase but there is a moderate rise in laxity again
between the progesterone phase and the relaxin phase.
A repeated measures ANOVA test applied to the data gave an extremely
significant result (p=<O.0001) suggesting that laxity changes did occur
during the menstrual cycle. A post hoc Tukey test involving a pair wise
jnultlple comparison of the means showed highly significant changes in
laxity between the base phase and each other phase (p<O.001), and no
further significant changes between each of the other phases when
tested against each other (p>O.05). The results indicate that laxity as
measured at the first metacarpo phalangeal joint of the experimental
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subjects changed during the menstrual cycle, and thus the main null
hypothesis can be rejected.
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Oestrogen in levels in the experimental group:
Figure 22: The comparative plot of change in laxity and oestrogen across one menstrual
cycle.
Figure 22 demonstrates that laxity rises as plasma oestrogen rises in the
first phase of the cycle. This confirms the expected rise of plasma
oestrogen in the follicular phase of the cycle when the developing follicle
, is producing the pre luteal surge of oestrogen needed for ovulation.
Without the rise in oestrogen there can be no corresponding rise in
Lutenising hormone, LH. After this first phase of the menstrual cycle,
:oestrogen levels fait as the luteal phase of the cycle proceeds and the
production of ovarian oestrogen is withdrawn. The scatter plot further
"
demonstrates, however, that laxity does continue to rise in the next
, phases independent of the oestrogen fall.
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A repeated measures ANOVA test applied to the data showed an
extremely significant difference in oestrogen levels between the various
phases of the cycle (p=O.0001). A post hoc Tukey test involving a pair
wise multiple comparison of the means showed a highly significant
change in oestrogen levels for the base to LH phase (p<O.001) with no
further significant changes between each of the other phases when
tested against each other (p>O.05).
Progesterone levels in the experimental group
Figure 23 demonstrates that there is only a minor rise in laxity from the
LH to the Progesterone phase of the cycle despite the rapid rise in levels
of progesterone in this phase.
A repeated measures ANOVA test applied to the data demonstrated that
there was a extremely significant (p<O.0001) change in progesterone
levels across the cycle.
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Figure 23: The comparative plot of change in laxity and levels of progesterone across
one menstrual cycle •
A post hoc Tukey test involving a pair-wise multiple comparison of the
means demonstrated extremely significant differences (p<O.0001) in
progesterone levels between the base versus progesterone phases the
LH versus progesterone phases (p<O.0001), and base versus relaxin
, phases (p<O.0001). Comparisons between each of the other phases was
not significant (p>O.05).
Relaxin levels in the experimental group
Figure 24 demonstrates that laxity undergoes a very small change in the
last phase of the cycle and that the levels of relaxin only really appear to
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become apparent in this phase of the cycle .A repeated measures
ANOVA applied to the data showed that there was a extremely significant
change in laxity at this time (p<O.0001 ).
/o~--~====~==~----~---+o
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Figure 24: The comparative plot of change in laxity and relaxin across one menstrual
cycle
A post hoc Tukey test involving a pair wise multiple comparison of the
means highlighted an extremely significant change in relaxin levels when
< comparing the base and relaxin phases (p<O.0001); the LH and relaxin
phases (p<O.0001); and the progesterone and relaxin phases (p<O.0001 ).
Comparisons between all other phases were not significant (p>O.05).
Thus it can be seen' that the laxity varied as the levels of specific
circulating sex hormones varied and thus the second null hypothesis can
be likewise rejected.
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Discussion and Conclusions
A number of conclusions can be drawn from the above.
Firstly not only did the laxity of every subject change between the various
phases of the menstrual cycle, but the degree of change differed
depending on the phase of the cycle when the measurements were
taken.
Secondly the general pattern was that the mobility as measured at the
metacarpo-phalangeal joint seemed to exhibit an increase in laxity as the
cycle progressed. However, only the change between phases one and
two was significant at a level of p<O.05.
Thirdly the presence of a specific hormone in a specific phase was
probably the important contributing factor relating to the change in laxity
within the phase. This related particularly to the oestrogen findings
• illustrated in figure 22.
The results from this study suggest that the laxity does change during
each phase in relation to the presence of the hormones concerned, and
: the most significan! change was found between the base and LH phases
of the cycle when the level of circulating oestrogen was rising. It strongly,
suggests that oestrogen is an important hormone responsible for the
. laxitx effect found. Progesterone was at its highest level in the third phase
of the cycle but the laxity did not change significantly, suggesting that any
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effects due to progesterone are minor. Surprisingly the effect of relaxin
was not considered significant (p<0.05), because there was no significant
change in the laxity found in the fourth phase of the cycle when relaxin
rises to its peak. This is in contradiction to the evidence found in the
literature review linking relaxin to ligamentous laxity during pregnancy
(Abramso et al., 1934; Calguneri et al., 1982; Svenson et al., 1990). This
might be explained by the relatively small concentrations of relaxin found
in the normal menstrual cycle when compared with the greater levels
found during pregnancy, especially the latter half of a normal pregnancy
(Johnson et al., 1993 and 1994).
The above results correlate well with the evidence in the literature of
receptors to the sex hormones in tissues that may be responsible for
controlling laxity. Receptors for oestrogen are plentiful in muscles and
fibroblasts whilst receptors for the other hormones are not found in such
abundance (Unemori et al., 1990; Smith et al., 1990; Chen et al., 1999;
• Siauterbeck et al., 2002).
The relation between the hormones and a propensity to injury may well
relate to the effects of these hormones on skeletal muscles and on
collagenous connective tissues, and the extent to which those tissues
contribute towards the protection mechanisms preventing the subject
. from overstrain and damage situations.
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The literature review demonstrated that the effects of oestrogen
hormones on skeletal muscles are profound, and the greater the number
of receptors the greater is the possibility of the direct action of the
hormone on the muscles concerned, especially if they are slow twitch
fibres as are often found in postural muscles. This may be important in
relation to the acute pain incidence reported in the pilot study when the
postural muscles are called into playas part of the overall protection
mechanism. It is the effects of the receptors to the various hormones
which can contribute towards the strength or weakness of individual
muscles, and therefore to the degree of protection available at various
phases of the menstrual cycle.
The fluctuations in female steroid hormones affect the autonomic nervous
system and metabolic functions as well as muscle function (Fiorini, 1987).
Whilst the skeletal muscles are under the control of the central nervous
system, the blood vasculature to the skeletal muscles is under the control
of the autonomic nervous system and so again there is a positive link
between the level of the female steroid hormones and way skeletal
muscles function.
The literature review showed that the evidence relating to skeletal muscle
strength is not conclusive. Onambele (2002) cited sources with negative
correlation between skeletal muscle force and menstrual cycle phase, no
correlation and positive correlation between the cycle phases. She
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maintained that it is unlikely that the reasons for these variations is
because of the variations in methods of muscle strength measurement
and cycle phase, and variations in oestrogen levels in different subjects in
the same phase of the menstrual cycle. More needs to be done in this
field to obtain a clearer picture about the relationship between oestrogen,
muscle strength, and joint laxity in the menstrual cycle.
The evidence linking the female steroid hormones and the collagenous
connective tissues revealed an abundance of receptors for oestrogen and
relaxin in various sites both genital and extra genital. Current thought is
that relaxin acts through an interplay between the synthesis and
demolition of collagen (Unemori et al.,1990) and that its effects might be
synergistic with the ovarian steroids. Relaxin receptors have been found
in the fibro- cartilaginous discs in the temporomandibular joint (Kapila and
Xie, 1998), the brain, renal and cardiovascular tissues (Hsu et al., 2002),
and in spinal apophyseal joints (Nadaud et al., 2001).
The widespread presence of these receptors together with the almost
ubiquitous presence of oestrogen receptors does suggest that these
.hormones can have a global effect of many tissues throughout the body,
not the least of which are the skeletal muscles and connective tissues.
The findings in this chapter have revealed a definite link between the
physiological levels of various reproductive hormones in the female and
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laxity as measured at the first carpo-metacarpal joint in normally
menstruating subjects.
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Introduction
Pregnancy has traditionally been accepted as a time when the joints,
especially the pelvic joints, become more lax (Abramson et aI., .1934;
Calgneri et al.,. 1982; Johnson et al.,. 1994). Obstetric text books refer to
changes in ligamentous laxity without reference to the studies quantifying
these changes (Llewelyn Jones, 1997; Bennet, 1993). The pregnancy
study examined a varied population of primaraparous and multiparous
women to see if this laxity can be quantified and to study women during
the different weeks of pregnancy to ascertain if the change in laxity was
uniform throughout the pregnancy or if in fact they were more likely to
undergo changes in laxity in one particular part of the pregnancy
compared to any.
The literature review of the hormone changes of
pregnancy
This series of experiments investigates the changes in laxity that take
: place specifically during pregnancy and during the post-partum period.
'"
The following paragraphs therefore review the roles of the sex hormones
on connective tissues at this time.
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The role of progesterone during pregnancy
Progesterone is secreted by the corpus luteum after ovulation and it
continues the preparation of the endometrium for a possible pregnancy
and inhibits the development of a new follicle (Kimball,2004). If
fertilisation takes place and once the placenta is established, it begins to
secrete progesterone itself which supplements and eventually replaces
that of the corpus luteum. The corpus luteum normally breaks down to
become the corpus albicans, but if fertilisation should occur the human
chorionic gonadotrophin ( HCG) secreted by the early products of
conception maintains the corpus luteum until the placenta is sufficiently
well developed to take over the role of progesterone production. By the
5th month of pregnancy the placenta alone is responsible for
progesterone secretion. The placenta continues to produce both
progesterone and oestrogen for the duration of the pregnancy and the
levels continue to rise until just before the birth.
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Figure 25: The rising levels of Oestrogen and Progesterone during pregnancy
from Pathophysiology of the reproductive system .Colorado State University Web Site
By Bowen RA http://arbl.cvmbs.colostate.edu/hbooks/pathphys/reprod/index.html
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Figure 25 shows the average growth in the level of progesterone within
the body during a pregnancy. A minimum level of about 10 ng.ml-1 is
required to sustain a pregnancy through the very early stages (Bennet,
1993). At the end of the pregnancy, the levels of progesterone secreted
by the placenta will decrease. It is this action that stimulates the
beginning of the contractions that lead to birth.
Progesterone has a number of important physiological functions during
the pregnancy. Amongst the functions are the maintenance and
development of the endometrial lining in conjunction with oestrogen;
maintaining the function of the placenta and stopping the uterus
undergoing spontaneous contractions; stimulating the growth of breast
tissue and preventing lactation until after the birth, again in conjunction
with oestrogen; strengthening the cervical mucus plug helping to maintain
the pregnancy for the full 40 weeks, and strengthening the muscles of the
pelvic floor in preparation for labour ( Khan-Dawood et al., 1989).
The role of Oestrogens during pregnancy
As with progesterone, oestrogen is produced by the placenta throughout
a pregnancy and the levels increase steadily until birth.
Each hormone has a specific role to play during pregnancy however
there can be a conslderaole overlap of functions and often the hormones
oestrogen and progesterone act in concert (Kimball,2004).
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Oestrogen plays a very important role in the development of the
foetus; without oestrogen, the lungs, kidneys, liver, adrenal glands and
other organs would never be triggered into maturation. In fact, the
placenta itself would never grow and operate properly if not for oestrogen
(Tortura and Grabowski, 2000).
Oestrogen also helps to trigger the maturation of reproductive organs,
and help in the development of sexual characteristics. It assists in the
lactation process and regulates bone density in a foetus. Along with
progesterone it maintains the endometrium during pregnancy and is
responsible for the promotion of blood flow within the uterine walls. Lastly
it protects female foetuses from the effects of maternal androgens
(Tortura and Grabowski, 2000).
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Figure 25: The rising levels of Oestrogen and Progesterone during pregnancy
Pathophysiology of the reproductive system .Colorado State University Web Site
By Bowen RA http://arbl,cvmbs.colostate.edu/hbooks/pathphys/reprod/index.html
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The role of Relaxin during pregnancy
Relaxin has been traditionally regarded as the main hormone affecting
connective tissue and thus causing joint laxity during a pregnancy (Weiss,
1991, Weiss, 1993, Weiss et al., 1995). The expression of relaxin
receptors is controlled by oestrogen (Tan et al., 1999, Siebel et al., 2003).
Oestrogen priming increases the release of endogenous relaxin,
increases the response of the target organs to relaxin, and increases the
number of relaxin binding sites on human smooth muscle and
myometrium (Bryant-Greenwood and Schwabe, 1994). It is not surprising
then that as the levels of oestrogen rise, so do the levels of relaxin.
Likewise after the delivery, oestrogen levels fall rapidly with the absence
of the placenta, and serum relaxin levels disappear within 48 hours post-
partum (Eddie et al., 1989).
Pregnancy and skeletal muscle force
During the first trimester of pregnancy, progesterone levels are very high
• so as to enable the pregnancy to continue. They continue to rise
throughout the pregnancy. From the end of the third trimester onwards a
"
continuous rise in maternal oestriol levels is seen but there is little
evidence to support correlating change in muscle performance and
strength (Elliott, 2(01). This research seems to show that there is no
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distinct link between muscle strength and hormone levels during
pregnancy.
Therefore it is likely as seen from the above that the main hormone that
affects and controls connective tissue tone and the control of mobility of
the joints during pregnancy is firstly oestrogen because it is necessary to
prime the tissues and aid the expression of the relaxin receptors, and
relaxin itself because there are specific receptors for this hormone in
connective tissues within the pelvis and elsewhere. There is little
evidence found in the literary review that progesterone has anything to do
with controlling either skeletal muscle tone or the tone of the ligaments.
The Hypotheses
The experimental hypothesis states that women undergo changes in joint
laxity as they proceed through the 40 weeks of pregnancy. The null
hypothesis states that that there is no change in joint laxity during the 40
weeks of pregnancy.
The second experilnental hypothesis states that if this change is present
it varies according to the number of weeks of her pregnancy. The
secondary null hypothesis states that the rate of change is uniform
throughout the pregnancy.
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The third experimental hypothesis states that a woman's pre-pregnancy
laxity has an influence on her rate of change, and that if she is
hypermobile at the start of the pregnancy her rate of change is different to
that of a subject who is normal or hypomobile compared to the others in
the group under test. The third null hypothesis states that there is no
difference between the two with regard to rates of change.
Method and research protocol
Forty subjects were recruited from the author's private osteopathic
practice. The average gestation at the start of the study ranged from 6
weeks to 30 weeks with a mean of 15.69 weeks. The subjects were
measured up to 39 weeks of gestation. The minimum number of readings
per subject was 3 and the maximum was 8 with an average of 5 readings
overall. Of the group under study 23 were primiparous pregnancies and
17 were multiparous pregnancies.
The only exclusion criteria were that there should be no history of
repeated spontaneous abortions, and that they should have no history of
bone or joint pathology prior to the study. A history of repeated
spontaneous abortion can have many causes one of which may be
unusual or insufficient hormones to maintain the pregnancy. Therefore
these subjects we~e excluded so as to ensure only those subjects with as
near normal hormones were included. Likewise subjects with joint
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pathology may exhibit unusual and non-representative changes in their
joints and connective tissues and give abnormal results.
The volunteers were given an information leaflet explaining the purpose
of the study. They then signed a consent form a copy of which was given
to them to keep. Ethical approval for the study had already been obtained
from the ethics committee of The British School of Osteopathy.
The first metacarpo-phalangeal (Mep) joint of the subject's dominant
hand was measured every four weeks throughout the pregnancy using
the Hyperextensometer as before. Three readings were taken each time
and the readings were averaged and recorded as mentioned before.
Results and statistical analysis
The data were subjected to a Shapiro-Wilk test to ascertain if the data
obtained were normally distributed. The results showed that the data
were unlikely to be from a normal distribution (p=O.0016, n=185) therefore
non-parametric tests were used for statistical analysis.
In order to investigate the first hypothesis, two scatter plots Figures 26
and 27 were produced from the raw data, one including and one
excluding a subject who was considerably more mobile that the rest of
the experimental group at the start of the experiment. This was
undertaken to give a more representative view of the laxity obtained in a
normal pregnancy.
103
Chapter Four: The Pregnancy Study
VI SO.OO
Q)e
Cl
Q)
,Q 40.00
80.00
40.00
Fig 26: Scatter plot weeks of gestation versus degrees of laxity including the
hypermobile subject
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The correlation calculation in both cases showed a strong correlation
between the weeks of pregnancy and joint laxity (p<0.0001; r = 0.518 with
the hypermobile subject included, and p<0.0001; r= 0.622, with the
hypermobile subject excluded respectively). The strength of the positive
relationship between laxity and weeks of gestation improved when the
hypermobile subject was excluded (~= 0.269 with the hypermobile
subject, ~ 0.387= without the hypermobile subject).
The scatter plots show that laxity increases as pregnancy progresses
therefore the first null hypothesis can be rejected.
In order to investigate the second hypothesis, the raw data were
separated into four groups being 0-10 weeks of pregnancy, 11-20 weeks
of pregnancy, 21-30 weeks of pregnancy, and 31-40 weeks of pregnancy.
This was to investigate when in the pregnancy the changes in laxity
occurred and to ascertain if a subject was more likely to experience a
change in laxity in one phase of a pregnancy than at any other. As the
data were not normally distributed, A Kruskal-Wallis test (a non-
parametric ANOVA test) was performed to measure the variance
between the weeks giving a highly significant result (p<0.0001). Laxity
•was not uniform throughout the pregnancy.
,-
A squared ranks approximate equality of variance test (non-parametric
equivalent of the Tukey post hoc test) performed on the data to ascertain
exactly where the variance between the weeks was occurring produced a
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highly significant result (Chi2 = 9.631, df = 3, P = 0.022). This test showed
highly significant changes in laxity between weeks 11-20 and 20 -30
(p=0.045) and between weeks 20 -30 and 30 -40 (p=0.003). However,
none of the other comparisons was found to be significant. Therefore the
second null hypothesis can be rejected as the change was not uniform
throughout pregnancy.
In order to investigate the third hypothesis the data were subjected to a
regression analysis to determine if the rate of change remains uniform
throughout the pregnancy, and also to see if those subjects who were
apparently hypermobile at the start of the study compared to the rest of
the group changed at a-different rate
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Figure28: The relationship between laxity at week 20 and the rate of change during the
pregnancy expressed as degrees per week.
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Figure 28 shows the relationship between laxity at 20 weeks, the mid
point in a 40-week gestation, and the rate of overall change as expressed
as degrees per week.
The scatter plot shows that in some subjects if the subject is very lax at
20 weeks her rate of change was small, conversely if her rate of change
was high then she was relatively hypomobile at 20 weeks (p= 0.2503, r2
=0.035). However this was not the case with every subject as some
subjects who were very lax at the start of the experiment also had a high
rate of change This is confirmed by correlation analysis which revealed
the correlation coefficient was not significantly different from zero (r=
0.186) and that there was no significant relationship between rate of
.
change in laxity over the pregnancy and laxity at week 20. Therefore the
experimental hypothesis for the third hypothesis can be rejected.
The Effects of Parity on Laxity
A review of the literature revealed little evidence that parity affects laxity
in pregnancy. It has been the author's experience that patients are
regularly told by obstetricians and midwives that once they have had one
baby then the second pregnancy is easier as the tissues have been
stretched before. There seems to be with little 'Scientific evidence to
support the claims. Using the National Library of Medicine data base and
Medli'ne only two papers were found that mentioned parity specifically in
association with joint laxity in pregnancy. Calguneri et al., (1982),
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compared primiparous and multiparous patients using a finger
hyperextensometer similar to that used above. A significant difference in
laxity in women having their second baby compared to those having their
first child was reported. The authors went on to state that further increase
in laxity occurred in subsequent pregnancies, but data were not shown
and the authors did not give a detailed physiological explanation of the
changes. Another paper in 1996 (Schauberger et al., 1996) looked at
laxity in peripheral joints but found no correlation with serum relaxin levels
or with parity again the cause of any changes during pregnancy was not
known. These were the only two papers found that even mentioned laxity
and parity and the results disagree.
The data obtained from the pregnancy study were analysed to see if
there was a difference between the laxity of the primiparous and the
multiparous subjects.
Of the 40 subjects studied, 23 were primiparous women and 17 were
multiparous women. Of the multiparous subjects 2 were pregnant for the
third time. All of the subjects had conceived by natural methods (as
.opposed to HRT pregnancies) and all were singleton pregnancies.
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The Hypotheses
The experimental hypothesis states that there isa significant difference in
laxity between primiparous and multiparous subjects under test. The null
hypothesis states that there is no difference in laxity between the two
groups.
The second experimental hypothesis states that if this change is present
it varies according to the number of weeks of her pregnancy. The
secondary null hypothesis states that the rate of change is uniform
throughout the pregnancy.
In order to examine the first experimental hypothesis, a Mann Whitney U
test was used to compare the means of the laxity readings obtained from
the two groups. It was decided once again to exclude the obviously
hypermobile subject from the analysis as it was thought that her obvious
laxity may have been a confounding variable .Using the observations
made across the pregnancies from both primiparous (n1) and multiparous
_(n2) subjects, (U= 2853.5, n1=105, n2=71) the results were found to be
..
significant (p=0.0081) for a two-tailed test.
The mean laxity was significantly different in each group.
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Figure 29: A scatter plot to show weeks of gestation versus degrees of change for the
primiparous subjects minus the hypermobile subject
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Figure 30: A scatter plot to show weeks of gestation versus degrees of change for the
multiparous subjects.
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Two scatter plots were produced from the raw data and these are
represented in figures 29 and 30 respectively.
The correlation calculation in both cases suggested a strong correlation
between the weeks of pregnancy and joint laxity for both groups (p<
0.0001; r = 0.327 for the primiparous group and p<0.0001; r= 0.683 for
the multiparous group). There was thus a highly significant correlation
between laxity and weeks of gestation (p<0.0001) for both primiparous
and multiparous subjects.
The statistical tests and the scatter plots show that laxity increases in
both groups as pregnancy progresses and thus the null hypothesis is
rejected.
In order to investigate the second experimental hypothesis that laxity
change if present varies according to the number of weeks, the raw data
for both the primaparous (without the hypermobiJe subject) and the
multiparous groups were separated into four groups being 0-10 weeks of
pregnancy, 11-20 weeks of pregnancy, 21-30 weeks of pregnancy, and
31-40 weeks of pregnancy in the same way that the data were examined
for the whole group in pregnancy. As once again the data were not
..normally distributed, a Kruskal-Wallis test was again performed to
measure the variance between the groups giving a result that was found
.-
to be highly significant for both the primiparous and multiparous subjects
(p<O.0001 for both groups). Laxity change was not found to be uniform in
either the primaparous or multiparous groups.
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A squared ranks approximate equality of variance test (non-parametric
equivalent of the Tukey post hoc test) was calculated for both the
primiparous and multiparous subjects to ascertain where the differences
appeared.
For the primiparous subjects it showed highly significant changes in laxity
between weeks 1 -10 and 11 20 (p=0.0118) and between weeks 1-10 and
31 -40 (p=0.0077). All other comparisons were not found to be significant.
For the multiparous subjects it showed a highly significant change
between weeks 1-10 and 31-40 and between weeks 11-20 and 31-40. All
other comparisons were not found to be significant.
Therefore the second null hypothesis can be rejected as the change was
not uniform throughout pregnancy for either primiparous or multiparous
subjects.
In order to investigate the third experimental hypothesis that a woman's
pre-pregnancy laxity has an influence on her rate of change, for
primiparous and multiparous women, regression analysis was used to
.observe the rates of change in the separate groups in the same way as it
was done for the analysis of the subjects in the pregnancy study looking
at all of the women in one combined group.
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Figure 31: The relationship between laxity at week 20 and the rate of change during the
pregnancy expressed as degrees per week for the primiparous subjects only.
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:Fig 32: The relationship between laxity at week 20 and the rate of change during the
pregnancy expressed as degrees per week for the multiparous subjects only.
The scatter plots shown above reveal that the rate of change between the
, two groups was quite different. The slope of the multiparous group is
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almost flat demonstrating little correlation between laxity at 20 weeks and
the rate of change.
This was confirmed with a correlation calculation that showed a strong
relationship in the primiparous group (without the hypermobile subject)
between the rate of laxity change and the laxity at 20 weeks (p=0.0194
,r=0.484, r2 = 0.234 ), whilst in the multiparous group the relationship
between the rate of laxity change and the change at 20 weeks was very
weak, (p=0.926, r= 0.024, r2= 0.0006).
Discussion and conclusions
The basis of this study was the fact that for the last eighty years
researchers have noted that pregnancy is associated with ligamentous
laxity and an increase in joint mobility (Hisaw, 1926; Abramson et al.,
1934). However little appears to have been done to quantify this change
or to understand the physiology behind the change. Do all women
change? When in the pregnancy does the change occur? Is the change
the same for all women or does her pre-pregnancy state have an effect
on the rate of change or the quantity of the change? What effects if any
'does parity have on'that change? These are the questions that the study
tried to address.
The study address~d the first question by looking at the scatter plots
obtained from the data both with and without a subject that was obviously
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hypermobile compared to the rest of the group. She is identified as the
outlier on the first scatter plot measured at more than sixty degrees on
the y axis of the graph. It was thought that the second scatter plot would
give a more representative view of a normal pregnancy. All statistical
analysis was done with the hypermobile subject excluded.
The study showed that changes in laxity were not uniform throughout the
pregnancy. On comparison of the mean laxity between different groups,
each relating to a specific ten weeks of pregnancy, the majority of
subjects changed during the middle part of the pregnancy which is earlier
than the findings in the literature review (Calguneri et al., 1982; Mamach
et al., 1983). Specifically the changes were highly significant between
weeks 11-20 and 20-30, and between weeks 20-30 and 30-40.
The significance of the timing of the laxity change may well have an effect
on the appearance of low-back pain and sacro-iliac joint pain during a
pregnancy.
These problems are described as minor problems of pregnancy in
standard obstetric text books (Llewelyn Jones, 1997; Bennet, 1993). The
literature shows that it may well be a minor problem associated with a low
rate of morbidity, and little obstetric risk, but it is a very common problem
• nevertheless. Research groups from around the world including
Scandinavia, the UK and Australia have studied the problem. Orvieto et
.-
al., (1994), reported an incidence of 54.8 % in 449 patients; Sturesson in
1997 reported an incidence of 51% in 335 patients and Mogren and
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Pohjanen in 2005 reported an incidence of 72% in 891 patients (Orvietto
et al., 1994; Sturesson et al., 1997; Mogren et al., 2005).
The relationship between the rising levels of the hormones relaxin and
oestrogen and joint laxity is potentially an important as a factor
contributing towards back pain in pregnancy. The fact that these women
are increasing their body weight by up to two stones (12 kg) at the end of
a' physiological pregnancy (Bennet RV 1993), means that as the weight
increases so does the physical stress placed upon the supporting
structures. Her posture will also change during the pregnancy so as to
adapt to the increasing weight and this too has been attributed as one of
the factors causing back pain (Dumas et al., 1995; Sihvonen et al., 1998;
.
Gilleard et al., 2002). Lumbar apophyseal joints are not usually weight
bearing joints but with the developing lordosis of the progressing
pregnancy they can become weight bearing, and if the rising levels of the
hormones cause a temporary laxity in the joints the instability will cause a
stretch on the capsules of the joints, rich in nocieceptive pain fibres, and
thus low-back pain (Nadaud et al., 2001).
The development of a spondylolisthesis during pregnancy has been
identified as part of pregnancy back pain syndrome for many years
_(Lansac et al., 1969). Pregnancy is a risk factor for those with an existing
problem as well as those with the problem as yet unidentified. A risk
"analysis published in 1986 found that pregnancy did not constitute a
major risk for the progression of an existing spondylolisthesis but it was
felt to be a contributing factor to early degeneration Saraste, (1986). A
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later paper in 1996 examined the evidence from 949 women and 120
men and they concluded that women who had borne children had a
significantly higher incidence of degenerative spondylolisthesis than
nullliparous women, (28% versus 16.7%) concluding therefore that
pregnancy was an important factor in the development of a degenerative
spondylolisthesis (Sanderson et al., 1996). The importance of these
works is the contribution they make to an understanding of the aetiology
of the problem. There are a number of reasons why there is a forward slip
of one vertebra on another. The origin can be a congenital defect of the
pars interarticularis or it may be a fracture of the pars. If there is
excessive wear of the L4/5 disc accompanied by either a change in facet
joint angles or degeneration of those facet joints at that level, this too can
lead to a forward slip of one vertebra on another. In all cases the stability
of the segment is controlled by the integrity of the ligaments of the spine
holding bones together. If the ligaments are weakened, or if there is an
increase in body weight then logically the risk of segment failure must be
increased.
The pregnancy study showed that all of the women measured underwent
an increase in joint laxity and that they changed in the middle of the
• pregnancy. An area of future research might be to devise a questionnaire
..
to see if this also corresponded with the onset of back pain in pregnancy.
In an as yet unpublished cohort analysis of patients attending the
Expectant Mothers Clinic at The British School of Osteopathy, back pain
was a common symptom for women presenting for treatment. The data
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analysis of that study reveals that the back pain came on as early as 12
weeks in some subjects, but it took a further 10 weeks for them to seek
help. This poses a question as to the relationship between the onset of
the pain, the time it takes it to report the pain and her pregnancy laxity.
She might be exhibiting early laxity change and therefore, she may start
to exhibit back pain earlier than someone whose rate of change and
therefore ligamentous laxity is slower.
The data relating to rate of change were found to be interesting. It might
be assumed that if one subject was demonstrably more lax (but not
hypermobile) compared to the rest of the group then she should change
quickly under the influence of the ovarian hormones. Whilst some
subjects did change in this expected way it was by no means universal as
can be seen on the scatter plots. This is confirmed by correlation analysis
which revealed the correlation coefficient was not significantly different
from zero (r= 0.186). Why this should have been apparent was not able to
be explained. The clinical relevance relating to this change shows that
because there was no significant rate of change difference based on the
laxity at the start of the pregnancy (and presumable therefore her pre-
pregnancy laxity), women who are relatively more lax at the start of the
• pregnancy should not necessarily exhibit any more or less tendency to
..
back pain when compared to any other women assuming laxity and back
pain are related. Future studies might explore this by trying to measure
women before they conceive and then try to follow them throughout their
pregnancy and measure the rates of change. An obvious place to recruit
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subjects for this prospective study would be a hypermobility clinic run at a
hospital rheumatology department
In the pregnancy study the parity of the subjects was considered worthy
of analysis in relation to joint laxity. The literature review only produced
two papers that even mentioned parity and joint laxity or back pain of
pregnancy and those authors held different views (Calguneri et al., 1982;
Schauberger et al., 1996).
A Mann Whitney U test showed a significant difference in mean laxity
readings obtained from the primaparous and multiparous subjects
(p=0.001 for both). The correlation calculation in both cases suggested a
strong correlation betWeen the weeks of pregnancy and joint laxity for
both groups (p< 0.0001).
A squared ranks approximate equality of variance test showed the
primaparous group exhibited change earlier than the multiparous group
with change being significant between weeks 1-10 and 11-20. The
multiparous group demonstrated this change between weeks 11-20 and
31-40. Both weeks demonstrated significant change between weeks 31-
40 .
• The rate of change was different between the two groups too. The
..
correlation calculation showed a very weak association between the rate
of laxity change and the laxity at twenty weeKs in the multiparous
group(r=0.484 for the primaparous group and r= 0.024 for the multiparous
group.
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The inference from this data analysis comparing prima parous to
multiparous subjects is that whilst both groups changed, the change in
the primaparous group was earlier and quicker than the multiparous
group. Once again the clinical significance of this change is yet to be
determined.
The explanations and thus the clinical significance of these results are
unexplained in the literature review. It may be that there was a difference
between subjects in the timing of subsequent pregnancies. If a woman
has children close together will this influence the laxity change exhibited
in the second pregnancy? The weight gain and the weight of the foetus at
term may be significant in the way her tissues changed too. Further
studies comparing prima parous and multiparous subjects would need to
investigate the descriptive statistics carefully in order to examine these
potential sources of error that might affect the results. Also increasing the
numbers of subjects recruited will reduce the magnitude of any error
observed.
The study has attempted to answer the research questions posed above
• and their potential clinical significance. When treating pregnant patients
with back pain, knowledge of when in the pregnancy laxity changes might
occur will lead to a different choice of rnanuaf techniques. For example a
long lever technique may overstress the tissues at the end of the
pregnancy. Likewise it would be better to restrict the treatments to shorter
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treatments in order to avoid overstraining the tissues. Advice about rest
and activity at different stages of the pregnancy too would be more
accurate if there was some knowledge of when laxity changes might
occur.
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Introduction
After studying the effects of pregnancy on peripheral joint laxity, it was felt
that logically a study into laxity in the post-partum period should be
undertaken next. Do women retain their laxity observed at the end of a
pregnancy into the post-partum period or not? If they do retain joint laxity,
what part does breast as opposed to bottle feeding have to play, if any?
How quickly after having a child do women appear to return to pre-
pregnancy laxity values?
These are the research questions the post-natal study addressed.
Literary review: Breast feeding and lactation.
It is the practice of midwifery departments and health visitors to
encourage breast feeding in new mothers if at all possible.
The Infant Feeding 2000 survey was conducted by BMRB Social
Research, on behalf of the Department of Health, the Scottish Executive,
the National Assembly for Wales and the Department of Health, Social
Services and Public Safety in Northern Ireland. The survey provides
'"
national statistics on the incidence, prevalence, and duration of
breastfeeding and other feeding practices adopted by mothers in the
early weeks up to about nine months after birth.
According to the survey 69% of mothers breast fed at birth. As expected
there was a general reduction in the proportion of mothers breast feeding
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as babies got older. The proportion of mothers still feeding by the time the
baby was six months old and nine months old respectively was down to
21% and 13% respectively, (Hamlyn et al., 2000).
In the Federal Drug Administration magazine of October 1995, Professor
Ruth Lawrence from The University of Rochester School of Medicine is
quoted as saying, "The academy recommends that babies be breast-fed
for six to 12 months. The only acceptable alternative to breast milk is
infant formula. Solid foods can be introduced when the baby is 4 to 6
months old, but a baby should drink breast milk or formula, not cow's
milk, for a full year". She goes on to say, "There aren't any rules about
when to stop breast-feeding; as long as the baby is eating age-
appropriate solid foods, a mother may nurse a couple of years if she
wishes. A baby needs breast milk for the first year of life, and then as
long as desired after that" (Williams, 1995).
The FDA advice is given to women in the USA; in the third world breast
milk is often the only food available for babies in their first few months of
life. The idea of breast feeding being the best thing for the baby is
promoted as being the natural thing to do. Certainly for a healthy baby the
physiological effects of breast feeding from a well fed and healthy
lactating mother are very difficult to challenge providing the mother wants
to breast feed and is able to do so.
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There are many reasons why mothers give up breast feeding or do not
want to start or are unable to start in the first place. They include personal
statements relating to how they felt about their own bodies or the
convenience of bottle feeding to reasons related to the baby such as not
latching on or failing to thrive. Nowhere is there any evidence that women
fail to breast feed, or stop breast feeding, because they have musculo-
skeletal pain.
Little research has been done on the adverse effects for the mother of
breast feeding. What evidence there is of mothers being advised not to
feed relates to either serious illness that may be passed on through the
.
child through the milk such as AIDS, or it may be because the mother is
taking medication that may pass through into the milk and thus adversely
affect the child (Department of Health advice leaflet, 2004).
Post-partum joint pain is not a major factor in women's lives but it can be
very real when present. Certainly anecdotally this author has encountered
many women with back pain later in life who have related the onset of this
pain to either pregnancy or the post-partum period.
A through search through the NLM and Medline data-bases failed to
"produce many papers that have explored laxity in peripheral joints at this
time. One paper mentioned post-natal laxity in passing but it did not give
a mechanism for this laxity and did not distinguish between those women
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who breast feed their babies and those who do not (Schau berger et al.,
1966).
Pelvic girdle pain, particularly pubalgia post-partum, has been studied in
depth with varying conclusions being drawn from the work. In a study in
Denmark in 2000, 1600 women entered the study and 2% reported post-
partum pelvic pain after 12 months (Larsen et al., 2000). Similarly in a
study in South Africa, 4.9% of a group of reported hypermobile women
reported pain continuing into the post-partum period (van Dongen et aI.,
1999). There was little evidence shown in the studies attributing the post-
partum pain to continuing laxity.
The physiology of lactation
Lactation is controlled principally by the hormones prolactin and oxytocin
produced by the anterior and posterior parts of the pituitary gland
respectively. Oxytocin is present during the third stage of labour when it
brings about the separation of the placenta and the contraction of the
uterine muscles to prevent post-partum haemorrhage. It then continues to
be secreted as a consequence of the infant's suckling and it aids the
involution of the uterus and the expression of-the milk (the so-called let
down reflex). As the placenta is expelled, the circulating level of human
chorionic gonadotrophin (HCG), human placental lactogen (HPL),
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oestrogen, and progesterone all fall rapidly within the next forty eight
hours (West et al., 1979; McNeilly 2001).
Prolactin acts on the hormones which control the fertility cycle. At the
level of the pituitary gland it interferes with the action of gonadotrophin
releasing hormone (GNRH) and lutenising hormone (LH). Thus there is
no stimulation of the ovarian follicles and no ovulation during breast
feeding and in this way the production of ovarian oestrogen in the form of
oestradiol is inhibited (Rolland et al., 1975; McNeilly, 2001).
During lactation, most women experience a time of amenorrhoea. This is
because of the effects of the circulating prolactin on the ovary and on the
hypothalamus. Whilst she is breast-feeding, ovarian secretion of
oestrogen and progesterone is below normal, and is equivalent to that
seen in post-menopausal women in spite of normal levels of FSH
(Rolland et al., 1975;Howie, 1993; Saarikoski, 1993; Jacob et al., 2004).
Complete weaning results in an immediate drop in the blood levels of
prolactin and an increase in blood levels of LH and oestradiol, indicating a
prompt resumption of ovarian activity. Ovulation usually occurs within 14
to 30 days. These results suggest that a maintained suckling stimulus,
d
and the associated hyperprolactinaemia, suppress LH but not FSH post-
partum and lead to both a failure of ovarian follicular development and
lactational amenorrhoea (Jacob et al., 2004).
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From the above then it is highly unlikely that the maintenance of
ligamentous laxity during breast-feeding if it exists is due to the effects of
oestrogen or progesterone because they are at sub-optimal levels.
At one stage relaxin was thought to have disappeared within forty eight
hours post-partum with the loss of the corpus luteum of pregnancy and
the placenta. However, recent studies seem to question this. In a study to
determine if relaxin could be measured in milk, and if so correlate to
concentrations in milk and serum (Eddie et al., 1989), paired samples of
milk and serum were collected from sixteen women three days after pre-
term delivery and from twelve women three days after term delivery. Eight
term and six pre-term women were sampled again six weeks post-
partum. At six weeks post-partum, relaxin was not measured in any sera
but was measured in milk from six of the eight patients in the term group
and five of six patients in the pre-term group. They concluded that the
presence of relaxin in milk at six weeks post-partum when there is neither
a corpus luteum of pregnancy nor any placental source, suggests a non-
luteal site of synthesis. Current thought is that mammary tissue is the
probable source of the relaxin from the breast tissue (Tregear, 2004).
This finding has yet to be confirmed by other co-workers.
In 1992 one study looked at the effect of relaxin on oxytocin levels (Way
and Leng, 1992) The researchers found that the injection of porcine
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relaxin caused a sustained increase in circulating plasma oxytocin and
vasopressin.
Another group a year later found a relationship between vasopressin and
relaxin (Weisinger et aI.1993). In order to make milk women are in a state
of negative water balance whereby they retain water in the tissues to
contribute towards the milk production. A study into thirst and breast
feeding (James et al., 1995) suggested a mechanism for the changes in
osmolarity. They suggested that suckling sends nerve impulses to the
paraventricular and supraoptic nuclei in the hypothalamus which may
have afferents within the central nervous system which stimulates a thirst
response simultaneous with oxytocin release. In theory the change in
osmolarity means that breast-feeding mothers are "water logged"
compared to the non breast-feeding mothers. This hypothesis is
supported by a research group in 1994 (Wilson et aI., 1994) who
examined the effects of exogenous relaxin on oxytocin and vasopressin
release.They found that when rats were injected with relaxin there was an
increase in the levels of both oxytocin and vasopressin, but that the
effects of oxytocin at the level of the mammary gland might be obscured
by the action of vasopressin affecting blood flow to the gland. In other
words the effect is central more than local., supporting the water retention
#
hypothesis. If the water is to be retained the ideal place would be the
loose interstitial tissues present at the end of pregnancy again due to the
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relaxin effect, and the maintenance of breast-feeding therefore has the
potential link with an increased joint mobility.
The aim of the post-natal study
The aim of the post natal study was to investigate the potential change in
laxity in breast and bottle feeding mothers.
The Hypotheses
The main experimental hypothesis was that there is a difference in
measured joint laxity in those mothers who breast fed their baby as
opposed to those who bottle fed their baby.
The null hypothesis is that there is no difference between the two groups.
The second experimental hypothesis was that there would be a
• significant statistical difference in measured joint laxity when comparing
the last pregnancy readings to the post natal reading in each group.
The second null hypothesis was that there is no significant difference
. when comparing the last pregnancy readings to the post-natal reading in
each group.
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Method and research protocol
Continuous quantitative data were collected from 28 subjects using the
hyperextensometer as described before. They were broken down into two
groups of subjects, 17 of whom were breast-feeding their babies and 11
were bottle-feeding their babies. If a mother had started to breast-feed
and then stopped in favour of bottle-feeding this was thought to be a
confusing variable in the data and so she was rejected from the study.
They were measured from between 2 and 9 weeks post-partum with an
average of 6 weeks post-partum. The subjects were studied when they
came back to the author's osteopathic practice for a post-natal check up,
or if they came back requiring treatment. All of the subjects had taken
part in the pregnancy phase of the study.
Results and statistical analysis
The data were analysed for normal distribution using a Shapiro-Wilk test.
• The result showed the sample was unlikely to be from a normal
'"distribution (p= 0.034 n= 28), therefore non-parametric tests were used
for the statistical analysis.
In order to investigate the first experimental hypothesis to compare the
measured laxity between the breast and bottle-feeding groups post-natal.,
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a Mann Whitney U test was applied to the data sh.owing the results to be
significant for a two tailed test (U= 137.5; n1=16 n2 = 11; p=O.0117).
Table 5: Descriptive statistics for the breast feeding group and the bottle feeding group
Breast Feeders Bottle Feeders
Weeks Weeks
Mean 6.375 Mean 5.363
SrDev 1.821 SrDev 1.567
SEM 0.455 SEM 0.472
Degrees Degrees
Mean 45.938 Mean 33.636
StDev 11.289 StDev 12.060
SEM 2.822 SEM 3.636.
The mean laxity was significantly different between those subjects who
breast fed their children and those who bottle fed their children. The null
hypothesis was thus rejected.
The data were subjected to a Kruskall Wallis test and the result showed
that there was no significant difference in variance between the
measurements obtained from the breast feeding and the bottle feeding
. gr.oups {p=O.084)."As this result was not significant, a post hoc test was
not c.onsidered necessary.
A correlation calculation for both gr.oups showed little evidence of
correlation between laxity and the number of weeks of breast .or bottle
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feeding respectively (p= 0.389, r=-0.2887, r= 0.0833 for the bottle
feeders and p= 0.864, r= 0.0466, r= 0.0021 for the breast feeders).
In order to investigate the second experimental hypothesis looking at the
potential difference in laxity change between the last pregnancy reading
and the post natal reading, a Mann Whitney U test was applied to the
data showing the results to be significant for a two-tailed test only in the
bottle fed group, (U=78.5, n=16, p=0.058 for the breast fed group;
U=107.5, n=11, p=0.001 for the bottle fed group). The experimental
hypothesis is thus rejected.
A Kruskall-Wallis test showed that there was a significant difference in the
variances when comparing the last laxity reading of pregnancy and the
post-natal laxity reading in both breast and bottle feeding groups The
breast feeding result did not show a significant difference in variance (p=
0.621) whilst the bottle feeding group did (p= 0.0002).
A correlation calculation found that there was no significant correlation
between laxity readings at the end of the pregnancy and the laxity
readings post natal in either group (r=0.4348, r =0.1891, p=0.0923 for
the breast feeding group; r=0.595, r =0.350, p=0.0835).
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Discussion and conclusions
The results draw mixed conclusions from the data.This was probably
because of the very small number of subjects available to test. If the
study were to be repeated then larger numbers would hopefully give more
meaningful data.
The literature review showed the importance given to breast feeding in
the current information available to mothers. It states that breast feeding
can continue until nine months post-partum and beyond. If there is an
effect on ligamentous laxity, such that the longer she feeds the greater
the effect on laxity then obviously there is a need for more information to
support the statement. This would be especially so if she was suffering
from post-partum back pain and it was felt that ligamentous laxity was
contributing to the problem. There is insufficient evidence available to
reliably inform patients that the continuation of breast feeding is having a
deleterious effect on her tissues. If her body is producing relaxin from a
non ovarian source (Eddie et al., 1989), then the effects if any of this
relaxin on post-natal ligamentous laxity have yet to be determined.
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Introduction
The final study in this series examines two groups of women after the
menopause. One group was using a prescribed HRT preparation, and the
other group, the control group, was not. The aim of the study was to
investigate if the use of HRT had any effect on the joint laxity in the
groups under study.
The menopause is a time in women's lives when changes to their
connective tissues occur due to oestrogen withdrawal. These changes
can be relatively minor changes to the skin and muscular tissues, or they
can involve muscular weakness of the pelvic floor leading to incontinence
and vaginal prolapse. As women get older they are liable to the effects of
osteoporosis in bone, and degenerative changes in the connective
tissues around their joints leading to osteoarthritis (Spector et al., 1997).
The following paragraphs review the role of the sex hormones on the
connective tissues at this time.
Literary Review: The Physiology of Menopause
Clinically, menopause is defined as Jhe cessation of menstrual cycles and
results from either follicular depletion, a "natural" menopause or surgical
removal of the ovaries defined as an "induced," or "surgicaL,"
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menopause (van Noord et al., 1997). However, apart from surgical
interventions, menstrual cycles seldom cease abruptly; there is an
interval termed the "peri-menopause" or "menopausal transition," during
which there are considerable hormonal fluctuations (Lobo, 2000). The
peri-menopause usually begins a few years before the last menstrual
cycle; the cycles become irregular, and there are often symptoms
suggesting a decline in oestrogen concentration. Oestrogen levels can
even swing higher than normal early in the peri-menopause, but an
abrupt decline in oestrogen occurs 6 months before menopause (Lobo,
2000).
The peri-menopause also extends for a few years after the last menstrual
cycle; during this time, transient and episodic bursts of ovarian activity
may occur, which may result in some vaginal bleeding (Lobo, 2000).
Natural menopause occurs in western Europe at a median age of 51.4
years, with a distribution ranging from 40-58 years (van Noord et al.,
1997). The age at onset of natural menopause and the risk for surgical
menopause both seem to be determined by familial factors as well as by
genetic polymorph isms of the oestrogen receptor (ER) (Weel et al.,1999).
Multiparity and increased body mass index (BMI) are associated with
later onset (Kato et al., 1998; Hardy, 1999), whereas smoking (Cramer et
al., 1995a; Windham et al.,1999), null parity and medically treated
"
depression, (Harlow et al., 1995), toxic chemical exposure, (Silbergeld
1998) and treatment of childhood cancer with abdominal-pelvic radiation
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and alkylating agents (Chiarelli et al., 1999) have been associated with a
younger age at onset.
All of these factors are important in themselves and in relation to the
woman's total physiology. One of the linking factors between the decline
of the sex hormones and the global effects of the menopause are the
effects of the declining hormone levels on the collagenous connective
tissues that form a fibrous connective tissue "skeleton" supporting all of
the body's structures. The connective tissues, and in particular collagen,
support and envelop the organs in the abdomen and pelvis, as well as
smooth and skeletal muscle in both form and strength throughout the
whole body ..The following paragraphs investigate the changes occurring
during the menopause and the effects in particular of the decline in the
levels of the sex hormones on the function of ligaments and muscular
tissues.
Hormonal Changes and the Menopause
The typical hormonal changes in the early follicular phase of
postmenopausal women compared with those of ovulatory women are..
shown in table 6. Compared with the typical hormonal changes in the
"
early follicular phase of ovulatory women, in post-menopausal women,
the most significant findings are the marked reductions in oestradiol (E2)
and oestrone .(E1) levels. The serum E2 level is lower than the serum E1
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level. Serum E1 is produced primarily by peripheral aromatization of
androgens, which are not as dramatically affected by menopause.
Apart from elevations in FSH and lutenising hormone (LH) occurring in
response to the oestrogen decline, pituitary hormones are not affected.
Specifically, growth hormone, thyroid-stimulating hormone, and
adrenocorticotrophic hormone levels are normal.
Table 6: Serum sex steroid concentration before and after natural and surgical
menopause.
From Hormone Replacement Therapy by Whitehead and Godfree Churchill Livingstone 1993
Oestrone Oestradiol
E1 E2 Progesterone Testosterone Androstenedione
. pmol/l pmilfl Nmol/l nmolll nmolll
Premenopausal
Early follicular 90-180 90-350 0.3-1.6 0.7-1.4 5.6-6.1
Late follicular 550-740 740-13909 0 1.0-2.8 6.4-7.0 ..
Mid luteal 260-370 520-870 >20-30 1.0-2.1 0
Postmenopausal
Natural. 75-150 35-55 0.3-0.8 0.7-1.0 2.1-3,1
Surgical 75-150 35-55 0.3-0.8 0.3-0.6 1.7-2.8
Serum prolactin levels may be very slightly decreased because prolactin
'"
is influenced by oestrogen status. Both the post-menopausal ovary and
the adrenal gland continue to produce androgens.
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Changes in mobility after the menopause are related to degeneration of
the joint surfaces that control the ability of the joints to move, the
supporting and moving skeletal muscles, both in bulk and in muscle
strength, and also the supporting connective tissues in the joint ligaments
and capsules.
The Effects of Declining Oestrogen
Oestrogen receptors are abundant throughout the body as has already
been seen in a previous the menstrual cycle chapter. The menopausal
decline of oestrogen leads to a decline in oestrogen stimulated effects on
a wide range of tissues other than in the genital tract. Oestrogen
receptors are abundant in the brain (Shughrue et aI.,1997) and oestrogen
is known to have a role in many brain processes, with the withdrawal of
oestrogen resulting in physiological and symptomatic changes.
Oestrogen is important for cerebral blood flow, cerebral glucose
administration, synaptic activity, neuronal growth, the survival of
cholinergic neurons, as well as such complex functions as cognition
(Saravia et al., 2004; Lu et al., 2004; Pfaff, 2004).
The decline of oestrogen and its effects specifically on
collagen
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Oestrogen levels have a positive effect on the stimulation of fibroblasts to
produce collagen, which is important for bone and skin (Bienkiewicz et
aI., 1966; Rajabi et aI., 1991). Both oestrogen and androgen receptors
have been identified in skin fibroblasts (Harvey et al., 1976). The loss of
collagen is more rapid in the first few years after menopause, and 30% of
skin collagen is lost within the first 5 years after menopause (Falconer et
al., 1996; Reay Jones et al., 2003).
The rate of collagen decrease is approximately 2% per year for the first
10 years after menopause. This statistic, which is similar to that of bone
loss after menopause, strongly suggests a link between skin thickness,
bone loss, and the risk of osteoporosis. In addition, reductions in collagen
support and atrophy of the vaginal and urethral mucosa have been
associated with a variety of symptoms, including uterine prolapse and
urinary incontinence (Slemenda et al., 1987). Therefore the loss of
oestrogen receptors after the menopause has a profound effect on
collagen and is an important reason why some patients are prescribed
HRT.
The decline of oestrogen and its effects specifically on
skeletal muscle
In the literature review in the chapter on the menstrual cycle study, ample
evidence was presented to suggest a strong link between phases of the
"
menstrual cycle and muscle performance.
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There have been many studies that have investigated the effects of HRT
and muscle strength after the menopause. A paper in 2005 suggested
that muscle strength begins to decline during the peri-menopausal years,
and this phenomenon is partly oestrogen dependant (Sirola and
Rikkonen, 2005). They go on to state that hormone replacement therapy
may prevent a decline in muscle performance. Patients must take the
hormone over an extended period if the effects are to work. In a paper
published in 2002, 40 post-menopausal women were randomly divided
into two groups. The study looked at hand strength, isokinetic knee
flexion and extension, and general physical activity, and the subjects
were measured before treatment and after three and six months. Their
data sugges_tthat the patients had to use HRT for longer than six months
for the muscle strength to be affected (Ribom et al., 2002). However, the
underlying mechanism of HRT action of muscle is still unclear as there is
considerable variation in the effects of HRT between different studies
(Siplia, 2003).
As women get older they are going to become more susceptible to
degenerative changes in their joints and in their supporting structures.
There have been studies that have linked degenerative change and HRT
(Spector et al., 1997) and they have concluded that HRT can reduce the
effects of osteoarthritis in penpheral joints. The changes in laxity in
particular have yet to be studied, and the effects of this laxity continuing
into the later years of a woman's life again have yet to be researched.
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The Hypotheses
The experimental hypothesis states that there is a difference in joint laxity
between those subjects who take an HRT preparation after the
menopause and a control group. The null hypothesis states that is no
difference in joint laxity after the menopause between women who take
HRT and a control group.
Ethical considerations
All subjects were given an appropriate information sheet about the
relevant study for them, and they were required to sign a consent form a
copy of which was given to them to keep. Ethical approval for the studies
had been obtained from the Ethics Committee of The British School of
Osteopathy.
Method and research protocol
Continuous quantitative data were collected using the
Hyperextensometer, as described in the previous chapters, from 50
female subjects. The subjects were obtained from the author's private
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practice and from a menopause clinic at a neighbouring GP practice. One
group of 25 subjects used Hormone Replacement Therapy (HRT) in a
combined oestrogen and progesterone preparation and the other group of
25 subjects did not use any HRT.
Hormone replacement therapy can be used in many forms and it was felt
that this may well be an important potential confounding variable to be
considered. Therefore only those women using a combined oral
preparation were accepted for measurement on the study.
The average ages of the groups were 54.44 years in the HRT group and
54.88 in the non-HRT group.
The patients at the GP practice were diagnosed as being post-
menopausal by a blood test for those experiencing menopausal type
symptoms. These included amenorrhoea, vaso-vagal symptoms and hot
flushes, and changes in connective tissues including vaginal mucosal
drying. Those who were diagnosed as being menopausal were then
offered HRT in various forms. On average the patients in the HRT group
had been taking the preparations for 1 year and three months.
The women were measured at weekly intervals on three consecutive
weeks.
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Results and statistical analysis
The data were analysed for normal distribution using a Shapiro-Wilk test.
The result showed the sample was unlikely to be from a normal
distribution (p= 0.0095 n= 150) therefore non-parametric tests were used
for the statistical analysis.
Table 7: Descriptive statistics for the HRT and non HRT groups
Reading One Reading Two Reading Three
HRT Non HRT HRT Non HRT HRT Non HRT
Mean 52.08 39.72 53.84 38.88 54.84 40.06
St Dev .19.31 13.48 18.7 13.24 18.69 13.77
SEM 3.86 2.7 3.74 2.65 3.74 2.75
HRTv non HRT
60 52.08 53.84 54.84e
1/1 50
Cl.= 1/1 40"tJ Q) HRTm ~ 30
... Cl .non HRT'0 .g 20
c::
lIS 10Q)
:!E
"" 0
Reading 1 Reading 2 Reading 3
Measuremept Intervals
Figure 33: The mean readings for the HRT and non HRT groups
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Figure 32 shows the mean readings taken from the HRT and non-HRT
groups over three weeks. It clearly shows that there is a difference
between the two groups. In order to investigate the significance of this
difference and to examine the experimental hypothesis, a Mann Whitney
U test was applied to the data showing the results to be significant for a
two tailed test (U= 3971.5; n1=75 n2 = 75; p=O.0001).
The mean laxity was significantly different between the HRT and the non
HRT groups, and the null hypothesis was thus rejected.
In order to ascertain where the differences lay, the data was subjected to
a Kruskall-wallls test to analyse the variances between the two groups.
The result showed that there was a highly significant difference in
variance between the group using HRT and the control group (p=O.0016).
A squared ranks approximate equality of variance test showed that there
was significant difference between the mean of HRT reading one and
each of the means of the non-HRT readings, but all other comparisons
were not significant.
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Discussion and Conclusions
The results clearly show that the experimental group did show a
significant increase in joint laxity as compared to the control group. It
appeared that the change was consistent across the three readings
The menopause represents a milestone in female health and, after
passing through it, women experience increased musculo-skeletal and
cardiovascular morbidity. One study from Oslo maintained that older age,
higher morbidity, and lower functional capacity are associated with fall
injuries. The inability to get up from the floor has been associated with
older age, higher morbidity and lower functional capacity. If a patient was
unable to get up from the floor it is a marker of failing health and a useful
predictor of serious fall injuries (Bergland et al., 2005). Muscle and joint
performance is an important determinant of functional capacity and
quality of life among the elderly and is involved in the maintenance of
balance.
A study from the Netherlands investigated the relationship between
duration and intensity of physical activity and disability ten years later. It
concluded that a physically active lifestyle was inversely proportional to
disability (van den Brink et al., 2005). If elderly patients suffer from
"degenerative diseases of the weight-bearing joints then they tend to sit
longer and not challenge their joints rather than walk and suffer pain. This
can have a negative effect on their cardio-pulmonary systems. A paper
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from Denmark looked at outdoor activity performance in patients suffering
from chronic obstructive pulmonary disease. Patients reporting on their
outdoor activity (n= 148), were compared to immobile patients. They
reported that the mobile group of patients had higher performance status,
higher body mass index, and lower duration of oxygen administration,
than the immobile group (Ringbaek, 2005).
The menopausal study showed a retained laxity, or reduced stiffness, in
the experimental group as compared to the control group. This laxity
allows patients a greater mobility and thus a better quality of life
alongside the muscle strength changes mentioned in the literature review.
Paradoxically it may lead on to degenerative changes in the joints
because they continue to be used for strenuous activities much later. The
early stage of degeneration of the synovial joints involves a phase of
hypermobility or joint looseness as the depth of the articular cartilage is
reduced (van der Esch et al., 2005). It may be that the measured joint
laxity reflected this early change.
In clinical practice, the assessment of joint stiffness as well as joint pain is
used as a diagnostic feature when treating patients with degeneration of
their synovial joints. It is this author's opinion that knowledge of their
medication as it relates to the use..of HRT may influence the assessment
of normal mobility in these patients.
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The inclusion of HRT as part of a raft of measures used in the treatment
of degenerative joint disease in elderly women must be weighed against
the potential risk factors. If it has been seen to have a positive effect on
joint mobility as well as muscle strength then it may well be a factor
worthy of consideration in the mind of the prescribing clinician.
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Summary of findings
The results form the questionnaire revealed that there was a strong link
between the menstrual cycle and the timing, the location, and the
chronicity of pain. It was very interesting to note that there were two
peaks relating to the onset of a patient's pain, one corresponding to
ovulation and one at the end of the cycle corresponding to the
premenstrual phase of the cycle. Low-back pain and cervical spine pain
were both present at these times in the cycle. What was surprising was
that upper extremity pain appeared in the middle of the cycle and lower
extremity pain at the end of the cycle. The explanation for these findings
was not clear. However, what was clear from the study was the similarity
of evidence of injuries that occur in athletes with the responses from the
questionnaire.
The menstrual cycle study gave clear evidence that laxity changes during
the menstrual cycle, and that the level of oestrogen was significant to this
change. There was not clear evidence linking other hormones to changes
in joint laxity.
The pregnancy study showed that as expected from the literary review,
changes in laxity occur during pregnancy, in both primaparous and
multiparous women. What was different about this study was the rate of
chanqe of that laxity. It was not uniform throughout the pregnancy and
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there did not appear to be a clear correlation between her laxity at the
start of her measurements and the rate of change. One might have
expected a subject who was clearly hypermobile at the start of her
measurements as compared to the rest of the group, to be even more so
at the end of the pregnancy, but this was apparently not so. Likewise very
stiff subjects when compared to other subjects at the start of their
measurements did not have a clearly different rate of change. The study
did not have the opportunity to measure hormone levels in these women
and therefore to correlate the changes in levels of oestrogen and relaxin
with joint changes as it did in the menstrual cycle study. This was
unfortunate as it would have provided clear data on which hormones
appear and YVhenin relation to the laxity change of pregnancy. Johnson's
group in 1991 and 1994 has shown that relaxin in both IVF and natural
conceptions appears to be present at the end of the pregnancy, but
information as to its first appearances is still unclear (Johnson et al.,
1992, 1994).
Unfortunately the post-natal study did not reveal a definite conclusion.
The small numbers of subjects involved who returned to be checked
meant that there was not sufficient data to give a clear picture of the laxity
changes. If the study were to be repeated, then firstly the importance of
coming for the post-natal check at slx weeks post-partum could be
emphasised to the participants which might encourage them to make the
effort to return to be measured. Alternatively if the subjects in the
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pregnancy and in the post-natal study came from an antenatal clinic
either in a hospital or in a GP practice, then they could be approached to
be measured when they attended for their six weeks post-natal obstetric
check.
The menopausal study again revealed a clear link between the increased
laxities in the experimental group when compared to the control group.
The implications of this that relate to the development of degenerative
changes in the weight-bearing joints are thought to be very interesting,
and they could be another factor to be borne in mind by a clinician who
was making the decision to prescribe HRT for a patient or not.
Further research opportunities
The questionnaire is worthy of refining and repeating. More attention to
the wording of the questions relating to the site of pain and giving more
groups for the patient to choose from would lead to greater specificity in
defining and describing the painful area. Also if the questionnaire could
be designed such that the patient filled out the form instead of the
practitioner it may well remove an element of bias from the study. The
use of tick boxes could be helpful here. The use of a visual analogue
scale would give an indication of the severity of the pain and thus add
weight to the questions relating to the nature of the pain.
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The menstrual cycle study could be repeated with greater numbers
without too much difficulty. If it was repeated in a institution such as a
university hall of residence, a military facility or a prison where the
population was fixed and resident, the subjects would be available for
measuring on a daily basis over a number of consecutive menstrual
cycles. The levels of oestrogen could be obtained from urine samples,
however, the levels of progesterone and relaxin would be much more
difficult to obtain as they do not appear in the urine. Repeated daily
serum samples are the only reliable way to obtain data about these
hormones, but this is a very invasive procedure and would require careful
ethical controls. Perhaps the collection of data in conjunction with an IVF
unit where women's blood was being measured on a daily basis for other
reasons would be a more practical solution. Following subjects over three
or more cycles would give a much clearer picture of what is happening
from cycle to cycle, giving the researchers a clearer understanding of just
how representative the data obtained from the menstrual cycle are.
The pregnancy study could be repeated when the women are going for
routine blood tests anyway during the pregnancy and this would give a
clearer picture of the changes occurring during pregnancy.
In each of the studies more subjects measured would give more data to
be analysed and thus a clearer view of the laxity changes at each stage
in a woman's reproductive life.
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The Hyperextensometer proved to be a reliable and cheap way of
examining the laxity at the first metacarpo- phalangeal joint with little
distress or inconvenience to the subjects being measured. For this
reason I would recommend its use again in this type of research .
..
155
SUMMARY
Fallarl tu Si.fJO
cOrJahll1of] bf:ibv
hlJdty )Jra~J::jt fa£:tJ]
IIWrIJar.s; ~wjd bOWB
in laxity were
women using
not. Oestrogen
responsible for
Bibliography
References
156
Bibliography
A
Abitbol J, Abitbol P, Abitbol B, 1999. Sex hormones and the female
voice. J Voice 13(3):424-46
Abramson 0, Roberts SM, Wilson P, 1934. Relaxation of pelvic
ligaments in pregnancy. Surg.Gynae. Obstet 58 (595)
Abubaker AO, Hebda PC, Gunsolley IN, 1996. Effects of sex
hormones on protein and collagen content of the temporomandibular joint
disc of the rat. Journal of Oral and Maxillofacial Surgery 54(6) 721-7
Albert H, Godskesen M, Westergard JG, Chard T, Gunn L, 1997.
Circulating levels of relaxin are normal in pregnant women with pelvic
pain. Eur J Obstet Gynael Reprod Bioi 74(1):19-22
Allen MJ, Bailey N, 1982. Stability of grip strength during the menstrual
cycle. Perceptual and Motor Skills 55: 1138
..
Arendt EA, 2001. Anterior cruciate ligament injuries. CUff Womens
Health Report, 1, 211-7.
157
Bibliography
Arendt EA, Bershadsky B and Agel J, 2002. Periodicity of non contact
anterior cruciate ligament injuries during the menstrual cycle. J Gend
Specif Medic, 5, 19-26.
Arnold C, Van Bell C, Rogers V and Cooney T, 2002. The relationship
between serum relaxin and knee joint laxity in female athletes.
Orthopaedics, 25, 669-73.
Aufdemorte TB, Van Sickels JE, Dolwick MF, Sheridan PJ, Holt GR,
Aragon SB and Gates GA ,1986. Oestrogen receptors in the
temporomandibular joint of the baboon: an auto-radiographic study Oral
Surg Med Qral Pathol, 61,307-14.
B
Bagnell CA, Zhang Q, Downey B, Ainsworth L, 1993.
Sources and biological actions of relaxin in pigs. Journal of Reproduction
and Fertility - Supplement 48: 127-38
Bajaj P: Arendt-Nielsen L, Bajaj P, Madsen H, 2001. Sensory changes
during the ovulatory phase of the menstrual cycle in healthy women.Eur J
Pain 5(2): 135-44
158
Bibliography
Bani 0, 1997.Relaxin: a pleotropic hormone (review)
General Pharmacology 28(1): 13-22
Barnes JM, 1934. Concerning X-Ray and clinical studies of pelvic joints
in pregnant humans. Roentgeonology 32 (333) :1934
Bassey EJ, 1997. Measurement of muscle strength and power.
Muscle Nerve Suppl. 5: S44-6.
Beehet OM, Perry BN, Toong A and Lovell RO, 1986. Oestrogen
specific binding sites in bovine muscle nuclei. J Steroid Biochem, 24:
1127-34.
Becker 0, Creutzfeldt OD, Sehwibbe M and Sehwibbe W, 1982.
Changes in physiological ECG and psychological parameters in women
during the spontaneous menstrual cycle and following oral contraception.
Psychoneuroendocrinology, 7 (1):75-90.
Bennett RV, and Brown LK, (1993). Myles Textbook for Midwives.
Churchill Livingstone
Benson JE, Geiger CJ, Eiserman PA and Wardlaw GM, 1989 .
.¥
Relationship between nutrient intake, body mass index, menstrual
function and ballet injury. Am Diet Assoc., 89 (1): 58-63
159
Bibliography
Bergland A Laake K, 2005. Concurrent and predictive validity of "getting
up from lying on the floor".Aging Clin Exp.Res 17(3): 181-5
Bienkiewicz A, Welfel J, Kus E, 1996.
The influence of oestrogens, progesterone, and their antagonists on the
collagen content of the pregnant rat uterus. Hormone and Metabolic
Research 28(11) 592-4
Bjorkland ~,Nordstrum Nl,Bergstrom S, 1999. Sonographic
assessment of symphaseal joint distension during pregnancy and post-
partum with special reference to pelvic pain. Acta Obstet Gynaecol Scand
78(2): 125-30
Blankenship T, Stewart DR, Benirschke K, King B, lasley Bl, 1994.
Immunocytochemical localisation of non luteal ovarian relaxin
J Reprod.Medicine 39(4):235-40
Blecher AM, Richmond JC, 1998. Transient laxity of an anterior cruciate..
ligament reconstructed knee related to pregnancy.
Arthroscopy 14(1):77-9
160
Bibliography
Bongers- Binder S, Burgardt A, Seeger H, Voleter W, Lippert TH,
1991. Distribution of immunoreactive relaxin in genital tract and in the
mammary gland of non pregnant women. Clin & Exper Obstetrics and
Gynaecol18 (3):161-4
Borel JP, 1991. Uterine collagens a general review. Rev. Fr Gynaecol
and Obstet 86 (12) 715-22
Bowen RA, 2004. Pathophysiology of the reproductive system.
Colorado State University Web Site
http://arbl.cvmbs.colostate.edulhbookslpathphyslreprodlindex.html
Boyce BF, Hughes DE, Wright KR, Xing L, Dai A, 1999. Recent
advances in bone biology provide insight into the pathogenesis of bone
disease. Lab. Invest. 79(2): 83-94.
Bradshaw JM, Downing SJ, Moffatt A, Hinton JC, Porter DG, 1981.
Demonstration of some of the physiological properties of rat relaxin. J
ReprodFertil63(1): 145-53.
Brizzi E, De Carro R, Sgambeti E, Todesean GC, Munari PF, 1994
161
Bibliography
The organisation of the sub peritoneal connective tissue in the female
pelvis. Clinical and Experimental Obstetrics and Gynaecology 21(4):253-
8
Brockbank Cl, Chatterjee F, Bruce SA, Woledge RC, 2000.
Heart rate and it's variability change after the menopause
Experimental Physiology 85.3 327-30 Feb 2000
Brown E, McKee T, diTomaso E, Pluen A, Seed B, Boucher V, Jain
RK, 2003. Dynamic imaging of collagen and it's modulation in tumors in
vivo using second harmonic generation. Nat Med 9(6): 796-800.
Brown JS, Grady 0, Ouslander JG, Herzog AR, Varner RE, Posner
SF, 1999. Prevalence of urinary incontinence and associated risk factors
in postmenopausal women. Obstet Gyneco/. 94: 66-70.
Bruce SA, Phillips SK, Woledge RC, 1992(a). Strength and cross
sectional area of adductor pollicis muscle in men and women Journal of
Physiol, 446 :266P .
..
Bruce SA, Phillips SK, Woledge~C, 1997. Interpreting the relation
between force and cross sectional area in human muscle. Med. Sci.
Sports Exerc. 29(5):677-683
162
Bibliography
Bryant-Greenwood GO, Greenwood FC, Mercado-Simmen R, Weiss
T, Yamamoto 5, Ueno M, Arakaki R, 1982. Relaxin secretion and
relaxin receptors the linkage. Ann N Y Acad Sci 380: 100-110.
Bryant-Greenwood GO, 1982. Relaxin as a new hormone. Endoc review
3: 62-90.
Bryant-Greenwood GO 1991. The human Relaxins; consent and
dissent. Molecular and cellular endocrinology 79: 125-132.
Bryant-Gr~enwood GO, Rutanen EM, Partanen 5, Coelho TK,
Yamamoto SY,1993. Sequential appearance of relaxin, prolactin, and
IGFBP-1 during growth and differentiation of the human endometrium.
Molecular and Cellular Endocrinology 95(1-2): 23-9.
Bryant-Greenwood GO and Schwabe C, 1994. Human Relaxins
Chemistry and Biology. Endocrine Reviews 15(1): 5-26.
Brynhildsen JO, Hammar J, Hammar ML, 1997. Does the menstrual
cycle and use of oral contraceptives influence the risk of low-back pain?
A prospective study amonqfemale soccer players. Scand J Med Sci
Sports 7(6): 348-53
163
Bibliography
Brynhildsen JO, Bjors E, Skarsgard C, Hammar ML, 1998. Is hormone
replacement therapy a risk factor for low-back pain among
postmenopausal women? Spine 23(7): 809-13.
Burger HG, 1999. The endocrinology of the menopause. J. Steroid
Biochem Mol Bioi. 69: 31-35.
Burger HG, 1989. Inhibin and the regulation of testicular function
.Historical and clinical aspects. Ann N YAcad Sci 564: 1-9.
c
Calaf I and Aisina J, 1997. Benefits of hormone replacement therapy.
Overview and Update. Int J Fertil Womens Med 42(Suppl 2): 329-46.
Calguneri M, Bird HA,and Wright V, 1982. Changes in joint laxity during
pregnancy. Ann Rheum Dis, 41:126-8
Campbell SE, Febbraio MA, 2001. Effects of ovarian hormones on
mitochondrial enzyme activity oxidation pathway of skeletal muscle. Am
J Physiol Endocrinol. Metab; 281(4):E803
164
Bibliography
Casten GG and Boucek R, 1958. Use of relaxin in the treatment of
scleroderma. JAMA 166: 319-324.
Charlton WP, Coslett-Charlton LM, Ciccotti MG, 2001. Correlation of
oestradiol in pregnancy and anterior cruciate ligament laxity. Clin Orthop
387: 165-70.
Chen GO, Oliver RH, Leung BS, Lin LY, Yeh J, 1999. Oestrogen
receptor alpha and beta expression in the vaginal walls and utero sacral
ligaments of pre-menopausal and postmenopausal women. Ferti/.Steri/
71(6): 1099.-102.
Chiarelli AM, Marrett LD, Darlington G, 1999. Early menopause and
infertility in females after treatment for childhood cancer diagnosed in
1964-1968 in Ontario, Canada."_Am J Epidemiol. 150: 245-254.
Cimino R, Farella M, Michelotti A, Pugliese R, Martina R, 2000. Does
the ovarian cycle influence the pressure-pain threshold of the masticatory
muscles in symptom-free women? J Orofac Pain 14(2): 105-11.
Copas P, Bukovsky A, Asbury B. Elder RF, Caudle MR, 2001.
Oestrogen progesterone and androgen receptor expression in levator ani
165
Bibliography
muscle and fascia. Womens Heath Gender based medicine 10(8): 785-
95.
Cramer OW, Harlow Bl, Xu H, Fraer C, Barbieri R, 1995. Cross-
sectional and case-controlled analyses of the association between
smoking and early menopause. Maturitas 22: 79-87.
Cramer OW, Xu H, Harlow Bl, 1995. Family history as a predictor of
early menopause._Ferlil Steril. 64: 740-745.
Czarnacki J, Jablonski M, Walawski J, Rechberger T, 1999. The
influence of hormone replacement therapy on the certain metabolites
Ginekol Pol 70(9):604-9 Sept 1999;
D
Dahlberg E, 1982. Characterisation of the cytosolic oestrogen receptor in
rat skeletal muscle. Biochem Biophys Acta 717(1): 65-75.
Dahlberg l, Friden T, Roos H, lark MW, lohmander lS, 1994. A
longitudinal study of cartilage matr1x metabolism in patients with cruciate
ligament rupture ..synovial fluid concentrations of aggrecan fragments,
166
Bibliography
stromelysin 1 and tissue inhibitor of metalloproteinase 1. Br J Rheum
33(12); 1107-11.
Daumerie C, ludgate M, Costagliola S, Many MC, 2002. Evidence for
thyrotropin receptor immunoreactivity in pretibial connective tissue from
patients with thyroid-associated dermopathy. _Eur J Endocrinol. 146(1):
35-8.
Davies BN, Elford JC, Jamieson KF, 1991. Variations in performance in
simple muscle tests at different phases of the menstrual cycle. Journal of
Sports Medicine and Physical Fitness 31: 532-537.
Deie M, Sakamaki V, Sumen V, Urabe V, Ikuta V, 2002. Anterior knee
laxity in young women varies with their menstrual cycle. Int Orthop 26(3):
154-6.
Delancey J, 1992. Anatomic aspects of vaginal eversion after
hysterectomy. American Journal of Obstetrics and Gynaecology
166(pt10) (17): 17-24.
Department of Health 2004. Guidance from the chief medical officers
advice group on AIDS. http://omni,.ac.uklbrowse/mesh/D001942.html
167
Bibliography
Devi A and Benn PA, 1999. X-chromosome abnormalities in women with
premature ovarian failure. J Reprod Med 44: 321-324.
DiBrezzo R, Fort IL, Brown B, 1991. Relationships among strength,
endurance,weight,and body fat during three phases of the menstrual
cycle. Journal of Sports Medicine and Physical fitness 31: 89-94.
Don Tigny RL 1985. Function and pathomechanics of the Sacro Iliac
Joint. A Review. Phys Ther. 65(1) 35-44.
Dragoo JL., Lee RS, Benhaim P, Finerman GA, Harne SL, 2003.
Relaxin receptors in the human female anterior cruciate ligament. Am J
Sports Med 31: 577-584.
Dschietzig T and Stangl K, 2003. Relaxin: a pregnancy hormone as a
central player of body fluid and circulation homeostasis. Cell Mol Life Sci
60(4): 688-700.
Dumas GA, Reid JG, Wolfe LA, Griffin MP, McGrath MJ.1995.
Exercise posture and back pain during pregnancy. Clin Biomech( Bristol
Avon) 10(2): 98-103.
168
Bibliography
E
Eddie LW, Martinez F, Healy OL, Sutton B, Bell RJ, Tregear GW,
1990. Relaxin in sera during the luteal phase of in vitro fertilization
cycles. British Journal of Obstetrics and Gynaecology 97(3): 215-220.
Eddie LW; Sutton B, Fitzgerald S, Bell RJ, Johnston PO, Tregear GW,
1999. Relaxin in paired samples of serum and milk from women after
term and pre term delivery. Am J Obstet and GynaecoI161(4): 970-3.
Elliott K, 2001. The influence of reproductive hormones on maximal force
production in females. PhD Thesis Liverpool John Moores University.
Erb A, Brenner H, Gunther KP, Sturmer T, 2000. Hormone
replacement therapy and patterns of osteoarthritis: baseline data from the
Ulm osteoarthritis study. Ann Rheum Dis 59(2): 105-9.
Ewies AA, AI·AEzawi F, Thompson J, 2003. Changes in extra-cellular
matrix proteins in the cardinal ligament of post menopausal women with
169
Bibliography
or without prolapse a computerised immuno-histomorphometric analysis.
Hum Reprod 18(10): 2189-95.
Eddie LW, Martinez F, Healy 0 L, Sutton B, Bell R J , Tregar G W,
1990. Relaxin in sera during the luteal phase of in vitro fertilization
cycles. British Journal of Obstetrics and Gynaecology 97(3) 215-220
F
Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF, 1992.
Accelerated disappearance of ovarian follicles in mid-life: implications for
forecasting menopause._Hum Reprod. 7: 1342-1346.
Falconer C, Ekman-Orderberg G, Ulmsten U, Westergren- Thorsson
G, Barchan K, Malmstron A, 1996. Changes in para-urethral connective
tissue at menopause are counteracted by oestrogen.
Maturitas 24(3):197-204
Fazleabas AT, Bell SC, Fleming 5, Sun J, Lessey BA, 1997 .
..
Distribution of integrins and the extracellular matrix proteins in the baboon
endometrium during the menstrua1 cycleand early pregnancy. Biology of
Reproduction 56(2): 348-56.
170
Bibliography
Fevold HL, Hisaw FW, 1930. The relaxative hormone of the corpus
luteum .It's purification and concentration. J.Am.Chem.Soc 52: 3340-
3348.
Fiorini JR, 1987. Hormonal control of muscle growth. Muscle and Nerve.
10: 577-598.
Foos MJ, Hickox JR, Mansour PG, Siauterbeck JR, Hardy OM, 2001.
Expression of matrix metalloprotease and tissue inhibitor of
metalloprotease genes in human anterior cruciate ligament. J Orthop
Res. 19(4): 642-9.
Foutz CP, Dolezal HG, Gardner TL, Gill DR, Hensley JL, Morgan JB,
1997. Anabolic implants effects on steer performance, carcass traits,
subprimal yields, and longissimus muscle properties. J Anim Sciences
75(5): 1256-1265.
Franchimont P, Demoulin A, Valcke JC 1988. Endocrine,paracrine,and
autocrine control of follicular development. Horm Metab Res20(4): 193-
203.
Friden C, Hirschberg AL., Saartpk T 2003. Muscle strength and
endurance do not significantly vary across phases of the menstrual cycle
171
Bibliography
in moderately active premenopausal women. Clin Jour Sport Med 13(4):
238-41.
Friden C, Hirschberg AL., Saartok T, Backstrom T, Leanderson J,
Renstrom P, 2003. The influence of premenstrual symptoms on postural
balance and kinesthesia during the menstrual cycle. Gynecol
Endocrinol.17(6):433-9.
Frieden EH, Adams we 1985. Stimulation of rat uterine collagen
synthesis by relaxin. Proc Soc Exp BioI Med. 180(1): 39-43.
Fritsch H, 1994. Topography and subdivision of the pelvic connective
tissues in human foetuses and in the adult. Surgical and Radilogic
anatomy 16(3): 259-65.
Fuchs AR, Fuchs F, 1984. Endocrinology of human parturition; a
review. British Journal of Obstetrics and Gynaecology. 91(10): 948-967.
G
Ganong WF, 2003. Review of Medical Physiology, Lange. New York
USA
172
Bibliography
Gavino ES, Furst DE, 2001. Recombinant relaxin: a review of
pharmacology and potential therapeutic use. BioDrugs 15(9): 609-14.
Gigli I, Bussman LE 2001. Exercise and ovarian steroid hormones: their
effects on mitochondria respiration. Life Sci 1668(13): 1505-1514.
Goldsmith LT, Lust G, Steinetz BG, 1994. Transmission of Relaxin from
lactating bitches to their offspring via suckling. BioI Reprod 50(2): 258-65.
Gorai I, Taguchi Y, Chaki 0, Kikuchi R, Nakayama M, Yang BC,
Yokota S, Minaguchi H, 1998. Serum soluble interlukin 6 receptor and
biochemical markers of bone metabolism show significant variations
during the menstrual cycle. Journal of Clinical Endocrinology and
Metabolism 83(2): 326-32.
Greeves JP, Cable NT, Luckas MJ, Reilly T, Biljan MM, 1997. Effects
of acute changes in oestrogen on female muscle function of the first
dorsal interosseous muscle in humans. J Physiol (Lond) 50 (part 1): 265-
270.
Gur H 1997. Concentric and eccentric isokinetic measurements in knee
muscles during the menstrual cycle: a special reference to reciprocal
173
Bibliography
moment ratios. Archives of Physical Medicine and Rehabilitation 78: 501-
505.
Gustafsson JA, Saartok T, Dahlberg E, Snochowski M, Haggmark T,
Eriksson E, 1984. Studies on steroid receptors in human and rabbit
skeletal muscle - clues to the understanding of the mechanism of
anabolic steroids. Prog. Clin.Bio/.Res 142: 261-90.
H
Hall JA, Anthony RV 1993. Influence of ovarian steroids on relaxin
induced distensibility and compositional changes in porcine cervix.
Biology of reproduction 48(6): 1348-53.
Hall JA, Cantley TC, Galvin JM, Day BN, Anthony RV 1992. Influence
of ovarian steroids on relaxin induced uterine growth in ovariectomized
gilts. Endocrinology 130(6): 159-66.
Hama H, Yamamuro T, Takeda T, 1976. Experimental studies on
connective tissue of the capsular ligament. Influences of aging and sex
hormones. Acta Orthop Scand 47(5): 473-9.
Hamlyn B, Brooker S, Oleinikova K, Wands S. 2000.
174
Bibliography
Infant Feeding 2000.
www.dh.gov.ukl ...IPublicationsStatisticsArticle
Hansen A, Jensen DV, larsen E, Wilken·Jensen C, Petersen lK,
1996. Relaxin is not related to symptom giving pelvic girdle relaxation in
pregnant women. Acta Obstet Gynaecol Scand 75(3): 245-9.
Hapidou EG, Rollman GB, 1998. Menstrual cycle modulation of tender
points. Pain 77(2)151-61
Hardy R, Kuh D, 1999. Reproductive characteristics and the age at
inception of the perimenopause in a British National Cohort. Am J
Epidemiol. 149: 612-620.
Harlow Bl, Cramer DW, Annis KM, 1995. Association of medically
treated depression and age at natural menopause. Am J Epidemiol.(141):
1170-76.
Harvey W, Grahame R, Panayi GS. 1974. Effects of steroid hormones
on human fibroblasts in vitro 1. Glucocorticoid action on cell growth and
collagen synthesis. Ann rheum dis 33(5): 437-441.
175
Bibliography
Harvey W, Grahame R, Panayi GS, 1976. Effects of steroid hormones
on human fibroblasts in vitro 2. Antagonism by androgens of cortisol
induced inhibition. Ann rheum dis 35: 148-151.
Hatae J, 2001. Effects of 17 beta oestradial on tension responses and
fatigue in ther skeletal muscle fibres of frog. Jpn J Physiol 51(6): 753-9.
Haycock CE, Gillette JV 1976. Susceptibility of women athletes to injury
.Myth vs reality. JAMA 236(2): 163-5.
Hewett TE, 2000. Neuromuscular and hormonal factors associated with
knee injury in female athletes. Strategies for intervention. Sports Med
29(5): 313-327.
Hillier SL, Lau RJ, 1997. Vaginal microflora in postmenopausal women
who have not received oestrogen replacement therapy. Clin Infect Dis. 25
(SuppI2): S123-S126.
Hisaw FL, 1926. Experimental relaxation of the pubic ligament of guinea
pig. Proc.Soc.Exp.Biol.Med 23: 661-663.
Howie PW, 1993. Natural regulation of fertiI ity.Br Med Bull 49(1): 182-99.
"
176
Bibliography
Hsu SV, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Bathgate RA,
Sherwood OD, Hsueh AJ, 2003. Relaxin signaling in reproductive
tissues. Mol Cell EndocrinoI202(1-2): 165-70.
Hsu SV, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD,
Hsueh AJ, 2002. Activation of hormone receptors by the hormone
relaxin. Science 295(5555): 671-4.
Huang C, Li V, Anderson LL, 1993. Stimulation of collagen secretion by
relaxin and the effect of oestrogens on relaxin binding tissue in uterine
cervical cells of pigs. Journal of Repro. and Fertility 98(1): 153-8.
Hudson P, Haley J, John M, Cronk M, Crawford R, Haralambidis J,
Tregear G, Shine J, Niall H, 1983. Structure of a genomic clone
encoding biologically active human relaxin. Nature. 17-23(301(5901)):
628-31.
Ivell R: Einspanier A, 2002. Relaxin peptides are new global players.
Trends Endocrinol Metab 13(8): 343-8.
177
Bibliography
Ivell R, Hunt N, Khan-Dawood F, Dawood MY, 1989. Expression of the
human relaxin gene in the corpus luteum of the menstrual cycle and the
prostate. Mol Cell EndocrinoI66(2): 251-5.
Iwahashi M, Muragaki Y, Ooshima A, Yamamoto M, Nakano R, 1996.
Alterations in distribution and composition of extracellular matrix during
decidualisation of the human endometrium. J Reprod and Fert
108(1):147-55 Sept 1996
J
Janse de Jonge XA, Boot CR, Thom JM, Ruell PA, Thompson MW,
2001. The influence of menstrual cycle phase on skeletal muscle
contractile characteristics in humans. J Physiol1(530 (part 1)): 161-166.
Jobbins B, Bird HA, Wright V, 1979. A joint hyperextensometer for the
quantification of joint laxity. I Mech E 8(2): 103-4.
Johnson MR, Abbas A, Nicolaides KH, Lightman SL, 1992.
Distribution of relaxin between human maternal and fetal circulations and..
amniotic fluid. J. of Endoc 134(2): 313-7.
178
Bibliography
Johnson MR, Abbas AA, Allman AC, Nicolaides KH, Lightman SL,
1994. The regulation of plasma relaxin levels during human pregnancy. J.
of Endocrin. 142(2): 261-5.
Johnson MR, Abbas AA, Irvine R, Riddle AF, Norman-Taylor JQ,
Grudzinskas JG, Collins WP, Nicolaides KH, 1994. Regulation of
corpus luteum function. Human Reproduction 9(1): 41-8.
Johnson MR, Abdalla H, Allman AC, Wren ME, Kirkland A, Lightman
SL, 1991. Relaxin levels in ovum donation pregnancies. Fertility and
Sterility 56(1): 59-61.
Johnson MR, Brooks AA, Steer PJ, 1996. The role of relaxin in the
pregnancy associated reduction in plasma osmolarity. Human
Reproduction 11(5): 1105-8.
Johnson MR, Carter G, Grint C, Lightman SL, 1993. Relationship
between ovarian steroids, gonadotrophins, and relaxin during the
menstrual cycle. Acta Endoc. 129(2): 121-5.
Johnson MR, Okokon E, Collins WP, Sharma V, Lightman SL, 1991.
The effect of human chorionic gO'1adotrophin and pregnancy on the
circulating level of relaxin. J Clin Endoc 72: 1042-47.
179
Bibliography
K
Kahlert S, Grohe C, Karas RH, Lobbert K, Neyses L, Vetter H, 1997.
Effects of estrogen on skeletal myoblast growth. Biochem Biophys Res
Commun 232(2): 373-8.
Kannus P, 2000. Structure of the tendon connective tissue. Scan J Med
Sports Sci 10(6): 312-20.
Kapila S, Xie V, 1998. Targeted induction of collagenase and stromelysin
by relaxin in unprimed and beta-oestradiol primed diarthrodial joint
fibrocartilagenous cells but not in synoviocytes. Lab Invest 78(8): 925-38.
Karageanes SJ, Blackburn K, Vangelos ZA, 2000. The association of
the menstrual cycle with the laxity of the anterior cruciate ligament in
adolescent female athletes. Clin .rSport Med 10: 162-8.
180
Bibliography
Karan A, Isikoglu M, Aksac B, Attar E, Eskiyurt N, Yalcin 0, 2004.
Hypermobility syndrome in 105 women with pure urinary stress
incontinence and 105 controls. Aech Gynaecol Obster 269(2): 89-90.
Kass L, Ramos JG, Ortega HH, Montes GS, Bussmann LE, Luque
EH, Munoz de Toro M, 2001. Relaxin has a minor role in rat mammary
gland growth and differentiation during pregnancy. Endocrine Reviews
15(3): 263-9.
Katayama H, Ohsawa K, Yaoita H 1984. Improvement of progressive
systemic sclerosis (PSS) with estriol treatment. Improvement of
proqresslve systemic sclerosis (PSS) with estriol treatment. Acta Derm
Venereol. 64(2): 168-71.
Kato I, Toniolo P, Akhmedkhanov A, Koenig KL, Shore R, Zeleniuch-
Jacquotte A, 1998. Prospective study of factors influencing the onset of
natural menopause. J Clin Epidemiol. 51: 1271-1276.
Khan-Dawood FS, Goldsmith LT, Weiss G, Dawood MY, 1989. Human
corpus luteum secretion of relaxin, oxytocin, and progesterone. J Clin
Endoccin Metab 68(3): 627-31.
181
Bibliography
Kimball J, 2004. Kimballs Biology Pages.
http://users.rcn.com/jkimball.ma.ultranetlBio/ogyPagesiPIProgesterone.ht
ml
Klute JJ, Bergman A, 1995. Hormonal Influence on the urinary tract.
Urologic Clinics of America 22(3): 629-39.
Kogestad 0, Biornstad N, 1990. Pelvic girdle relaxation. Pathogenesis
etiology, definition,and epidemiology. Tid esskraft For Den Norske
Laegeforening (Norwegian) 110(17): 2209-11.
Kramer MS, Kakuma R, 2002. Optimal duration of exclusive
breastfeeding. Cochrane Database Syst Rev. CD003517
Kristiansson P, Nilsson-Wikmar L, von Schoultz B, Svardsudd K,
Wramsby H, 1998. Back pain in invitro fertilised and spontaneous
pregnancies. Hum Reprod 13(11): 3233-8.
Kristiansson P, Svardsudd K, von Schoultz B, 1996. Serum relaxin,
symphaseal pain, and back pain during pregnancy. Am J Obstet
GynaecoI175(5): 1342-7.
Kristiansson P, Svardsudd K, von Schoultz B, 1999. Reproductive
.hormones and amnioterminal propeptide of type III procollagen in serum
182
Bibliography
as early markers of pelvic pain during late pregnancy. Am J Obstet and
Gynaecol 180(Part 1): 128-34.
Kucharz EJ, (1988). Hormonal control of collagen metabolism Part 1.
Endocrinologie 26(2): 69-79.
Kucharz EJ, 1988. Hormonal control of collagen metabolism Part 2.
Endocrinologie 26(4): 229-37.
Kuh H, 1996. Effects of progestogens on homeostasis. Maturitas 24(1-2):
1-19.
Kuhl H , 2000. Influence of the ovarian cycle on the central nervous
system. Ther Umsch. 59(4): 175-81.
Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson
S, Gustafsson JA, 1997. Comparison of the ligand binding specificity
and transcript tissue distribution of oestrogen receptors alpha and beta.
Mol Endocrinol. 138: 863-870.
L
183
Bibliography
Landgren BM, Unden AL., Diczfalusy E, 1980. Hormonal profile of the
cycle in 68 normally menstruating women. Acta Endocrinol (Copenh).
94(1): 89-98.
Lang JH, Zhu L, Sun ZJ, Chen J, 2003. Estrogen levels and estrogen
receptors in patients with stress urinary incontinence and pelvic organ
prolapse. Int J Gynae Obstet 80(1): 35-9.
Lansac J, Nelken S, Gaja J, Dumont M, 1969. Spondylilisthesis and
pregnancy. Rev Fr Gynae Obstet 64(12): 689-93.
Larsen EC, Wilken-Jensen C, Hansen A, Jensen DV, Johansen S,
Mineck H, Wormsley M, Davidsen M, Hansen TM, 2000. Pregnancy
associated pelvic pain. 1. Prevelance and risk factors. Ukeskr Laeger
162(36):4808-12
Lebrun CM, McKenzie DC, Prior JC, Taunton JE, 1995. Effects of
menstrual cycle phase on athletic performance. Med Sci Sports Exerc
27(3): 437-444.
Lee AB, Hwang JJ, Haab LM, Fields PA, Sherwood 00,1992.
Monoclonal antibodies specific for rat relaxin VI. Passive immunisation
"
with monoclonal antibodies during the second half of pregnancy disrupts
184
Bibliography
histological changes associated with cervical softening at parturition in
rats. Endocrinology 130(4): 2386-91.
Lemoine S, Granier P, Tiffoehe C, Berthon PM, Thieulant ML, Carre
F, Delamarehe P, 2002. Effect of endurance training on estrogen
receptor alpha transcripts in rat skeletal muscle. Acta Physiol Scand
174(3): 283-9.
Lemoine S, Granier P, Tiffoehe C, Rannou-Bekono F, Thieulant ML,
Delamarehe P, 2003. Estrogen receptor alpha mRNA in human skeletal
muscles. Med Sci Sports Exerc 35(3): 439-43.
LeResehe L, Manel L, Sherman JJ, Gandara B, Dworkin SF, 2003.
Changes in temporomandibular pain and other symptoms across the
menstrual cycle. Pain 106(3): 253-61
Lievertz RW,1987. Pharmacology and pharmacokinetics of estrogens.
Am J Obstet Gynecol. 156(5): 1289-93.
Liu SH, al·Shaikh R, Panossian V, Yang RS, Nelson SO, Soleiman N,
Finerman GA, Lane JM, 1996. Primary immunolocalisation of estrogen
and progesterone target cells in Jhe human anterior cruciate ligament. J
Orthop Res. 14(4): 526-33.
185
Bibliography
Liu SH, AI-Shaikh RA, Panossian V, Finerman GA, Lane JM, 1997.
Estrogen affects the cellular metabolism of the anterior cruciate ligament.
A potential explanation for female athletic injury. Am J Sports Med 25(5):
704-9.
Llewelyn Jones 0, 1990. Fundamentals of Obstetrics and Gynaecology,
Mosby.
Lobo R, 2000. Menopause management for the millennium. Medscape.
Loumaye E, Depreester S, Donnez J, Thomas K, 1984.
Immunoreactive relaxin surge in the peritoneal fluid of women during the
mid luteal phase. Fertil. Steril. 42(6): 856-60.
Lu H, Nishi M, Matsuda K, Kawata M, 2004. Estrogen reduces the
neurite growth of serotonergic cells expressing estrogen receptors.
Neurosci Res 50(1): 23-8.
Luque EH, Munoz de Toro MM, Ramos JG, Rodriguez HA, Sherwood
OD, 1998. Role of relaxin and oestrogen in the control of eosinophilic
lnvaslon and collagen remodelling in rat cervical tissue at term. Biology of
Reproduction 59(4): 795-800.
186
Bibliography
Luque EH, Ramos JG, Rodriguez HA, Munoz de Toro MM, 1996.
Dissociation in the control of cervical eosinophilic infiltration and
collagenogenesis at the end of pregnancy or alter pseudo pregnancy in
ovarectomised steroid treated rats. Biology of Reproduction 55(6): 1206-
12.
M
Maclennan AH, 1991. The role of the hormone relaxin in human
reproduction and pelvic girdle relaxation. Scandinavian journal of
Rheumatology Supplement(88): 7-15.
Maclennan AH, Nicolson R, Green RC, Bath M, 1986. Serum Relaxin
and the pelvic pain of pregnancy. Lancet 2(8501): 243-5.
Magos Al., 1998. The effects and analysis of the menstrual cycle. J
Biomed Engineering 10: 105-109.
187
Bibliography
Mann FA, Nonneman OJ, Pope ER, Boothe HW, Welshons WV,
Ganjam VK, 1995. Androgen receptors in the pelvic diaphragm muscles
of dogs with and without perineal hernia. Am J Vet Res 56(1): 134-9.
Marnach ML, Ramin KO, Ramsey PS, Song SW, Stensland JJ, An
KN, 2003. Characterisation of the relationship between joint laxity and
maternal hormones in pregnancy. Obstet GynaecoI101(2): 331-5.
Masiukiewicz US, Insogna KL, 1998. The role of parathyroid hormone,
in the pathogenesis,prevention,and treatment of postmenopausal
osteoporosis. Aging (Milano) 10: 232-239.
Mathias JR, Clench MH 1998. Relationship of reproductive hormones
and neuromuscular disease of the gastrointestinal tract. Digestive
diseases 16(1): 3-13.
Matrisian LM, 1994. Matrix metailopoteinase gene expression. Ann N Y
Acad Sci 732: 42-50.
McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW, 1995.
Analysis of oestrogen receptor function in vitro reveals three distinct
classes of anti-oestrogens. Mol Endocrinol. 9: 659-669.
188
Bibliography
Meyer HH, Rapp M 1985. Estrogen receptors in bovine skeletal muscles.
Anim Sci 60(1): 294-300.
Michel G, Baulieu EE, 1980. Androgen receptor in rat skeletal muscle:
characterisation and physiological variations. Endocrinology 107(6):
2088-2098.
Milam SB, Aufdemorte TB, Sheridan PJ, Triplett RG, Van Sickels JE,
Holt GR, 1987. Sexual dimorphism in the distribution of oestrogen
"
receptors in the temporomandibular joint complex of the baboon. Oral
Surg Med Oral Patho/64(5): 527-32.
Mogren 1M,Pohjanen AL 2005. Low-back pain and pelvic pain during
pregnancy: prevelance and risk factors. Spine 30(8):983-991
Mokrzycki ML, Mittal K, Smilen SW, Blechman AN, Porges RF,
Demopolous RI, 1997. Estrogen and progesterone receptors in the utero
sacral ligaments. Obstetrics and Gymaecology 90(3): 402-4.
Moller-Neilsen J, Hammar M,1989. Women's soccer injuries in relation
to the menstrual cycle and oral contraceptive use. Med Sci Sports Exerc.
21(2):1216-9.
189
Bibliography
Moore K, Dumas GA, Reid JG, 1990. Postural changes associated with
pregnancy and their relationships to low-back pain. Clinical Biomechanics
5(3): 169-74.
N
Nadaud MC, McClure 5, Weiner BK, 2001. Do facet joint capsular
ligaments contain estrogen receptors? Application to pathogenesis of
degenerative spondylolisthesis. Am J Orthop 30(10): 753-4.
Nicozisis Jl, Nah-Cederquist HO, Tuncay OC, 2000. Relaxin affects
the dentofacial sutural tissues. Clin Orthod Res 3(4): 192-201.
Norman RJ, Mcloughlin JW, Borthwick GM, YohkaichiyaT, Matthews
CD, Maclennan AH, de Kretser OM, 1993.lnhibin and relaxin
concentrations in early singleton,multiple and failing pregnancies:
relationship to gonadotrophins and steroid profiles. Fertility and Sterility
59(1) 130-7
Norstrom A, Bryman I, Wiqvist N, Sahni 5, Lindblom B, 1984.
Inhibitory action of relaxin on human cervical smooth muscle. J Clin
Endocrinol Metab 59(3): 379-82.
o
190
Bibliography
O'Byrne EM, Carriere BT, Sorensen L, Segaloff A, Schwabe C,
Steinetz BG, 1978. Plasma Immunoreactive relaxin levels in pregnant
and non pregnant women. J Clin Endocrinol Metab 47(5): 1106-10.
O'Day-Bowman MB, Winn RJ, Dzuik PJ, Lindley ER, Sherwood OD,
1991.Hormonal control of the cervix ill pregnant gilts III. Relaxin's
influence on cervical biochemical properties in ovarectectomized
hormone treated pregnant gilts. Endocrinology 129(4) 1967-76
Oettling G, Franz HB, 1998. Mapping of androgen, oestrogen and
progesterone receptors in the anal continence organ. Eur J Obstet
Gynecol Reprod 8ioI77(2) 211-6
Ohtera K, Zobitz ME, Luo ZP, Morrey BF, O'Driscoll SW, Ramin KO,
An KN, 2002. Effect of pregnancy on joint contracture in the rat knee. J
App PhysioI92(4): 1494-8.
Onambele G, 2002. Muscle strength control in women :Oestrogen ,ACE
and training effects. PhD Thesis University of London.
On Line Medical Dictionary 1, 2002. "Biotinylation: A technique
whereby biotinyl groups are incorporated into a molecule in vitro to
191
Bibliography
visualise specific substrates by incubating them with biotin labelled
probes." http://www.online.medical.dictionary.
Online Medical Dictionary 2, 2002. "Transcription factors are
endogenous substances usually proteins which are effective in the
initiation, stimulation, or termination of the genetic transcription process."
http://www.online.medical.dictionary.
Osgaard He, Andersson GBJ, Schultz AB, Miller JAA, 1993.,
Influence of some biomechanical factors on low-back pain in pregnancy
Spine 18(1) 61-65.
Ostergaard M ,Bind B, Thomsen BS, 1992. Pelvic insufficiency during
pregnancy. Ugeskrit For Laeger154(50) 3568-72.
Ostrowska Z, Swietochowska E, Zwirska-KOrezala K, Buntner B,
Pardela M, Drozdz M, 1997. Assesment ofthe relationship between
collagen metabolism : selected hormonal factors in extremely obese
women before a jejunoileostomy .Endocr. Regu 31(1) 55-62.
Overlie I, Moen MH, Morkrid L, Skjaeraasen JS, Holte A, 1999. The
endocrine transition around menopause--a five year prospective study
192
Bibliography
with profiles of gonadotropins, oestrogens, androgens and SHBG among
healthy women. Acta Obstet Gynecol Scand. 78: 642-647.
Orvieto R, Achiron A, Ben-Rafael Z, Gelernter I, Achiron R. 1994.Low-
back Pain of Pregnancy. Acta Obstet Gynaecol Scand 73(3) 209-14.
p
,
Palmer JA, Lau 1M, Hickey M, Simbah M, Rogers PH, 1996.
Immunohistochemical study of endometrial microvascular basement
membrane components in women using Norplant.
Human Reproduction 11(10) 2142-50.
Parry LJ, Poterski RS, Summerlee AJ, 1994. Effects of Relaxin on
blood pressure and the release of Vasopressin and Oxytocin in
anaesthetised rats during pregnancy and lactation. BioI Reprod 50(3):
622-8.
Persky AM, Green PS, Stubley L, Howell CO, Zaulyanov L, Brazeau
GA, Simpkins JW. 2000. Protective effect of oestrogens against
oxididative damage to heart and skeletal muscle in vitro. Proc Soc Exp
BioI Med 223(1): 59-66Peterson LK, Skajaa K, Uldbjerg N
Serum relaxin as a potential marker for preterm labour
193
Bibliography
British J Obstet and Gynae 99(4) 292-5 April 1992.
Petersen LK, Hvidman L, Uldjberg N, 1994. Normal Serum relaxin in
women with disabling pelvic pain during pregnancy. GynaecolObstet
Invest 38, 21-23 ..
Petersen LK, Skajaa K, Uldbjerg N, 1992. Serum relaxin as a potential
marker for preterm labour. British J Obstet and Gynae 99(4): 292-5.
Pfaff DW, 2004. Mechanisms of estrogenic effects on neurobiological
functions._Ernst Schering Reasearch Foundation Workshop 46: 79-88.
Phillips SK, Bruce SA, Woledge RC, Siddle N, 1992. Force and cross
sectional area of adductor pollicis muscles in post menopausal women
with and without hormone replacement therapy. J Physiol vol. 446
p.364
Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC, 1992.
Muscle weakness in women occurs at an earlier age than in men, but
strength is preserved by hormone replacement therapy. Clinical Science
vol 84 95-98.
194
Bibliography
Phillips SK, Gopinathan K, Meehan K, Bruce SA, Woledge RC, 1993.
Muscle strength changes during the menstrual cycle inhuman adductor
policis. Journal of Physiology vol. 473 p. 125 .
Phillips SK Rutherford OM, Birch K, Bruce SA Wolctdge RC, 1995.
Hormonal influences on muscle: evidence for the inotrophic effect of
oestrogen. Sports Exercise and Injury, 1 58-63
Phillips SK, Sanderson AG, Birch K, Bruce SA Woledge RC, 1996.
Changes inmaximal voluntary force of human adductor policis muscle
during the menstrual cycle. J. PhysioI496(2), 551-557
Pope WF, Maurer RR, Stormshak F, 1982. Distribution of progesterone
in the uterus, broad ligament, and uterine arteries of beef cattle . Anat
Rec 203(2): 245-50.
Q
Quadango O,Faquin L, (1991). The menstrual cycle: Does it affect
athletic performance? Physician and Sports Medicine 19: 121-124.
195
Bibliography
R
Rajabi MR, Dodge GR, Solomon S, Poole AR, 1991. Immunochemical
and immunohistochemical evidence of oestrogen mediated collagenolysis
as a mechanism of cervical dilatation in the guinea pig at parturition.
Endocrinology 128: 371-378.
Rao SS, Ranganekar AG, Saifi AQ, 1987. Pain threshold in relation to
sex hormones. Indian J Physiol Pharmacol31 (4): 250-4.
Rasanen T, Messner K, 2000. Estrogen dependent tensile properties of
the rabbit knee medial collateral ligament. Scand J Med Sci Sports 10(1):
20-7.
Reay Jones NH, Healy Je, King LJ, Saini S, Shousha S, Allen-Mersh
TG, 2003. Pelvic connective tissue resilience decreases with vaginal
delivery menopause and uterine collapse. Br J Surg 90(4): 466-72.
Rechberger T, Donica H , Baranowski W, Jacowicki J, 1993.
Female urinary urinary stress incontinence in terms of connective tissue
biochemistry. European J Obstet and Gynaecol and Reproductive Bioi
49(3) 187-91
196
Bibliography
Reginster JY, Kvasz A, Bruyere 0, Henrotin Y, 2003. Is there any
rationale for prescribing HRT to prevent or treat osteoarthritis?
Osteoarthritis Cartilage 11(2): 87-91.
Reis E, Frick U, Schmidtbleicher 0, 1995. Frequency, variations of
strength training sessions triggered by the phases of the menstrual cycle.
Int J Sports Med 16(8): 545-50.
Rennie MJ, 1999. Teasing out the truth about collagen. J Physiol
15.(521): Pt 1:1.
Ribom El, Piehl-Aulin K, ljunghall S, ljunggren 0, Naessen T, 2002.
Six months of hormone replacement therapy does not influence muscle
strength inpost menopausal women. Maturitas 42(£):225-31
Rice Pl, 1988. Relationship of estrogen to strength, percent body fat and
oxygen uptake in women. J Sports Med Phys Fitness. 28(2): 145-50.
Richards M, Kuh 0, Hardy R, Wadsworth M, 1999. Lifetime cognitive
function and timing of the natural menopause. Neurology 53: 308-314.
Ringbaek TJ, lange P, 2005. Outdoor activity and performance status
as predictors of survival in hypoxic chronic obstructive pulmonary
disease. elin Rehab 19(3): 331-8
197
Bibliography
Robinson D, Cardozo L, 2003. The menopause and HRT Urogenital
effects of hormone therapy. Best Practice Clin Endocr Metabolism 17(1):
91-104.
"
Robinson D, Rainer RO, Washburn SA, Clarkson TB, 1996. Effects of
oestrogen and progesterone replacement in the urogential tract of the
ovarectomised cynomolgus monkey. Neurology and Urodynamics 15(3):
215-21.
s
Saarikoski S,1993. Contraception during lactation. Ann Med, 25(2): 181-
4.
Saartok T, 1984. Steroid receptors in two types of rabbit skeletal muscle.
lnt J Sports Med 5(3): 130-6.
Saatok T, Dahlberg E, Bylund P, Eriksson E, Gustafsson JA.. 1984.
Steroid hormone receptors, protein, and DNA in erector spinae muscle
from scoliotic patients. Clin Orthop 183: 197-207.
198
Bibliography
Samsoie G, 1998. Urogenital aging: a hidden problem. Am J Obstet
Gynecol. 178: S245-S249.
Samuel CS, Butkus A, Coghlan JP, Bateman JF, 1~96.
The effect of relaxin on collagen metabolism in the non pregnant rat
symphasis pubis: the effect of oestrogen and progesterone on regulating
relaxin activity. Endocrinology 137(9) 3884-90
Samuel CS, Coghlan JP, Bateman JF, 1998. Effects of pregnancy and
parturition on collagen metabolism in the rat pubic symphasis
J EndocrinoI159(1) 117-25
Samuel CS, Parry LJ, Summers RJ, 2003. Physiological or
pathological-- a role for relaxin in the cardiovascular system. Curr Opin
PharmacoI3(2): 152-8.
Sanderson PL, Fraser RD, 1996.The influence of pregnancy on the
development of degenerative spondylolisthesis. J Bone Joint Surg Br.
78(6):951-4
Saraste H 1986. Spondylolisthesis and pregnancy, a risk analysis. Acta
Obstet Gynaecol Scand. 65(7): 727-9
199
Bibliography
Saravia F, Revsin V, Lux-Lantos V, Beauquis J, Homo-Delarche F,
De Nicola AF, 2004. Oestradiol restores cell proliferation in dentate
gyrus and subventricular zone of stereptozocin-diabetic mice. J
Neuroendocrino/16(8): 704-10.
Sarwar R, Niclos BB, Rutherford OM, 1996. Changes in muscle
strength, relaxation rate and fatigability during the human menstrual
cycle. J Physio/15(493): 267-72.
Schauberger CW, Rooney Bl, Goldsmith l, Shenton 0, Silva PO,
Schaper A, 1996. Peripheral joint laxity increases in pregnancy but does
not correlate with serum relaxin levels. Am J Obstet. Gynaeco/174(2):
667-71.
Schiessl H, Frost HM, Jee WS, 1998. Oestrogen and bone muscle
strength and mass relationships. Bone 22(3): 290-91.
Schlemmer A, Haassager C, RisteU J, RisteU l, Jenson SB,
Christianson C,1995. Possible variation in bone density during the
normal menstrual cycle. Acta Endocrin%gica 129(5) 388-92
Schwabe C, Bullesbach EE, 1990. Relaxin. Compo Biochem. Physio/. 96
(1):15-21
200
Bibliography
Schwabe C, Bullesbach EE, 1994. Relaxin: structures functions
promises and non evolution. FASEB Journal 8(14) 1152-60
Schw~be C, McDonald JK, 1976. Primary structure otthe A chain of
porcine relaxin. Biochem. Biophys.Res.Comm 70: 397-405.
Schwabe C, McDonald J, 1977. Primary structure of the B chain of
porcine relaxin. Biochem. Biophys.Res.Comm 75: 503-510.
Schwartz NB, 1991.Why I was told not to study inhibin and what I did
about it. Endocrinology, 129(4): 1690-1.
Sciore P, Frank CB, Hart DA, 1998. Identification of sex hormone
receptors in human and rabbit ligaments of the knee by reverse
transcription polymerase chain reaction : evidence that receptors are
present in male and female subjects. J Orthop Res. 16(5): 604-10.
Sherwood OD, 1979. Purification and characterisation of rat relaxin.
Endocrinology104: 886-892.
201
Bibliography
Sherwood OD 1994. Relaxin. The Physiology of Reproduction 2nd
Edition edited by Knobil E and Neil J(New York Raven Press): 861-101.
Sherwood OD, Downing SJ, Guico-Lamm Ml, Hwang JJ, O'Day-
Bowman MB, Fields PA 1993 .. The physiological effects of relaxin
during pregnancy: studies in rats and pigs. Oxford Reviews Of
Reproductive Biology 15: 143-89.
Sherwood OD, O'Byrne EM, 1974. Purification and characterisation of
porcine relaxin. Arch.Biochem.Biophys 160: 185-195.
Shughrue PJ, Lane MV, Merchenthaler 1,1997. Comparative
distribution of oestrogen receptor-alpha and-beta mRNA in the rat central
nervous system. J Comp Neurol. 388: 507-525.
Siebel AL., Gehring HM, Reytomas IG, Parry LJ, 2003. Inhibition of
oxytocin receptor and oestrogen receptor alpha expression, but not
relaxin receptors (LGR7) in the myometrium of late pregnant relaxin gene
knockout mice. Endocrinology 10: 4272-5.
Sihvonen T, Huttenen M, Makkonen M, Airaksinen O. 1998. Functional
changes in back muscle activity correlate with pain intensity and
predictionof low-back pain during pregnancy. Arch Phys Med Rehab
79(10):1210-2
202
Bibliography
Silbergeld EK, Flaws JA, 1999. Chemicals and menopause: effects on
age at menopause and on health status in the postmenopausal period.
J Womens Health(8): 227-234.
Sipila S, 2003. Body composition and muscle performance during
menopause and hormone replacement therapy. J Endocrinollnvest
26(9):893-901
Sirola J, Rikkonen T, 2005. Muscle performance after the menopause.
J Br Menopause Soc 11(2):24-50.
Skelton OA, Phillips SK, Bruce SA, Naylor CH, Woledge RC, 1999.
Hormone replacement therapy increases isometric muscle strength of
adductor pollicis in post menopausal women. Clinical Science 96, 357 -
364
Smith P Heimer G Norgren A Ulmstein U
Steroid hormones in pelvic receptor muscles and ligaments in women
Gynecol Obstet Invest 30(1) 27-20 1990
Smith P Heimer G Norgren A Ulmstein U
The round ligament a target organ for steroid hormones
Gynecol Endocrinol 7(2) 97-100 June 1993
203
Bibliography
Skilling PM, Petros P, 2004. Synergistic non surgical management of
pelvic floor dysfunction second report. Int Urogynaecol J Pelvic floor
dysfunction 15(2): 106.
Skott 0, CarterJM 2002. Relaxin is a vasodilator hormone. Am J Physiol
Regul, Intrgr Comp Physio/ 283(2): 347-348.
Siauterbeck J, Clevenger C, lundberg W, Burchfield OM, 1999.
Oestrogen level alters the failure load of the rabbit anterior cruciate
ligament. J Orthop Res. 17(3): 405-8.
Siauterbeck JR, Fuzie SF, Smith MP, Clark RJ, Xu K, Starch OW,
Hardy OM, 2002. The menstrual cycle, sex hormones, and anterior
cruciate ligament injury. J Ath Train 37(3): 275-278.
Siauterbeck JR, Hardy OM2001. Sex hormones and knee ligament
injuries in female athletes. Am J Med Sci 322(4): 196-9.
Slemenda C, Hui Sl, longcope C, Johnston CC, 1987. Sex steroids
and bone mass: a study of changes about the time of menopause. J Clin
Invest. 80: 1261-1269.
204
Bibliography
Smith P, 1993. Oestrogens and the urogenital tract. Studies on the
steroid hormone receptors and a clinical study on the new oestriadiol
releasing vaginal ring. Acta Obstet Gynaecol Scand Supp1157: 1-26.
Smith P, Heimer G, Norgren A, Ulmsten U, 1990. St~roid hormones in
pelvic receptor muscles and ligaments in women. Gynecol Obstet Invest
30(1): 27-30.
Smith P, Heimer G, Norgren A, Ulmsten U, 1993. Localization of
steroid hormone receptors in the pelvic muscles. Eur J Obstet
Gynecol Reprod Bioi. 50(1):83-5.
Smith P, Heimer G, Norgren A, Ulmsten U, 1993. The round ligament a
target organ for steroid hormones. Gynecol EndocrinoI7(2): 97-100.
Sokol RZ, Wang XS, Lechago J, Johnston PO, Swerdloff RS, 1989.
Immunohistochemical localisation of relaxin in human prostate. J
Histochem Cytochem 37(8): 1253-5.
Spector TO, Nandra 0, Hart OJ, Doyle DV, 1997. Is hormone
replacement therapy protective for hand and knee osteoarthritis in
women. The Chingford Study. Ann Rheum Dis 56(7): 432-4.
205
Bibliography
Stapleton DB, Maclennan AH, Kristiansson P, 2002. The prevalence of
recalled low-back pain during and after pregnancy: a south Australian
population survey. Aust NZJ Obstet GynaecoI42(4) 482-5
Steinetz BG, 2000. Hooked on Relaxin. Proceedings Qf the 3rd
International Conference on Relaxin and Related Peptides 22-27
October Broome Australia 2000:
Steinetz BG, Beach VL, Kroc RL, Stasilli NR, Nussbaum RE, Nemith
PJ, Dun RK, 1960.Bioassay of relaxin using a reference standard; a
simple and reliable method utilising direct measurements of interpubic
ligament formation in mice." Endocrinology 67: 102-115.
Steinetz BG, Randolph C, Mahoney CJ, 1992. Serum concentrations of
relaxin chorionic gonadotrophin, oestradial 17 beta, and progesterone
during the reproductive cycle of the chimpanzee. Endocrinology 130(6):
3601-7.
Steinetz BG, Whittaker PG, Edwards JR, 1992. Maternal relaxin
concentrations in diabetic pregnancy. Lancet 340 (8822) 752-5
Stevens and Low, 1992. Histology. Gower Medical Publishing. London.
206
Bibliography
Stewart OR, Celniker AC, Taylor CA Jr, Cragun JR, Overstreet JW,
lasley Bl, 1990. Relaxin in the peri implantation period. J of Clin
Endocrin and Metabolism 70(6) 1771-3
Stewart OR, Cragun JR, Boyers SP, Oi R, Overstre~~ JW, lasley
Bl,1992. Serum relaxin concentration in patients with out of phase
endometrial biopsies. Fertility and Sterility 57(2) 453-5
Stewart EA, Freidman J, Peck K, Nowak RA, 1994. Relative over
expression of collagen type I and collagen type III messenger ribonucleic
acids by uterine leiomyomas during the proliferative phase of the
menstrual cycle. J Clin Enocrin and Metabolism 79(3) 900-6
Stjernholm V, Sahlin l, Akerberg S, Elinder A, Eriksson HA,
Malmstrom A, Ekman G, 1996. Cervical ripening factor in humans:
potential role of oestrogen progesterone and insulin like growth factor 1.
American J of Obstet and Gynaecol 174(3) 1065-71 March 1996
Stjernholm V, Sahlin l, Malmstrom A, Barkan A, Eriksson HA,
Ekman G, 1997. Potential roles for gonadal steroids and insulin like
growth factor 1during final cervical ripening. Obstetrics and Gynaecology
90(3) 375-80
207
Bibliography
Stoelk E, Chegini N, Lei ZM, Rao CV, Bryant Greenwood G ,Sanfillipo
J, 1991. Immunocytochemical localisation of relaxin inhuman corpa lutea:
cellular and sub cellular distribution and dependence of the reproductive
state. Biology of reproduction 44(6) 1140 -70
,\
Stone C, 1999. Science in the art of osteopathy, Stanley Thomes.
Oxford.
Straneva PA, Maixner W, Light KC, Pedersen CA, Costello NL,
Girdler SS. 2002 Menstrual cycle, beta-endorphins, and pain sensitivity
in premenstrual dysphoric disorder. Health Psychol. 21(4):358-67
Strickland SM, Belknap TW, Turner SA, Wright TM, Hannafin JA,
2003. Lack of hormonal influences on mechanical properties of sheep
knee ligaments. Am J Sports Med 31(2): 210-15.
Sturesson B, Uden G, Uden A, 1977. Pain patterns in pregnancy and
"catching" of the leg in pregnant women with posterior pelvic pain. Spine
22(16): 1880-3
Svenson HO, Gunnar BJ, Andersson J, Hagstad A, Jansson PO,
1990. The relationship of Low-back Pain to pregnancy and gynaecologic
factors. Spine 15(5) 371 -375
208
Bibliography
T
Tan YV, Wade JD, Tregear GW, Summers RJ, 1999. Quantitative
autoradiographic studies of relaxin binding in rat atria .uterus , and
cerebral cortex: characterisation and effects of oestrogen treatment. Br J
Pharm 127(1): 91-8.
Tang XM, Chegini N, 1995. Human fallopian tube as an extra ovarian
source of relaxin: Messenger ribo nucleic acid expression and cellular
localisation of immunoreactive protein 1251 relaxin binding sites. Biology
of Reproduction 52(6): 1343-9.
Taylor AH, AI-Azzawi F, 2000. Immunolocalisation of oestrogen receptor
beta in human tissues. J Mol Endocrinology 24(1): 145-55.
Taylor MJ, Clark CL ,1992. Evidence that basal secretion of relaxin by
individual cultured large luteal cells is influenced by mobilisation of
intracellular calcium : analysis by reverse haemolytic plaque assay.
Cell calcium 13(9) 571-80
te Velde ER, Scheffer GJ, Dorland M, Broekmans FJ, Fauser BC,
1998. Developmental and endocrine aspects of normal ovarian aging.
Mol Cell Endocrinol.(145): 67-73.
209
Bibliography
Teitz CC, Hu SS, Arendt EA, 1997. The female athlete: Evaluation and
Treatment of Sports Related Problems. JAm Acad Orthop Surg 5(2): 87-
96.
1\
Thompson HS, Hyatt JP, De Souza MJ, Clarkson PM, 1997. The
effects of oral contraceptives on delayed onset muscle soreness following
exercise. Contraception 56(2): 59-65.
Tincello OG,Adams EJ, Richmond OH, 2002. Antenatal screening for
postpartum urinary incontinence in nulliparous women: a pilot study. Eur
J Obstet Gynaecol Reprod Bio/10(101(1)): 70-3.
Torgerson OJ, Thomas RE, Reid OM, 1997. Mothers' and daughters'
menopausal ages: is there a link? Eur J Obstet Gynecol Reprod Bioi 74:
63-66.
Toth AP, Cordasco FA 2001. Anterior cruciate ligament injuries in the
female athlete.
J Gend Specifi Med 4(4): 25-34.
u
210
Bibliography
Unemori EN,Amento EP,1990. Relaxin modulates synthesis and
secretion of procollagenase and collagen by dermal fibroblasts
Journal Biological Chemistry 265(18) 10681-5
Unemori EN, Bauer EA, Amento EP, 1992. Rela)'dn alone and in
conjunction with interferon --gamma decreases collagen synthesis by
cultured human scleroderma fibroblasts. J Investigative Dermatology
99(3) 337-42 September 1992
Unemori EN, Beck lS, lee WP, Xu V, Siegel M, Keller G, liggitt HD,
Bauer EA, Amento EP, 1993. Human relaxin decreases collagen
accumulation in vivo in two rodent models of fibrosis. J of Investigative
Dermatology 101(3) 280-5
v
van den Brink Cl, Picavet H, van den Bos GA,Giampaoli S, Nissinen
A, Kromhout D. 2005. Duration and intensity of physical activity and
disability among European elderly men. Disabil rehab 27(6): 341-7
211
Bibliography
van der Esche M, Steultjens M, Wieringa H, Dinant H, Dekker J, 2005.
Structural Joint changes, maJignement,and laxity inosteoarthrosis of the
knee. Scan J Rheum 34(4):298-301
van Dongen PW, de Boer M, lemmens WA, ThElron GB, 1999.
Hypermobility and peri-partum pelvis pain syndrome in pregnant South
African women.Eur J Obstet Reprod Biology 84(1): 77-82
van Noord PA, Dubas JS, Dorland M, Boersma H, te Velde E, 1997.
Age at natural menopause in a population-based screening cohort: the
role of menarche, fecundity, and lifestyle factors. Fertility and Sterility.,
68(1): 95-102.
Varila E, Rantala I, Oikarinen A, Risteli J, Reunala T, Oksanen H,
Punnonen R, 1995. The effect of topical oestradial on skin collagen of
post menopausal women. Br J Obstet Gynaco 10-2(12): 985-9.
von der Recke P, Hansen MA, Hassager e, 1999. The association
between low bone mass at the menopause and cardiovascular mortality.
Am J Med. 106: 273-278.
w
212
Bibliography
Way SA, Leng G 1992. Relaxin increases the firing rate of supra optic
neurones and increases oxytocin secretion in the rat. J EndocrinoI132(1):
149-58.
Weel AE, Uitterlinden AG, Westendorp IC, Burg~r H, Schuit SC,
Hofman A, Helmerhorst TJ, van Leeuwen JP, Pols HA, 1999.
Oestrogen receptor polymorphism predicts the onset of natural and
surgical menopause. J Clin Endocrinol Metab 84: 3146-3150.
Weisinger RS, Burns P, Eddie LW, Wintour EM, 1993. Relaxin alters
the plasma osmolarity-arginine-vasopressin relationship in the rat. J
EndocrinoI137(3): 505-10.
Weiss G, 1991. The physiology of human relaxin. Contributions to
Obstetrics and Gynaecology 18: 130-146.
Weiss G, 1995. Relaxin used to produce the cervical ripening of labour.
Clinical Obstetrics and Gynaecology 38(2): 293-300.
Weiss G, Goldsmith LT, Sachdev R, Von Hagen S, Lederer K, 1993.
Elevated first trimester serum relaxin concentrations in pregnant women
following ovarian stimulation predict prematurity risk and pre term
delivery. Obstetrics and Gynaecology 82(5): 821-8.
213
Bibliography
Weiss G, Goldsmith LT, Schoenfeld C, D'Eletto R, 1986. Partial
purification of relaxin from human seminal plasma. Am J Obstet Gynaecol
154: 749.
Westling L, 1992. Tempero Mandibular Joint dysfunction and systemic
joint laxity. Swedish Dental Journal supplement 81: 1-79.
Wiik A, Glenmark B, Ekman M, Esbjornsson-Liljedahl M, Johansson
0, Bodin K, Enmark E, Jansson , 2003. Oestrogen receptor beta is
expressed in adult human skeletal muscle both at the mRNA and protein
level. Acta Physiol Scand 179(4): 381-387.
Williams RD,1995. Breast feeding best bet for babies. FDA Consumer
Magazine 28 8.
Wilson BC, Summerlee AJ, 1994. Effects of exogenous relaxin on
oxytocin and vasopressin release and the intra mammary pressure
response to central hyper-osmotic challenge.
J EndocrinoI141(1): 75-80.
Windham GC, Elkin EP, Swan SH, Waller KO, Fenster L, 1999.
Cigarette smoking and effects on menstrual function. Obstet Gynecol. 93:
59-65.
214
Bibliography
Winn RJ, O'Day-Bowman MB, Sherwood 00,1993. Hormonal control
of the cervix in pregnant gilts. IV relaxin promotes changes in the
histological characteristics of the cervix that are associated with cervical
softening during the late pregnancy in gilts. Endocrinology 133(1): 121-
81Ju11993.
Winslow JW, Shih A, Bourell JH, Weiss G, Reed B, Stults JT,
Goldsmith LT, 1992. Human seminal relaxin is a product of the same
gene as human luteal relaxin. Endocrinology 130(5): 2660 -2668.
Wiqvist I, Norstrom A, Wiqvist N, 1984. Effects of oxytocin on cervical
and uterine connective tissue. Acta Endocrin (Copenhag) 106(2): 271-6.
Wiqvist I, Norstrom A, Wiqvist N, 1985. Oxytocin and cervical
connective tissue. Acta Physiol Hung 65(3): 323-6.
Wojtys EM, Huston LJ, Boynton MD, Spindler KP, Lindenfeld TN,
2002. The effect of the menstrual cycle on the anterior cruciate ligament
injuries in woman as determined by hormone levels. Am J Sports Med
30(2): 182-8.
Wojtys EM, Huston LJ, Boynton MD, Spindler KP, Lindenfeld TN,
1998. Association between the menstrual cycle and anterior cruciate
ligament injuries in female athletes. Am J Sports Med 26(5): 614-9.
215
Bibliography
Woledge RC, 1996. The relationship between oestrogen and muscle
strength. British Journal of Therapy and Rehabilitation 3(6): 319-321.
Wreje U, Kristiansson P, Aberg H, Bystrom B, von Schoultz B, 1995.
Serum levels of relaxin during the menstrual cycle and oral contraceptive
use. Gynecologic and Obstetric Investigation 29(3): 197-200.
Wu KH, Tobias ML, Kelley DB, 2003. Estrogen receptor expression in
laryngeal muscle in relation to estrogen dependant increases in synapse
strength. Neuroendocrinology 78(2): 72-80.
y
Yadav A, Tandon OP, Vaney N, 2003. Long latency auditory evoked
responses in ovulatory and anovulatory menstrual cycle. Indian J Physiol
Pharm 47(2): 179-84.
Yaffe K, BrownerW, Cauley J, Launer L, Harris T, 1999. Association
between bone mineral density and cognitive decline in older women. J
Am GeriatrSoc. 47: 1176-1182.
216
Bibliography
Yeh JK, Chen MM, Aloia JF, 1997. Effects oestrogen and growth
hormone on skeleton in the ovariectomised rat with hypophysectomy. Am
J Physiol273(4 part 1): E734-742.
Yen SS, 1977. The biology of menopause. J Reprod Med 18: 287.
Yki-Jarvinen H, Wahlstrom T, Seppala M, 1983. Immunohistochemical
demonstration of relaxin in the genital tract of pregnant and non pregnant
women. J Clin Endocrinol Metab. 57(3): 451-4.
Yu WO, Liu SH, Hatch JO, Panossian V, Finerman GA, 1999. Effect of
oestrogen on cellular metabolism of the anterior human cruciate ligament.
Clin Orthop 366: 229-38.
Yu WO, Panossian V, Hatch JO, Liu SH, Finerman GA, 2001.
Combined effects of oestrogen and progesterone on the anterior cruciate
ligament. Clin Orthop 383: 268-81.
z
Zhang B, Roth RA, 1992. The insulin related receptor. Tissue
expression, ligand binding specificity, and signalling capabilities.
J Chem 8;01267(26) 18320-18328
217
Bibliography
Zhao S, Sherwood OD, 1998. Monoclonal antibodies specific for rat
relaxin X _ Endogenous relaxin induces changes in the histological
characteristics of the rat vagina during the second half of pregnancy.
Endocrinology 139(1) 4726-34
218
The Appendices
The Appendices
219
The Appendices
Appendix One
The Histology and Physiology of Collagen
Of all of the non-mineral constituents of the mammalian body there is
more collagen than anything else other than water and possibly fat.
Nevertheless our understanding of the physiology of collagen is
rudimentary (Rennie MJ 1999).
All cells and tissues are supported by a network of collagen fibres, the
arrangement of which appears to be specifically site adaptive. All
collagen molecules are made within fibroblasts (or modifications of them
such as osteocytes). The large collagen molecule is secreted in a soluble
form, with hydrophilic ends which are enzymatically cleaved to leave the
insoluble core collagen, called tropocollagen, in the extra cellular space.
Collagen is has a high tensile strength due to the cross linking which
makes it resistant to many proteases other than collagenase.
Collagens are a family of closely related proteins and are the most
abundant and important extra cellular fibrillar proteins.
The main role of collagen is to provide tensile strength to tissues by
forming collagen fibres; in addition one type of collagen forms the
structural scaffold of basement membranes.
Fibrillar collagen is formed from three polypeptide (alpha) chains
consisting of repeating sequences of 3 amino acids, 2 of which are
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proline or Iycine or glycine and the third another. These are initially
secreted with both amino and carboxyl terminal extensions to prevent
collagen forming inside cells. Initial assembly of these chains is into a
triple helix called procollagen.
Cleavage of the amino and carboxyl extensions to leave the functional
mid section, tropocollagen, allows the molecules to align themselves into
linear arrays to form long filaments. The individual collagen molecules are
300 nm long, and give rise to a periodicity of 67 nm.
The initial filaments or collagen micro-fibrils become arranged into fibrils
are arranged with a 67 nm overlap between adjacent molecules. This and
the fibres into larger bundles by tight cross linking between adjacent
molecules via lysine residues; this contributes to the mechanical strength
of collagen in tissues.
There are at least 20 different types of alpha chain which combine to
produce different forms of collagen. Type III and III collagen are arranged
as rope like fibrils and are the main forms of fibrillar collagen.
Collagen fibres have a high tensile strength, thus their orientation and
cross linking varies according to the local environment.
Reticular fibres (also called reticulin) are thin fibrils (20nm in diameter) of
type III Collagen They form a loose mesh in many support tissues and
are particularly evident in a zone beneath basement membranes where
they are thought to have a support function as part of the fibro-reticular
lamina.
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Reticular fibres can be considered fine scaffolding supporting specialised
extra cellular matrix components. In lymph node, spleen, and bone
marrow, they fibres form the main extra cellular matrix fibres supporting
the haemopoietic and lymphoid tissues. In parenchymal organs, such as
the liver and kidneys, reticular fibres form a network supporting
specialised epithelial cells.
Type I II III IV V VI
small small
Morphology Large banded banded banded sheetlike thin fibrils thin fibrils
collagen fibre collagen collagen layers
fibre fibre
blood
skin dermis,
vessels,
tendon, hyaline and parenchymal basement
bone,ligaments, elastic organs,bone
basement membranes
fascia, fibrous cartilage, marrow,
membranes, of placenta,
Distribution cartilage, vertebral lymphoid
external smooth and ubiquitous
discs, tissue, laminaecornea, loose
vitrious of smooth lens capsule
skeletal
connective muscle
tissue the eye muscle,nerves,lung,
foetal skin
Type VII VIII IX X XI
short striated uncertain uncertain uncertain uncertainfibrils
anchoring fibrils
in basement mineralising
membrane of endothelium cartilage cartilage
skin and
cartilage
amnion
Figure 34: Molecular Forms of Collagen from Histology by Stevens and Lowe (Stevens
A and Lowe J 1992)
Type IV collagen assembles into a mesh network rather than fibrils and is
restricted to basement membrane formation.
Type VII collagen forms the anchoring fibres of some basement
membranes.
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Although the main cells producing collagen are fibroblasts, it can also be
produced by other mesenchyme derived cells (of the support cell family,)
as well as by a variety of epithelial and endothelial cells which produce
the type IV collagen of basement membranes.
Tendons consist of collagen (mostly type I collagen) and elastin
embedded in a proteoglycan-water matrix with collagen accounting for
65-80% and elastin approximately 1-2% of the dry mass of the tendon.
These elements are produced by tenoblasts and tenocytes, which are the
elongated fibroblasts and fibrocytes that lie between the collagen fibres,
and are organized in a complex hierarchical scheme to form the tendon
proper. Soluble tropocollagen molecules form cross-links to create
insoluble collagen molecules which then aggregate progressively into
microfibrils and then into clearly visible units when viewed with an
electron microscope, these are the collagen fibrils.
A bunch of collagen fibrils forms a collagen fibre, which is the basic unit of
a tendon.
A fine sheath of connective tissue called endotenon invests each collagen
fibre and binds fibres together. A bunch of collagen fibres forms a primary
fibre bundle, and a group of primary fibre bundles forms a secondary fibre
bundle. A group of secondary fibre bundles, in turn, forms a tertiary
bundle, and the tertiary bundles make up the tendon. The entire tendon is
surrounded by a fine connective tissue sheath called epitenon.
The three-dimensional ultra structure of tendon fibres and fibre bundles is
complex. Within one collagen fibre, the fibrils are oriented not only
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longitudinally but also transversely and horizontally. The longitudinal
fibres do not run only parallel but also cross each other, forming spirals.
Some of the individual fibrils and fibril groups form spiral-type plaits. The
basic function of the tendon is to transmit the force created by the muscle
to the bone, and, in this way, make joint movement possible. The
complex macro- and microstructure of tendons and tendon fibres make
this possible. During various phases of movements, the tendons are
exposed not only to longitudinal but also to transversal and rotational
forces. Inaddition, they must be prepared to withstand direct contusions
and pressures.
This description of the three-dimensional internal structure of the fibres
forms a buffer medium against forces of various directions, thus
preventing damage and disconnection of the fibres (Kannus, 2000).
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Appendix Two
Muscle fibre types
Different muscles are characterised by different physiological and
metabolic properties, which are determined by differences in the structure
of their constituent muscle fibres. In both animals and man it has been
possible to define several sub types of muscle fibre by macroscopic,
physiological., biochemical and histological criteria. Histochemical
staining for specific enzymes delineates several types of fibre. Two main
types of fibre are identified, the type 1 and the type 2 fibres. Type 2 fibres
are further su7bdivided into types 2A 28 and 2C. Not all muscles have
the same proportion of type 1 and type 2 fibres. In generaL, muscles with
a role in maintaining posture such as the calf muscles have a higher
proportion of type 1 fibres and are designated "fast twitch" fibres. While
muscles used for short bursts of power are designated "slow twitch"
fibres.
Fibre Type Colour Metabolism Contractile
behaviour
1 intermediate oxidative Slow twitch
2A red Oxidative and Fast twitch
glycolytic fatigue resistant
2B white glycolytic Fast twitch
fatigue sensitive
Figure 35: The Physiological features of different skeletal muscle fibre types
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Comparison of fast twitch (the gastrocnemius/plantaris complex) and slow
twitch (soleus) muscles revealed that the latter contained higher
concentrations (expressed per gram of tissue wet weight) of
glucocorticoid and oestrogen receptors but not androgen receptors.
Expressed per milligram of soluble protein, the slow twitch fibres
contained higher concentrations of all three receptors. When related to
the concentration of DNA, only the concentration of oestrogen receptors
was higher in the slow twitch muscles.
Different response of the two fibre types to the direct action of the steroid
hormones can therefore be expected. The fast twitch muscle contained a
higher concentration of soluble protein, whereas the slow twitch muscle
contained a higher concentration of DNA, resulting in lower protein /DNA
ration Le. smaller cell units in the slow twitch muscles, soleus v
gastrocnemius.
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Information leaflet for the questionnaire
My name is Stephen Sandler and I am an osteopath registered with The
General Council and Register of Osteopaths.
I am currently engaged in researching into women's musculo skeletal
injuries in relation to the timing of the menstrual cycle.
This will involve volunteers being asked a short serious of questions by
your osteopath prior to your treatment. The questions will ask you about
the length of your menstrual cycle. Only those women who have a regular
and predictable menstrual cycle are being asked to take part in this
research. Also only those women who are not using any hormone
preparations such as Hormone Replacement Therapy (HRT), an oral
contraceptive, or hormone implants are being asked to take part in the
study because the menstrual cycles of those patients is not under the
control of a natural hormone profile.
The wholes thing will take less than five minutes and the results are kept
anonymous so that individual responses cannot be identified. When your
osteopath has collected the data they will be sent back to me.
If for any reason you decline to take part in the study please tell the
osteopath who will then go on to choose someone else.
Ethical approval for the study has been given by the Ethical Research
Committee at The British School of Osteopathy.
Thank you
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Information leaflet for menstrual cycle study:
My name is Stephen Sandler and I am an osteopath in private practice
registered with the General Osteopathic Council.
I am currently engaged in a research project that is investigating laxity in
ligaments in women of various ages.
The project will involve you being measured at specific times over the
next few weeks. The measurement involves you having your finger
measured for joint looseness. It is a painless procedure that takes just a
few seconds.
At the same time as the joint measurement I will need to take a small
sample of blood from a vein in your arm. This blood will be analysed at
the Chelsea and Westminster Hospital for levels of the hormones
Oestrogen, Progesterone and Relaxin which are present during your
menstrual cycle. All samples will be destroyed after the results have
been obtained. In this way it is hoped that I will be able to see if there is a
change in the looseness of the finger joint which corresponds to changes
in hormones present in a woman's menstrual cycle. You do not need to
undress for the procedure to be performed, and it will take place at a time
and place convenient to you. You are free to withdraw from the study at
any time and all of the results from the study will be printed such that they
are completely anonymous.
Ethical approval for the study has been given both by the Ethical
Research Committee at the British School of Osteopathy and at the
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Chelsea and Westminster Hospital who will analyse the blood at the end
of the study.
If you feel that you are happy to take part in the study please sign and
date the attached consent form.
Thank you
229
The Appendices
Information leaflet for the men involved as the control
group for the menstrual cycle study:
My name is Stephen Sandler and I am an osteopath in private practice
registered with the General Osteopathic Council.
I am currently engaged in a research project that is investigating laxity in
ligaments in women of various ages. Men are being measured too as a
control group because the main hypothesis of the study is that it is the
level of circulating female hormones that has a part to play in changing
laxity in women's joints. If the hypothesis is correct the men in the control
group will not change.
The project will involve you being measured at specific times over the
next few weeks. The measurement involves you having your finger
measured for joint looseness. It is a painless procedure that takes just a
few seconds. You do not need to undress for the procedure to be
performed, and it will take place at a time and place convenient to you.
You are free to withdraw from the study at any time and all of the results
from the study will be printed such that they are completely anonymous.
Ethical approval for the study has been given by the Ethical Research
Committee at The British School of Osteopathy.
If you feel that you are happy to take part in the study please sign and
date the attached consent form.
Thank you
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Information leaflet for the pregnancy, post natal and the
menopause studies:
My name is Stephen Sandler and I am an osteopath in private practice
registered with the General Osteopathic Council.
I am currently engaged in a research project that is investigating laxity in
ligaments in women of various ages.
The project will involve you being measured at specific times over the
next few weeks. The measurement involves you having your finger
measured for joint looseness. It is a painless procedure that takes just a
few seconds. You do not need to undress for the procedure to be
performed, and it will take place at a time and place convenient to you.
You are free to withdraw from the study at any time and all of the results
from the study will be printed such that they are completely anonymous.
Ethical approval for the study has been given by the Ethical Research
Committee at The British School of Osteopathy.
If you feel that you are happy to take part in the study please sign and
date the attached consent form.
Thank you
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Consent Form:
NAME .
ADDRESS .
............................................................
I herby give my informed consent to take part in the study entitled
Which I understand is a research study approved by the Ethics
Committee of The British School of Osteopathy and of the Chelsea and
Westminster Hospital.
I have read and had explained to me the attached information leaflet and
I understand that I can withdraw from the study at any time.
S·Igned ..
Dated .
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